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CHAPTER ONE: glycomimetics 
Sugars are the most abundant class of organic molecules on Earth. They are essential components of life and 
are some of the most complex natural oligomeric structures present in Nature. Glycans can be found as 
monosaccharides, that are the principal source of energy for cellular metabolism, and as polysaccharides or 
glycoconjugates (with proteins or lipids), that are involved in many other important biological processes.1-2  
They coat the cell surface of every organism, creating a nanolayer (called glycocalix) that plays a crucial role 
in the interaction with the surrounding biological environment. 3-4  
Although the structures of the monosaccharidic units were first elucidated by Fischer in the mid-1880s, it 
took nearly a century before scientists began to appreciate the complex roles of carbohydrates.5 Maybe this 
delay was due to the high density of functional groups, the large variety of glycans and their structural and 
synthetic complexity that made the comprehension of their biological functions an incredible challenge, 
certainly more complicated compared to proteins and nucleic acids. 
Nowadays, it is well known that glycans play an essential role in many biological events including cellular 
adhesion and migration, organism development, disease progression and the modulation of immunological 
responses.6-8 Recently, an increased understanding of the glycans ability to encode a large number of 
biochemical information, in both physiological and pathological conditions, has inspired numerous efforts 
towards an intensive investigation about glycobiological and glycochemical processes.  In particular, it was 
recognized the crucial role played by carbohydrates in recognition events involved in a large number of 
normal cell functions which are found to be decisive in the first stages of inflammation, cancer proliferation 
and infection processes. This is the main reason why glycosidic and pseudo-glycosidic molecules are being 
increasingly involved in drug discovery for the treatment of diverse pathologies.9 Furthermore, the recent 
development of new tools and techniques to study and produce structurally defined carbohydrates has 
spurred renewed interest in the therapeutic applications of glycans. 
The often insufficient metabolic stability of carbohydrate-based drugs, which compromises both their 
bioavailability and potency, have pushed the development of chemically modified analogues designed as 
potential alternative therapeutic agents. Recently, the meaning of carbohydrate mimetics has been 
reformulated by the scientific community and now it is mainly used to refer to any compounds that have 
been demonstrated to truly mimic the structural and functional aspects of the corresponding natural 
carbohydrates. These glycomimetics potentially show enhanced enzymatic stability and, at the same time, a 
better selectivity towards the desired protein-target.  
In the list of the main objectives pursued by synthetic chemists that modify the natural structure of 
carbohydrates, we can include: 
- increasing the metabolic and chemical stability of the compounds 
Chapter one 
4 
 
- improving the interaction with receptors/enzymes through the insertion of proper functionalities in the 
molecule 
- providing functionalities for chemoselective ligation to other chemical entities, such as  proteins, lipids, 
solid supports or nanoparticles. 
The main goal of using glycomimetics, e.g. as therapeutic agents, is the manipulation of the chemical 
information encoded by sugars, controlling and altering the flow of information they direct. Thus, sugar 
mimics can become fundamental tools for the investigation of biological processes and interesting candidates 
for the development of new drugs. 
Although these structures still remain challenging from a synthetic point of view, the noteworthy 
development of carbohydrate chemistry has led to a wide variety of structural modifications to generate 
glycomimetics with improved drug-like characteristics and in vivo stability. Generally speaking, two major 
groups of sugar mimics have been devised by replacement of either the endo-or exo-cyclic oxygen atom with 
another atom (e.g. carbon, sulphur, nitrogen), effectively disrupting the reactivity of the anomeric position. 
These modifications therefore induce a change in the chemical and enzymatic stability, polarity, charge, 
conformation, ring flexibility, and hydrogen-bonding pattern of the molecule, influencing at the same time 
their affinity for the target protein.10  
In the next chapters (1.1-1.3), some of these glycomimetics will be introduced and discussed mainly from a 
synthetic point of view. 
1.1 Endocyclic oxygen replacement 
Some examples of glycomimetics obtained through the replacement of the endocyclic oxygen are reported 
below (Fig. 1.1). 
 
Fig. 1.1 Examples of glycomimetics obtained through the replacement of the endocyclic oxygen atom 
1.1.1 Iminosugars 
Iminosugars (called also azasugars or iminosaccharides) are obtained through the substitution of the 
endocyclic oxygen atom with a nitrogen.11 Without any doubt, they are the most outstanding class reported 
so far in the field of glycomimetics. One of the reasons is their application as candidates for the treatment of 
various diseases, including cancer, diabetes, viral infections and lysosomal storage disorders, such as Gaucher 
and Fabry diseases.12 
Iminosugars have been reported as potent inhibitors of carbohydrate processing enzymes such as glycoside 
hydrolases, glycosyltransferases or glycogen phosphorylases.13-14 Their inhibitory potency against 
glycosidases was demonstrated to depend on the structural and electronic similarity to the transition state 
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of the natural substrate, preventing the normal hydrolysis/glycosylation process: at phisiological pH, the 
ammonium cation shows close resemblance to the typical carbocation/oxocarbenium ion.15 
These glycomimetics can be classified into two major groups: monocyclic (pyrrolidines, piperidines or seven 
membered azepanes) and bicylic iminosugars (pyrrolizidines, indolizidines or nortropanes), both classes have 
been recently exstensively reviewed.13, 15 Here I will highlight some of the more recent and innovative results 
in this field.  
In 2014, in the Crich’s laboratory a set of hydroxylamine-linked di- and trimeric polyhydroxypiperidines were 
synthetized, with the aim of creating mimetics of β-(13)-glucans (Fig. 1.2).16 
 
Fig. 1.2 Hydroxylamine-linked di- and trimeric polyhydroxypiperidines as mimetics of β-(1->3)-glucans 
β-(13)-glucans are well-known immunomodulating agents that occur widely in nature. However, the 
difficulties in the isolation of pure oligomers have stimulated considerable interest in the chemical synthesis 
of their mimetics. The corresponding hydroxylamine-based structures, in particular, were found to inhibit 
binding of anti-CR3 and anti-dectin-1 fluorescent antibodies to their respective binding sites and to stimulate 
phagocytosis. 
Recently it was reported that multivalent iminosugars (obtained through a number of different conjugation 
chemistry to a variety of scaffolds) allowed a significant enhancement of inhibitory activity per ligand unit 
and a remarkable selectivity against a panel of glycosidases when compared to their monovalent 
derivatives.17-18 
Recently, also fluoro–containing iminosugar C-glycosides have gained the attention of the scientific 
community for their promising inhibitory activity against various glycosidases. The impact of fluorine atoms 
on the glycosidases inhibition potencies of iminosugars still remains not predictable, because this 
modification might deeply influence the hydrophobicity or the electron density of the molecule, as well as 
the pKa of the amine function.19 Behr and his team have recently reported the synthesis of iminosugars that 
bear a perfluoroalkyl chain at the pseudo-anomeric position, where the key synthetic step is the 
stereoselective nucleophilic addition of fluorinated Grignard reagents onto a cyclic nitrone (Fig. 1.3).20  
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Fig. 1.3 Structure of iminosugars bearing a perfluoroalkyl chain at the pseudo-anomeric position (on the left); the key step of 
stereoselective nucleophilic addition of Grignard reagent onto a cyclic nitrene (on the right) 
These two fluorinated iminosugars with a perfluoropropyl or a perfluorobutyl chain were tested against a 
panel of glycosidases: while the introduction of a C4F9 group (Fig. 1.3, compound 1.2) proved to be 
deleterious for enzyme binding, the presence of C3F7 (Fig. 1.3, compound 1.1) moiety afforded potent and 
selective inhibition of α-fucosidase and α-glucosidase from yeast.  
1.1.2 Carbasugars 
The substitution of the ring oxygen in carbohydrates by a methylene group leads to a group of glycomimetics 
called carbasugars. This substitution abolishes the anomeric effects, modifies the intramolecular hydrogen-
bond pattern, modulates the amphiphilicity of the sugar ring and results in changes of the flexibility and 
conformation population distributions.21 Furthermore, the lack of anomeric reactivity implies an increased 
metabolic stability towards glycosidases and glycosyltrasferases. 
The term carbasugar was first proposed by McCasland et al. in 1966.22 Since then, carbasugars have been 
extensively studied and some of the synthetized compounds were later found in Nature, such as myo-inositol, 
validamycin (antibiotic) and acarbose (commercialized by Bayer to treat obesity and Type 2 diabetes mellitus, 
Fig.1.4).23  Some of these compounds revealed high therapeutic potential, a condition that has led to a 
growing interest in the development and identification of new carbasugars.24-25 
An authorative review article about the synthetic methodologies and the conformational and the biological 
aspects of carbasugars was published by Plumet et al. in 200726 and has been recently updated and extended 
to include both carbapyranoses and carbafuranoses.27 
 
Fig. 1.4 Examples of bioactive carbasugars 
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Most of the synthetic procedures to generate carbasugars, that have found wide application, are based on 
Ferrier rearrangement, the Hg2+ promoted process shown in Fig. 1.5.28 
 
Fig. 1.5 Ferrier rearrangement 
The proposed mechanism for the rearrangement of compound 1.3 is described below (Fig. 1.6) and it goes 
through the hydroxymercuriation of the terminal olefin 1.3 producing an hemiacetalic species 1.3a as the 
first intermediate. Loss of MeOH from 1.3a generates an aldehyde and a mercury enolate that cyclize by 
intramolecular aldol condensation to form the carbocycle 1.4 as the product. 
 
Fig. 1.6 Proposed mechanism for Ferrier rearrangement of 1.3 
The method has been strongly improved replacing HgCl2 with AlBu3 (TIBAL) or Ti(OiPr)Cl3 which, upon 
coordination of the anomeric and the C-2 oxygens, allows the rearrangement to proceed while maintaining 
the glycosidic bond. Interestingly, this protocol can be applied to disaccharides (e.g. 1.5, Fig. 1.7) generating 
disaccharidic cyclitols.29 
 
Fig. 1.7 Generation of disaccharidic cyclitols 
In 2009, a tandem isomerisation lactonization pathway has been proposed for the construction of 
carbasugars (Fig. 1.8).30 In this pathway methylenation of the non-reducing end of the sugar generates an 
allyl ether (1.7, Fig. 1.8) which, in a photochemical reaction catalyzed by Fe(CO)5, isomerises into a vinyl ether 
that spontaneously undergoes the aldol cyclisation, forming the carbasugar core (1.8). 
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Figure 1.8 Synthesis of cyclitols exploiting a photochemical protocol 
Also the ring-closing metathesis reaction has been used to generate carbasugars from the corresponding 
sugars.31 The general strategy, reported in Fig. 1.9, involves the insertion of two double bonds in the sugar 
skeleton, one at the reducing end and the other at the non-reducing end. Finally, the carbasugar is obtained 
using Grubb’s catalyst.32 
 
Figure 1.9 Synthesis of cyclitols exploiting a ring-closing metathesis reaction 
In 2017, Mayer and co-workers proposed the synthesis of mono-fluoro-modified carba variants of α-D-
glucosamine and β-L-idosamine as synthetic mimics of the natural glmS ribozyme ligands (see chapter 1.2 for 
all the synthetic details).33 In particular, for the construction of the carbocyclic moiety of compound 1.15, 
they also exploited the Ferrier reaction. In particular, the Ferrier carbocyclization of 1.14 (Fig. 1.10) was 
performed under catalytic conditions to generate the carbocyclic compound 1.15 as a mixture of 
diastereoisomers.34 
 
Figure 1.10 Synthesis of the carbacyclic compound 1.15 through Ferrier carbocyclization of 1.14 
In 2016 the synthesis of aminocyclitols, an amino-carbasugar structural motif found in a variety of 
aminoglycoside antibiotics,35 was proposed (Fig. 1.11). 
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Figure 1.11 Synthesis of aminocyclitols 
The synthesis started with the conversion of the tri-O-benzyl-D-glucal 1.20 to 2-deoxy-2-sulfonamido-D-
glucose 1.19, following a modified procedure of the Danishefsky reaction.36 Selective debenzylation of the 
primary benzyl ether of 1.19 and bis-acetylation afforded compound 1.18, that was reduced (using LiAlH4) 
and at the same time opened to give a diol as intermediate. This intermediate underwent protection 
(silylation), benzylation of the amino group and deprotection (desilylation) to obtain diol 1.17, that was 
oxidized to aldehyde 1.16 under Swern conditions (DMSO and oxalyl chloride) in order to generate a suitable 
substrate for McMurry coupling.37 
Carba-cyclophellitols 1.24 (Fig. 1.12) were originally reported by Hashimoto and co-workers38 via Simmons-
Smith cyclopropanation of cyclohexene 1.23. The class was recently expanded by Overkleeft and his team 
that prepared the corresponding cyclophellitol 1.21 and cyclophellitol aziridine 1.22 (Fig. 1.12),39 using Ethyl 
DiAzoacetate (EDA) as the cyclopropanating agent.40-41 Their optimized synthetic pathway allowed the 
construction of gluco- and galacto-pyranose-configured cyclophellitol cyclopropanes, as potential enzyme 
inhibitors (1.25, 1.40; Fig. 1.14) 
 
Fig. 1.12 Simmons-Smith cyclopropanation reaction of cyclohexene 1.23 (on the left); cyclophellitol 1.21 and cyclophellitol aziridine 
1.22 proposed as carbohydrate mimics by Overkleeft39 
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Fig. 1.13 Gluco- and galacto-pyranose-configured cyclophellitol cyclopropanes 
The rise of drug-resistant influenza A virus strains led to great efforts in the development of new antiviral 
drugs, with different structural motifs and functionalities. Recently, a bicyclic (bicyclo[3.1.0]hexane, with 
general structure of 1.41 reported in Fig. 1.14) analogue of sialic acid was designed to mimic the 
conformation adopted during enzymatic cleavage within the neuraminidase (NA; sialidase) active site. 42  
 
Fig. 1.14 Bicyclo[3.1.0]hexane scaffolds as analogues of sialic acid  
Retrosynthetically, these derivatives were synthetized through a Johnson-Corey-Chaykovsky 
cyclopropanation (that allowed systematic variation of the relative stereochemistry of the scaffold’s 
stereocenters) that followed a photochemical pyridine ring contraction. 
The compounds displayed 'slow-binding' time-dependent inhibition of N1 and N2 sialidases with IC50 values 
in the micromolar range. The strongest inhibition exhibited by these compounds (IC50= 10 μM) was observed 
with compound 1.41a (R = 4-phenylbenzyl). 
To further develop the structure activity relationship of this new scaffold, a second set of compounds was 
synthesized in order to analyze the effect of replacing the amino group of 1.41 with a larger guanidium moiety 
and to probe the role of the ether side chain (compounds of general formula of 1.42, Fig. 1.15).43 
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Fig. 1.15 General structure of new sialidase inhibitors bearing a guanidium moiety (on the top); general synthetic strategy (on the 
bottom) 
The introduction of a guanidium group as a substituent took inspiration from the example of Zanamivir, 
where the presence of this motif is crucial for the antiviral activity.44 In this work, a new, much simplified 
synthetic route for the bicyclo[3.1.0]hexane framework was adopted, starting from cyclopropanation of 
cyclopentenone followed by aziridination and further functionalization of the five membered ring. This 
strategy allowed the efficient preparation of a small library of 10 bicyclic ligands (Fig. 1.15), densely 
functionalized, designed with the aid of molecular modelling to engage in additional interactions within the 
NA binding site. However, these compounds were tested against various influenza A neuraminidases and 
none of the new structural variants displayed activity at concentrations less than 2 mM. 
Another class of antiviral molecules, where the carbasugar moiety was introduce in order to both mimic the 
natural ligand conformation and improve the metabolic stability, has the lectin DC-SIGN as protein target. 
DC-SIGN (see Chapter 2.1) is known to be involved in the recognition of viruses and pathogens at the mucosal 
level and it contains a binding site selective for mannose- and fucose-based carbohydrates. In 2016, the 
synthesis of the pseudo-disaccharide 1.43 (Fig. 1.16), containing a mannose connected with a D-
carbamannose unit, was reported: these structures were designed to mimic the minimal natural epitope 
Manα(1,2)Man 1.44 of DC-SIGN.45 
 
Fig. 1.16 Chemical structures of pseudo-disaccharide 1.43 as carba-analogue of epitope 1.44. 
The stereoselective synthesis of pseudo-disaccharides 1.43 proceeded through the construction of the 
precursor 1.47 by glycosylation of the carbamannose glycosyl acceptor 1.46 with tetrabenzoyl mannose 
trichloroacetimidate 1.45 as typical glycosyl donor (Fig 1.17). 
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Fig. 1.17 Glycosylation reaction between donor 1.45 and acceptor 1.46 to obtain the pseudo-disaccharide 1.47 
The synthesis of 1.46 started from the construction of the carbocyclic system 1.49 through a Claisen 
rearrangement developed by Sudha and Nagarajan46 to the glycal substrate 1.48 (Fig. 1.18). 
 
Fig. 1.18 Synthesis of the acceptor 1.46 starting from the glycal substrate 1.48 
Allyl alcohol 1.49 is stereoselectively epoxidized by m-CPBA, which reacts with the double bond face syn to 
the allyl hydroxy group affording epoxide 1.50 as the only reaction product. Followed the ring opening with 
azido-ethanol in a copper catalysed process in the presence of a Lewis Acid to give the cyclohexanol derivative 
1.46. 
1.1.3 Thio sugars 
Thio-sugars are carbohydrate mimics obtained by replacement of the endocyclic oxygen atom with a sulphur 
atom, in both furanose and pyranose structures.47-48 Due to the unique conformational and electronic 
properties imparted by the sulphur atom, these compounds have found widespread applications as 
glycosidase inhibitors, demonstrating potent biological activity as antiviral, antidiabetic or anticancer 
compounds. 49-50 
Recently, it was demonstrated that the introduction of the endocyclic sulphur atom can be achieved via thiyl 
radical mediated cyclization. This process has been extensively investigated for the preparation of 
carbohydrate derivatives, due to the mild reaction conditions, the high yields and the tolerance to a wide 
range of functional groups. The Scanlan group has recently reported the application of the intramolecular 
thiol-ene and thiol-yne cyclisation reaction for the preparation of both thiosugars and thioglycals.51 This 
approach allows the construction of both thiofuranoses and thiopyranoses from a single acyclic starting 
material, usually obtained from commercially available O-benzyl protected sugars (see compound 1.52 in Fig. 
1.19), subsequently modified into the corresponding alkene-glycosyl thiol derivatives through a multistep 
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process that involves a Witting olefination and an SN2 displacement of the triflate group by KSAc and finally 
the hydrolysis of the thioester to the corresponding thiol.  
 
Figure 1.19 Example of intramolecular thiol-ene cyclisation reaction for the preparation of thiosugars 
In Fig. 1.19 the main strategy of this work is described. It involves the formation of the thiyl radical 1.53 (upon 
photochemical irradiation and using 2,2-Dimethoxy-2-phenylacetophenone (DPAP) as photoinitiator) 
followed by intramolecular thiol-ene cyclisation that leads to both the 5-exo and the 6-endo products.52 The 
free-radical version of the intramolecular thiol-yne cyclisation reaction was investigated again by Scanlan and 
co-workers.53 
 
Fig. 1.20 The free-radical version of the intramolecular thiol-yne cyclisation reaction proposed by Scanlan et al.53 
The introduction of the alkyne function onto 2,3,5-tri-O-benzyl arabinose 1.56 was perfomed through Colvin 
rearrangement, via a lithiated trimethylsilyl diazomethane intermediate (Fig. 1.20). Afterwards, the thioester 
1.58 was obtained by treatment of alchol 1.57 with triflic anhydride followed by nucleophilic displacement 
with KSAc. Finally, the Zemplén conditions (Na, MeOH) promoted spontaneous formation of the 5-exo-glycal 
product 1.59. 
1.1.4 Oxaphosphinanes 
Another class of carbohydrate mimetic structures obtained through an endocyclic modification is 
represented by phosphorus-based sugars, where the ring oxygen or the anomeric carbon are replaced by a 
P=O group. These compounds have received continuous attention in the past 20 years as sugar analogues 
because of considerable interest in their physiochemical properties and potential biological activity. 
Depending on how the phosphorous atom is inserted into the cycle, three main classes of compounds can be 
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obtained: phospha-sugars, phosphono-sugars (or phostones) and phosphino-sugars (or phostines), 
schematically reported below (Fig. 1.21). 
 
Fig. 1.21 General classification of phosphorous containing glycomimetics 
Generally, these compounds, containing a phosphoryl bond (P=O), show high Lewis/Brønsted basicity.54 As 
observed with glycopyranoside derivatives, phosphorus six-membered rings show also stereoelectronic-
dependent interactions with phosphorus atoms that are closely related to the anomeric effect.55 Another 
important feature of oxaphosphinanes is that such phosphorus heterocycles are considerably more resistant 
to the ring-opening/closure processes occurring between the open-chain and the cyclic pyranose forms.56-57 
1.1.4.1 Phospha-sugars 
The compounds obtained through the replacement of the ring oxygen with a phosphorous atom are called 
phospha-sugars. Hanaya with his team have dedicated an intense activity to the investigation and the 
development of new methods for the introduction of a phosphinyl group into the sugar skeleton. In 2002, 
they published a procedure for the preparation of D-mannopyranose analogues (with general structure of 
1.60, Fig. 1.22).58 
 
Fig. 1.22 D-mannopyranose phospha-sugar analogue 
In details, the synthetic pathway started from the α-D-mannofuranoside 1.61 that underwent epoxidation 
under Mitsonobu conditions affording derivative 1.62 (Fig. 1.23). Epoxide opening by treatment with BnONa 
led to the 6-O-benzyl compound 1.63, which after a Swern oxidation led to the key intermediate 1.64 where 
the phosphonyl group was introduced as dimethyl-phosphonate, in the presence of DBU as a base. This 
reaction generated two epimers in C(5): the major product 1.65a was converted in methoxalyl ester 1.66a 
and then reduced with Bu3SnH to afford a mixture of the 5-deoxy products. 
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Fig. 1.23 Synthetic pathway of phospha-sugars proposed by Hanaya et al.58 
The desired mannofuranoside derivative (1.67a) was obtained in minor quantity respect to the 
gulofuranoside isomer (1.67b). However, 1.67a was then reduced to generate the 5-phopshino derivative 
1.68, which after acetal ring opening in acidic conditions and oxidation with H2O2 afforded the phospha-
mannopyranose 1.69 (or 1.70, by treatment with Ac2O/pyridine and then ethereal CH2N2) (Fig. 1.24). 
 
Fig. 1.24 Synthetic pathway of phospha-sugars 1.71a-d proposed by Hanaya et al.58 
To allow the separation of the diastereomeric mixture through chromatographic column, compound 1.70 
was converted into the corresponding penta-acetates 1.71a-d. 
The same strategy was then employed and optimized for the synthesis of other phospha-sugars.59-60 
1.1.4.2 Phosphono-sugars (phostones) 
Phosphono-sugars (or phostones) are obtained replacing the anomeric carbon with a phosphonate group. 
Their similarity to natural carbohydrates suggested that they should have interesting and potentially useful 
biological properties. 
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One of the first example reported in literature for the synthesis of phosphono-sugars (phostones) was 
reported by Hanessian in 1999.61 The target molecule 1.73 (Fig. 1.25) was an analogue of phosphoramidon 
1.72, a compound derived from cultures of Streptomyces tanashiensis with activity as inhibitor of the enzyme 
thermolysin,62 as membrane metallo-endopeptidase inhibitor63 and as endothelin converting 
enzyme inhibitor.  
 
Fig. 1.25 Phosphoramidon 1.72 and its phostone analog 1.73 
The synthetic pathway is reported below (Fig. 1.26). 
 
Fig. 1.26 Synthetic pathway for the preparation of phosphonic acids 1.81 and 1.82 
Natural L-rhamnose underwent modification to afford rhamnal derivative 1.7564 that was cleaved by 
ozonolysis to produce the corresponding lyxose ester 1.76 (Fig. 1.26). Introduction of the phosphonate group 
occurred through Abramov reaction,65 in the presence of trimethylphosphite in glacial acetic acid led to a 
mixture of two epimers (1.77 and 1.78). 66 The subsequent ring closure afforded the corresponding cyclic 
phosphonate esters 1.79 and 1.80 which were finally treated with trimethylsilyl bromide to give phosphonic 
acids 1.81 and 1.82, as an inseparable mixture. The final coupling with the L-Leu-Trp-OMe unit required to 
obtain the target mimetic 1.73 was performed with the corresponding phosphonyl chlorides of 1.81 and 1.82 
in the presence of trimethylamine. 67-68 
More recently, Hanson and co-workers published an efficient strategy for the diastereoselective generation 
of a number of novel phosphono-sugars.69 
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Fig. 1.27 Synthetic pathway proposed by Hanson et al.69 for the preparation of allyl phostone 1.88 through RCM  
The stereoselective alkoxide addition of allylic alcohols (1.84, 1.85 or 1.86) to the allyl diphenyl phosphonate 
1.83 afforded diene 1.87 as intermediate (Fig. 1.27). The acyclic precursor was closed through a Ring Closing 
Metathesis (RCM) catalysed by a 1st generation Grubbs catalyst to give allyl phostone 1.88.   
Dihydroxylation of 1.88 provided diol 1.89 with high stereoselectivity (Fig. 1.28). Subsequent eliminative 
opening of the corresponding carbonate or mesylate of 1.89 afforded vinyl phostones 1.90 (R1= H) and 1.91 
(R1= Ms). 
 
Fig. 1.28 Hanson’s synthesis of vinyl phostones 1.90 and 1.9169 
Directed dihydroxylation of 1.90 using the Donohoe protocol with stoichiometric amounts of OsO4/TMEDA 
provided the C(3)-C(5) all syn-triol 1.92 with excellent selectivity (Fig. 1.29). 
 
Fig. 1.29 Final steps for the preparation of phosphono-sugars 1.92 and 1.94 
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The authors further improved this selectivity by protecting the hydroxyl-group of 1.90 as benzyl ether (Fig. 
1.29). The subsequent dihydroxylation of compound 1.93 generated triol 1.94 in excellent yield and 
selectivity. 
 
Fig. 1.30 Configuration of 1.92 and 1.94 
The configurations of compounds 1.92 and 1.94 was finally confirmed by the NMR analysis of the coupling 
constants between C(4) protons and P(1) atoms (Fig. 1.30).  
1.1.4.3 Phosphino-sugars (phostines) 
Phosphino-sugars (or phostines) are those compounds that present an 1,2-oxaphosphinane heterocyclic 
core. They are still considered glycomimetics since the phosphinolactone group represents an isoster (i.e. a 
group with similar shape and electronic properties) of the corresponding lactol. Furthermore, since the 
phosphinolactone is an hydrogen bond acceptor and a metal-complexing agent, the compounds containing 
this motif become very attractive structures for drug discovery.  
Similar modifications of lactol groups have already been exploited in C-glycosides and aza- or thio-sugars, 
leading to compounds of therapeutic interests. However, these compounds are different from the phostone 
family because of the exocyclic P−C bond, which confers to the molecules a higher stability. 
No example of synthesis of phostines was described before 2005, when Pirat and his group published the 
first synthesis of 2-phenyl-1,2-oxaphosphinane under base-catalyzed transesterification conditions.70 They 
combined C-arylglycosides and phosphonosugars in the same molecule to obtain a cyclic polyhydroxylated 
phosphino-sugar (Fig. 1.31). 
 
Fig. 1.31 Combination of C-arylglycosides and phosphonosugars proposed by Pirat et al.70 to obtain aryl-phosphinosugars 
In Fig. 1.32 the general strategy for the synthesis of these compounds is reported. 
Methylphenylphosphinate 1.96 was prepared following the procedure described by Afarikna and Yu, using 
phenylphopshinic acid and methyl chloroformate.71 Compound 1.96 reacted with the protected 
mannofuranose 1.95 under basic conditions to give a mixture of three cyclic P-phenyl-oxaphosphinanes 1.98. 
Potassium tert-butoxide allows not only the activation of 1.96 by removing its acidic proton and enhancing 
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its nucleophilicity, but it is also responsible for the deprotonation of the intermediate 1.97 allowing the 
spontaneous transesterification. 
 
Fig. 1.32 General strategy proposed for the synthesis of aryl-phosphinosugar 1.9870 
This procedure allowed the synthesis on large scale of P-phenyl-phopshinosugars and for this reason was 
employed later on for the preparation of other phosphinosugars.72 
In 2017, phostines were employed as glycomimetic compounds in drug design to interfere with glycosylation 
processes in cancer cells.73 In particular, the glucose-like phostine 1.99 (reported in Fig. 1.33) was selected 
for its ability to inhibit the Mannoside acetyl GlucosAminylTransferase-5 (MGAT5), whose overexpression is 
associated to malignancies and correlates with cell migration, invasion, and epithelial–mesenchymal 
transition. 
 
Fig. 1.33 Glucose-like phostine 1.99 
There are also example of pseudo-disaccharides containing the oxaphosphinane core (Fig. 1.34). This kind of 
compounds are obtained by replacing the glycosidic linkage with a phosphalactone (phosphino- or 
phosphono-lactone) in order to create more stable pseudoglycans, avoiding all the drawbacks related to the 
anomeric position. 
 
Fig. 1.34 General structures of pseudo-disaccharides containing the oxaphosphinane core 
Very recently, Pirat and co-workers74 proposed a synthetic pathway for these structures, starting from 
oxaphosphinanes 1.100 and 1.101 (cyclic phosphinates, Fig. 1.35) that can be compared to C-aryl 
hexopyranoses which were found to have potent anti-proliferative, anti-migration and anti-invasion 
activities.72, 75-76 
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Fig. 1.35 Oxaphosphinanes 1.100 and 1.101 
Pseudo-disaccharides were synthesized by introducing a furanosyl or pyranosyl sugar unit on 
oxaphosphinane moiety, creating a glycosidic bond at the free hydroxyl group in position 2. In this way, the 
phostines were used as glycosyl acceptors: due to the presence of the phosphoryl group in adjacent position, 
the –OH in that position becomes more acidic (pKa≈ 13.5) than a typical sugar alcohol (pKa usually between 
16 and 19),77 thus improving the glycosidation results. 
The starting oxaphosphinanes 1.100 and 1.101 were prepared following a previously published procedure 
(Fig. 1.36).72, 78  
 
Fig. 1.36 Synthesis of phosphinosugars 1.100 and 1.101 
For the coupling reaction, a series of glycosyl donors were prepared as trichloroacetimidates (1.104a-c; Fig. 
1.37).  
 
Fig. 1.37 Synthesis of glycosyl donors 1.104a-c 
Afterwards, the first coupling reaction occurred between the α-mannosyl donor 1.104a and the glucose-like 
oxaphosphinane 1.100, in the presence of a Lewis acid at 0°C (Fig. 1.38). 
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Fig. 1.38 Coupling reaction between α-mannosyl donor 1.104a and oxaphosphinane 1.100 
In these conditions, the authors observed a partial deketalisation that led to the formation of the side product 
1.106. 
Since with the arabinofuranosyl donor 1.104b in these conditions no reaction occurred, the glycosylation 
reaction in this case was performed by using a palladium/silver catalytic system (Fig. 1.39).79  
 
Fig. 1.39 Pd-catalysed coupling reaction between α-mannosyl donor 1.104b and oxaphosphinane 1.100 
The cationic specie generated in situ by the palladium catalyst is known to generally direct the β-selectivity. 
However, the selectivity seemed to be very sensitive to the oxaphosphinane acceptor when the reaction 
occurred at room temperature. Indeed, the reaction between 1.100 and the glucopyranosyl acetimidate 
1.104c afforded 1.107 as a mixture, where the major diastereoisomer had the unexpected α-configuration 
(Fig. 1.40).  
 
Fig. 1.40 Pd-catalysed coupling reaction between α-mannosyl donor 1.104c and oxaphosphinane 1.100 
Another method to create pseudo-disaccharides with the oxaphosphinane core was proposed by again Pirat 
and his group in 2015.76 Their strategy relied in the use of α-halogenated oxaphosphinane (with general 
structure of Fig. 1.41). 
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Fig. 1.41 α-halogenated oxaphosphinanes 
In this case, the phosphino sugar would represent the donor in the glycosylation process.  
1.2 Fluorosugars 
The incorporation of fluorine atoms into bioactive molecules is a general strategy in medicinal chemistry to 
improve their pharmacokinetics properties and to modulate their biological properties.80 From the 
perspective of steric effects, fluorine is the smallest substituent that can be used as replacement of the C-H 
bond, with a van der Waals radius of 1.47 Å, close to the 1.20 Å value for hydrogen. However, the high 
electronegativity of fluorine (3.98 on the Pauling electronegativity scale compared to 2.20 for H, 3.44 for O, 
and 2.55 for C) results in a highly polarized C−F bond, which presents a strong dipole moment. This feature 
has been exploited in many ways for the development of enzyme inhibitors or to render molecule resistant 
to chemical degradation. Furthermore, it was demonstrated that fluorination can influence the molecular 
conformation and can change the lipophilicity profile of drug molecules, influencing solubility, permeability 
and protein binding. 
Fluorinated glycomimetics have been explored as well. Some examples of fluoro-containing carbohydrate 
mimetics are reported in Fig. 1.42. 
 
Fig. 1.42 Examples of fluorinated glycomimetics 
Depending on the substituted position, the fluorine substituent can have remarkable effects upon the 
physical and chemical properties of the molecule. As already mentioned, it could induce increase of 
lipophilicity, decrease in pKa values of certain groups by OH–F electrostatic interaction, modulate the 
hydrogen-bond acceptor/donor ability or foster the presence of a particular ring conformation.81 
The strategic fluorination of antigenic glycans has also emerged as an interesting approach for 
glycoconjugates vaccine development: selectively fluorinated carbohydrate antigens have shown improved 
metabolic stability, as well as comparable or even enhanced immunogenicity.82  
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More recently, carbasugars were combined with fluorination strategies to increase their stability, lipophilicity 
or to modulate the acidity and basicity (see chapter 1.1.2 of carbasugars).33 Moreover, fluoro-carbasugars 
revealed to be advantageous in mimicking the natural sugar conformations.83 
Recently, in two different papers Jiménez-Barbero and co-workers highlighted the importance of 
fluorination, preparing and investigating the behaviour of a new generation of fluorine-containing 
glycomimetics.83-84 They proposed a synthetic route for the preparation of gem-difluorocarbadisaccharides 
and gem-difluorocarbasugar analogues of β-L-idose (1.110 and 1.109a, while 1.109b is the Glc analogue; Fig. 
1.43). The presence of fluorine atoms emulates, to a certain degree, the properties of the endocyclic oxygen. 
 
Fig. 1.43 Examples of gem-difluorocarbadisaccharide and gem-difluorocarbasugar analogues of β-L-idose 
The synthesis of compounds 1.109a, 1.109b and 1.108 building block followed similar strategy and involved 
a firstly modified Pummerer reaction using diethylaminosulphur trifluoride (DAST) as fluoride source in 
combination with the N-iodosuccinimide (NIS) for the synthesis of α-fluoro-sulphide derivatives.85 The 
mechanism of this process is similar to the usual Pummerer reaction and proceeds through a selective 
iodination of the sulphur atom, followed by HI elimination triggered by succinimide to give the sulfonium ion, 
which is attacked by fluoride to give the final α-fluoro-sulphide product. 
The second fluorination process was performed using Selectfluor in the presence of DAST (see reaction from 
1.113 to 1.114 in Fig. 1.44). Afterwards, m-CPBA oxidation generated the corresponding sulphoxide that 
underwent thermolysis using Bn3N in Ph2O at 190°C for 120 hours to give the difluorovinyl compound 1.16. 
This alkene was then treated with triisobutylaluminium (TIBAL) giving the desired carbacycle that was 
oxidized into ketone 1.117 with Dess-Martin periodinane. The reaction using Tamao’s reagent provided β-
hydroxysilanes which were subjected to oxidative cleavage of the Si-C bond by basic hydrogen peroxide giving 
diols 1.118 and 1.119 which were separated. 
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Fig. 1.44 Synthesis of gem-difluorocarbasugars 1.109a and 1.109b 
Final deprotection of both 1.118 and 1.119 through hydrogenolysis using Pd/C gave the target gem-
difluorocarbasugars 1.109a and 1.109b in quantitative yields. 
For the synthesis of compound 1.110, the authors followed a different strategy, in which the fluorine atoms 
are introduced after carbocyclisation of the sugar by difluorination of a ketone.84 
Since for ido-like sugars, flexibility is intrinsically related to biological activity, 19F and 1H homo- and 
heteronuclear NMR spectroscopic experiments (performed in water and dimethyl sulfoxide solutions), 
supported by computational methods were carried out to determine the intrinsic conformational and 
structural properties of 1.109a, 1.109b and 1.110 and in particular to investigate the conformational effects 
of the difluoromethylene function.84 It is, well known that for L-idopyranoses the theoretically more 
favourable 1C4 chair displays three axially oriented hydroxyl groups, with the corresponding steric 
consequences. The alternative 4C1 chair places the bulky hydroxymethyl group at the axial orientation, with 
the corresponding collapse. Therefore, alternative skew-boat conformers are also present in the 
conformational equilibrium, depending on the hydroxyl substitution, chemical environment, and solvent.86-
88 Ido-like carbasugars, with a CH2 group mimicking the endocyclic oxygen atom, did not show any 
conformational plasticity.89 In contrast, the β-L-idose analogues 1.109a, 1.109b and 1.110, with CF2 moieties 
replacing the endocyclic O, show important conformational plasticity. The dynamic process has been 
quantified in terms of energy barriers and free-energy differences. Compound 1.109b (Glc-like) displays a 
unique 4C1 chair conformer with a very well defined geometry, as in the natural compound.  Compound 1.110 
displays significant conformational distortions. 19F-based variable temperature experiments demonstrated 
the existence of a conformational equilibrium between two forms between the canonical 4C1 (minor) and 1C4 
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(major) chair forms. In contrast, compound 1.109a shows a unique conformational behaviour: the chemical 
shift and coupling constant values drastically changed upon temperature variation indicating that its 
conformational distributions depend on the temperature. This observation strongly suggests that the 
conformational entropy of the contributing geometries is different. The major and enthalpy-favoured 
conformer is the 4C1 chair, while the other participating conformers display a skew boat geometry. In 
conclusion, only in the presence of a CF2 group replacing the endocyclic oxygen atom, the ido-like six-
membered ring recovers its required flexibility, absent in regular CH2-Ido-carbasugars,90 while the presence 
of a bulky substituent at position C5 strongly reduces the ring flexibility and introduces important steric 
clashes. 
In 2017, Mayer and co-workers have focused their attention on the development of new artificial cofactors 
of the glmS ribozyme (a bacterial gene-regulating riboswitch that controls cell wall synthesis, present in 
several human pathogen bacteria). 91-92  The natural glmS cofactor is the glucosamine-6-phosphate (GlcN6P) 
(Fig. 1.45). 
 
Fig. 1.45 α-D-glucosamine-6-phosphate: the natural glmS cofactor 
Mayer and his team proposed the synthesis of mono-fluoro-modified carba variants of α-D-glucosamine and 
β-L-idosamine as synthetic mimics of the natural glmS ribozyme ligands in order to interfere with the cell wall 
synthesis and thereby inhibit bacterial cell growth. 
With this aim, carbocyclic mimics of GlcN6P and IdoN6P that bear fluorine at the carba-position were 
synthesized (Fig. 1.46). 
 
Fig. 1.46 Carbocyclic 1.120 and 1.121 mimics of GlcN6P and IdoN6P that bear fluorine at the carba-position 
Compound 1.122 (Fig. 1.47) was obtained following the procedure already discussed before (see chapter 
1.1.2 Carbasugars).33 The synthesis then proceeded with compound 1.123 that was converted to the 
corresponding enolate by treatment with lithium diisopropylamide (LDA) and finally fluorinated using N-
fluoro-benzenesulfonimide (NFSI) as fluorinating agent (Fig. 1.47).93  
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Fig. 1.47 Synthesis of compound 1.125 
In this way, the mono-fluorinated cyclohexanone 1.124 was isolated in moderate yield (46%) as a single 
diastereoisomer. Finally, exposure of 1.124 to Petasis reagent ((C5H5)2Ti(CH3)2) provided olefin 1.125 that 
underwent hydroboration and subsequently oxidation to afford the fluoro-carba idopyranose compound 
1.126 in a stereoselective way (Fig. 1.48). 
 
Fig. 1.48 Hydroboration of 1.125 to obtain the fluoro-carba idopyranose 1.126 
The corresponding isomer 1.128, where the configuration at C(5) should be inverted, was not accessible 
directly from 1.126 through simple isomerization. The alternative route developed to obtain 1.128 required 
a first epoxidation of the double bond (that needed 14 days to form compound 1.127 in 59% yield) and a 
subsequent regioselective epoxide opening (Fig. 1.49). 
 
Fig. 1.49 Synthesis of the corresponding isomer of 1.126 
However, this latter process represented a not trivial step: indeed, all the attempts reported in literature 
regarding ring opening in the presence of a fluorine in the same molecule (but in particular in the adjacent 
position) have failed. The authors in this case developed a catalytic approach using TiCp2Cl and collidine 
hydrochloride that, protonating the titanocene, had the role to regenerate the titanium specie. However, 
even if this procedure allowed the isolation of the desired product with high diastereoselectivity, compound 
1.128 was obtained in only 33% yield. 
The deprotection of compounds 1.126 and 1.128 was achieved through removal of the TBS protecting group 
(using the tris(dimethylamino)sulfonium difluorotrimethylsilicate TASF) followed by hydrogenolysis with 
Pd/C that afforded compounds 1.129 (in 34% yield) and 1.130 (53%) (Fig. 1.50).  
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Fig. 1.50 Final compounds 1.129 and 1.130 obtained through hydrogenolysis of 1.126 and 1.128 
Finally, the corresponding 6-phoshorylated compounds were synthesized starting from 1.126 and 1.128 
giving the corresponding α-D-glucosamine-6-phosphate 1.120 and β-L-idosamine-6-phosphate 1.121 that 
were analysed to test their capability to induce glmS ribozyme self-cleavage in vitro. 
1.3 Exocyclic oxygen replacement 
Sugar mimics have also been created by replacement of the exocyclic oxygen atom. One must be aware that 
the conformational behaviour of these mimetics can drastically change compared to their natural 
counterparts: for example a greater flexibility around the interglycosidic linkage can be observed as well as 
the presence of conformations that are not available to the native compound.83 These changes are often 
detrimental to the efficient interaction of such molecules with target proteins. On the other hand, they may 
become instrumental when the bound conformation of an oligosaccharide ligand differs from the most 
abundant in water solution. The change in conformational behaviour has been attributed to the absence of 
the anomeric effects, especially the exo-anomeric one.94 The exo-anomeric effect plausibly finds its origin in 
the favourable interaction between a lone pair of electrons on the exocyclic anomeric oxygen atom with the 
parallel s* orbital of the adjacent C1–O5 bond. 
In the figure below (Fig. 1.51), some example of glycomimetics obtained through replacement of the 
exocyclic oxygen are reported. 
 
Fig. 1.51 Examples of glycomimetics obtained through the replacement of the exoocyclic oxygen atom 
1.3.1 C-glycosyl compounds 
The replacement of the exocyclic anomeric C–O bond with a C–C bond is a good strategy to provide 
hydrolytically stable derivatives, called C-glycosides. These carbohydrate mimetics have received 
considerable attention due to their diverse and valuable properties. Since the nature of the anomeric centre 
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is electrophilic, the most obvious way to generate a C-glycoside is to exploit a nucleophilic carbon atom.23 
However, there are many examples in the literature describing the efforts made to generate an anomeric 
nucleophile (as carbo- or organometallic-anion) that, through the reaction with an electrophilic carbon atom 
or an anomeric radical, can generate the C-glycoside. 
The general approaches to synthesize C-glycosides are reported in Fig. 1.52. 
 
Figure 1.52 General approaches to obtain C-glycosides 
Glycoside 1.131 can be converted into an activated glycosyl donor 1.132 (where X is typically an halide) that, 
undergoing nucleophilic substitution by treatment with a carbon nucleophile (such as a Grignard reagent or 
a malonate anion), gives a C-glycoside. The glycosyl halide 1.132 can also give rise to a glycosyl radical 1.134 
or a glycosyl anion 1.135. Alternatively, treatment of the glycoside 1.131 (or even the activated glycosyl donor 
1.132) with a Lewis acid affords the oxacarbenium ion 1.133, which is able to react with an electron-rich 
carbon atom. 
For all the details regarding recent synthetic advances for the preparation of C-glycosides, the review of Yu 
and Yang summarizes all the methodologies developed between 2000 and 2016.95 
Various strategies have been also devised to introduce acyl groups at the anomeric carbon in glycosides. C-
acyl glycosides are a subfamily of C-glycosides that display interesting biological activity, 96-97 such as 
inhibition of reactive oxygen species (ROS, involved in oxidative stress cell-signaling) and glutamate-induced 
cell death. From a synthetic point of view, they are generally prepared either by nucleophilic addition of 
organometallic reagents to C-glycosyl aldehydes followed by oxidation,98 addition of aldehydes99 or 
electrophilic acylating agents100 to glycosyl-based lithium, tin or samarium reagents (Fig. 1.53, A), or the 
addition of Grignard reagents to glyconitriles101 or glycosyl benzothiazoles.102 However, all these 
methodologies rely on harsh conditions and require the use of organometallic reagents, limiting their 
applicability in drug development with sensitive protecting groups, generally used in carbohydrate chemistry. 
In 2014, Gong et al. proposed a nickel-catalyzed reductive coupling of aliphatic carboxylic acids with glycosyl 
bromides under milder conditions (Fig. 1.53, B).103 
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Fig. 1.53 Pathway A: addition of aldehydes or acylating agents to C1 glycosyl nucleophiles. Pathway B: Ni-catalysed reductive 
coupling of aliphatic acids with glycosyl bromides proposed by Gong et al.103 
Very recently, Molander and co-workers have published a report proposing a practical and versatile route 
towards the acylation of highly functionalized C-acyl glycosides.104 By utilizing a dual-catalytic Ni/photoredox 
system, they were able to employ a vast array of glycosyl based radicals that preserve the anomeric carbon 
up to the final stage of the synthesis (Fig. 1.54). 
 
Fig. 1.54 Dual-catalytic Ni/photoredox system proposed by Molander et al.104 for the acylation of highly functionalized non-
anomeric C-acyl glycosides 
Another type of C-glycosyl compounds of interest are the so called aryl C-glycosides: these molecules have 
been found as common structural motif in many bioactive natural products, imaging agents and 
glycoproteins.105-106 Walczak and co-workers proposed a stereospecific cross-coupling reaction using a 
diaryliodonium triflate with glycosyl stannanes (Fig. 1.55).107 This process, promoted by a palladium catalyst 
in the presence of a bulky phosphine ligand (JackiePhos), proceeds with an exclusive transfer of the anomeric 
configuration from the substrate to the product, thanks to the prerogative of configurationally stable C1 
stannanes that promote a stereoretentive reaction.  
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Fig. 1.55 The stereospecific cross-coupling reaction using a diaryliodonium triflate with glycosyl stannanes proposed by Walczak et 
al.107 and the substrate scope 
This methodology was then employed to examine a substrate scope (Fig. 1.55), where all the aryl C-glycosidic 
compounds were obtained in moderate to excellent yields with complete retention of the anomeric 
configuration. 
1.3.2 N-glycosyl compounds 
N-glycosides are a class of carbohydrate mimetics in which the anomeric oxygen is replaced by a nitrogen 
atom. Although such compounds are of great pharmaceutical interest, for example as anti-cancer agents,108-
109 almost all the reports present in the literature are about N-glycosidic linkages created between a sugar 
and an aglycon (often a peptide),110-112 while synthetic methods for the synthesis of N-glycosidic bonds 
between two monosaccharide units remain scarce. 
One of the most important contribution in this field came from the work of Renaudet and Dumy who 
developed in 2002 a stereoselective synthesis of β-N(OMe)-linked disaccharides using the Koenigs-Knorr 
method;113 in the same year Pinto and colleagues described the preparation of N-linked disaccharides with a 
4-thiogalactofuranosyl moiety.114 Chemoselective ligation with oxime bond formation by N,O-disubstituted  
hydroxylamine reagents has also been used extensively.115 This approach allows to connect the 
hydroxylamine directly to the aldehydic carbon of the sugar (generally unprotected), but it does not always 
allow to fully control the anomeric configuration of the product. More recently, glycosyl azides have been 
Chapter one 
31 
 
used for the synthesis of N-glycosyl amides116-117 and N-glycosyl triazoles.118-119 N-glycosyl amides have also 
been obtained by direct glycosylation of carboxyamides.120-121  
 
Fig. 1.56 Examples of N-glycosyl compounds 
1.3.3 Selenoglycomimetics 
Recently, another class of glycomimetics have raised great interest in the scientific community: 
selenoglycosides. They are known to possess various useful biological activities and thus they have been 
employed in the development of new carbohydrate-based drugs for anti-metastatic, anti-tumor122-123 and 
immunostimulatory124 therapeutic treatments (an example in Fig. 1.57).  
 
Fig. 1.57 An example of selenoglycomimetic used as immunostimulant 
These compounds can be used also as tools for the investigation of sugar-protein interactions.125-127 
From a synthetic point of view, selenoglycosides show a unique reactivity as glycosyl donors:128 indeed, the 
C-Se bond can be readily ionized under photo-129-131 and electro-chemical132 conditions, generating very 
reactive cationic and radical-cationic species. However, the preparation of selenoglycosides involves major 
limitations, related to restricted substrate scope (e.g. unprotected sugars are not tolerated under the 
reaction conditions) and to the limited access to only one anomer.  
Walczak and co-workers in 2018 proposed a stereoretentive preparation of Se-glycomimetics, through a 
stereospecific cross coupling process between anomeric stannanes and symmetrical diselenides that allow 
to obtain both the anomeric products (Fig. 1.58).133   
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Fig. 1.58 Stereoretentive glycosyl cross-coupling proposed by Walczak and co-workers for the synthesis of Se-glycosides133 
Anomeric stannanes represent configurationally stable nucleophiles that can be stored and manipulated 
under ambient conditions without loss of stereochemical integrity, even after extended periods of time (six 
months at room temperature or one year at -20°C). They can be easily prepared starting from the 
corresponding glycals, affording either 1,2-cis or 1,2-trans, thus allowing the formation of both the C(1) 
anomers.107, 134-135 
 
Fig. 1.59 Synthesis of configurationally stable anomeric stannanes 
The preparation of the 1,2-trans anomer 1.138 (Fig. 1.59), for example, starts from the epoxidation with 
dimethyldioxirane (DMDO) of the protected glycal 1.136 followed by ring opening by Bu3SnMgMe. For the 
synthesis of the 1,2-cis stannane 1.140, glycal 1.136 has to be converted into the α-chloride 1.139, using HCl, 
and then exposed to a strong base (such as n-BuLi) to deprotonate the free hydroxyl group. Afterwards the 
resultant lithium alkoxide is treated at -100°C with lithium naphthalenide and finally quenched with Bu3SnCl. 
This procedure allows the transfer of the configurational information from the α-chloride 1.139 to the 
corresponding anomeric stannane 1.140. 
At this point, glycosyl stannanes can be employed as nucleophilic species in the cross-coupling with 
symmetrical diselenides for the preparation of selenoglycosides. The proposed mechanism of this copper-
catalysed process is reported below (Fig. 1.60): 
Chapter one 
33 
 
 
Fig. 1.60 Proposed mechanism for the cross-coupling between anomeric stannanes with symmetrical diselenides 
Copper replaces the Sn-substituent generating the intermediate 1.41/1.42 that is configurationally stable at 
the C(1); it undergoes nucleophilic reaction with the diselenide, giving 1.43/1.44 and subsequently the 
seleno-copper by-product 1.147. Under oxidative conditions 1.147 can be reconverted into the original 
diselenide (RSe)2 which can enter again in the cycle. In this reaction, the presence of fluoride ions seem to 
facilitate the stereoretentive transmetalation from the nucleophile 1.138/1.140 to the copper, possibly the 
activation of the anomeric stannane that results in the formation of an insoluble Bu3SnF by-product. 
When the symmetric diselenide bears two sugar units, the cross-coupling reaction with the anomeric 
stannane generates an 1,1-selenodisaccharide. In particular, the retention of the configuration along all the 
process allows a perfect stereocontrol of the final product by the proper selection of the corresponding 
coupling partners. In Fig. 1.61 are reported some examples as the proof of the concept. 
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Fig. 1.61 Cross-coupling reaction between symmetric diselenides and anomeric stannanes to generate 1,1-selenosaccharides 
Finally, the authors applied the same method to the synthesis of selenium-containing peptides. Below it is 
reported the cross-coupling between seleno-L-cysteine 1.148 and protected glycosyl stannanes that 
produced the corresponding selenocysteine glyconjugates in good yields (Fig. 1.62). 
Chapter one 
35 
 
 
Fig. 1.62 Examples of stereospecific synthesis of selenoglycopeptides 
These results represent the first example of stereospecific glycodiversification of selenopeptides with 
exclusive control of anomeric configuration and unprecedented functional-group tolerance.  
1.3.4 Thioglycosides 
The acidic and enzymatic sensitivity of O-glycosidic bonds stimulated the development of more stable 
glycosides, such as thio-linked oligosaccharides. 
Belonging to the same group in the periodic table, oxygen and sulphur share similar bonding and geometries: 
indeed, although the C-S bond is longer than the corresponding C-O bond by about 0.4 Å, the C-S-C bond 
angle is smaller than the C-O-C angle, which renders thioglycosides conformationally similar to the 
corresponding O-glycosides, with a very small difference in the positions of the atoms along the glycosidic 
linkage. However, since sulphur is less basic than oxygen, the S-glycosidic linkage is typically more resistant 
toward both acid-catalyzed and enzymatic hydrolysis and thus thioglycosides are often competitive inhibitors 
of glycosidases and are considered promising molecules for the development of new therapeutics.136 The 
higher stability of thioglycosides could be ascribed to the lower proton affinity of sulphur in comparison to 
O-glycosides. According to the Hard−Soft Acid−Base (HSAB) theory, sulphur behaves more like soft base while 
oxygen is a hard base; a hard acid like proton is thus prone to attack the hard base O-glycosides, not the soft 
base thioglycosides.137 
Furthermore, sulphur is more nucleophilic than oxygen and thus it can allow simpler synthetic approaches 
for the construction of more complex systems. 
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Another property of thiodisaccharides, due again to the larger bond distance between carbon and sulphur, 
is their often enhanced conformational flexibility. Thus, thioglycosides can adapt their conformation to 
enable a better fit into the catalytic site of a receptor.138-140 Indeed, their different conformational 
preferences compared to O-glycosides could influence their biological properties and often lead to more 
potent biological activity.  
Thioglycosides can also be employed as donors in glycosylation reactions. Indeed, they can be activated 
under extremely mild conditions: numerous promoters have been developed and tested for the activation 
of alkyl/phenyl 1-thioglycosides for the construction of glycosidic linkages.141 The promoters are molecules 
capable of generating thiophilic species and they can be classified as metal salts, halonium reagents, 
organosulphur reagents, single-electron-transfer reagents. Under classical glycosylation conditions, 
thioglycosides can also be employed as glycosylation acceptors when the alkyl/aryl-thio group serves as an 
anomeric group. 
Another important advantage of this class of compounds is their easy accessibility: thioglycosides can be 
prepared from readily available starting materials, such as free sugars via peracetylation and subsequent 
treatment with thiols in a Lewis acid catalysed process. Moreover, unlike O-glycoside formation, the synthesis 
of S-linked glycosides can be achieved through SN2 displacement of sugar halides by sugar thiolates.142 
Another important property of these molecules concerns their configurational stability: anomeric thiolates, 
once formed, often retain their anomeric configuration in subsequent reactions.143 Glycosyl thiols do not 
mutarotate easily, unless they are exposed to harsh conditions. However, although their compatibility with 
numerous protection/deprotection steps and with biological systems, it was demonstrated that 1-
thioaldopyranoses undergo mutarotation in aqueous media in a pH dependent way.144 In particular, this 
process proceeds at lower and neutral pH, while is slower or even blocked under basic conditions.  
Working under controlled and mild conditions, their stability allows to perform stereoselective S-alkylation 
and thiol-ene or thiol-yne coupling processes, thanks to the retention of the anomeric configuration during 
synthetic transformations. 
Despite all these valid reasons to promote the use of thioglycosides, they implicate an inevitable 
disadvantage: the very unpleasant odor of the starting thiols and of the resulting wastes. This point makes 
thioglycosides unfavourable alternatives in the large scale synthesis, especially in industrial applications.  
As already mentioned above, most of these thioglycosides are prepared from glycosyl thiols (or 1-thio sugars) 
by alkylation,145-150 conjugate-addition151-152 or thiol-ene coupling reactions.153-155  
1.3.4.1 Glycosyl thiols 
The great utility and potential that glycosyl thiols have exhibited in carbohydrate chemistry brought great 
impetus to the development of procedures for their stereoselective preparation. In recent years, glycosyl 
thiols have become key building blocks for the construction of thio-oligosaccharides and S-glycoconjugates 
that often show increased chemo- and enzymatic stability and are tolerated by most biological systems.  The 
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good affinity of glycosyl thiols towards gold also stimulated interest in their application as drugs (like 
auranofin).156-157 
There are various methods available in literature for the preparation of glycosyl thiols. 
The first methods have involved either the treatment of glycosyl halides with sulphur nucleophiles (such as 
thiourea158-159 or potassium thioacetate) followed by hydrolysis,160-162 or the conversion of the same halide 
1.149 into a thioacetate group that finally underwent deacetylation by NaSMe163 to give the thiol function at 
the anomeric position (Fig. 1.63). 
 
Fig. 1.63 Methods for the preparation of glycosyl thiols 
In 2006, Davis et al. proposed a new procedure for the preparation glycosyl thiols where Lawesson reagent 
was employed.164 In this process, considering how Lawesson’s reagent (LR) works,165-166 it was reasonable for 
the authors to believe that it could act as both oxaphilic electrophile and sulphur source. Previously, this 
reagent had found application in the conversion of benzylic alcohols into the corresponding thiols trough an 
SN1 or SN1-like pathway.167-168 Taking into account the high reactivity of anomeric hydroxyl groups in SN1-like 
processes, Davis and co-workers applied the same methodology for the preparation of anomeric thiols (Fig. 
1.64).  
  
Fig. 1.64 Preparation of glycosyl thiol 1.152 by using Lawesson’s reagent 
The substrate scope was also investigated and it was demonstrated that this procedure is applicable for the 
preparation of a variety of differently protected 1-thiosugars, in good yields (>70 % in all the cases). 
The same process was then investigated for unprotected sugars (Fig. 1.65): 1-thio-glucose, -mannose and -
galactose were synthetized in moderate yields (60-70%). However, in these cases the purification and the 
subsequent isolation of the resulting thiols turned out  to be very complex. 
 
Fig. 1.65 Synthesis of glycosyl thiols using Lawesson’s reagent, starting from unprotected sugars 
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Although this method allowed the direct formation of glycosyl thiols in a single step and in acceptable yields, 
it led to anomeric mixtures. Furthermore, besides the formation of the desired thiol, in almost all the cases 
also the generation of the corresponding disulphide side-products was observed as well. This and the 
presence of LR decomposition products in the reaction crude made the chromatographic purification step 
very complicated.  
In 2011, Wang and co-workers reported the first direct stereospecific procedure for the preparation of α-
glycosyl thiols starting from 1,6-anhydrosugars.137 Their aim was to develop a method to selectively introduce 
a sulfhydryl group in the anomeric position with a specific configuration. The Wang’s method consists in a 
ring opening reaction of the previously synthesized 1,6-anhydrosugars169 using bis(trimethylsilyl)sulphide as 
a nucleophilic specie that, attacking from the less hindered side, and generating only α-thiols, since the β-
face is blocked by the intramolecular dioxolane ring (Fig. 1.66). 
 
Fig. 1.66 Ring-opening reaction of 1,6-anhydrosugars proposed by Wang et al.137 for the synthesis of α-glycosyl thiols 
Finally, the trimethylsilyl group is cleaved in situ under glycosylation conditions (e.g. using TMSOTf). 
The same procedure was then applied for the preparation of differently protected and even partially 
unprotected anhydrosugars, generating the corresponding α-thiols in good/excellent yields without 
observing the formation of the corresponding β-product.  
A few years later (in 2015), a series of thio-α/β-D-mannose derivatives (Fig. 1.67) were synthesized by Wu 
and his team in order to investigate the role of the thiol group in different positions of the mannopyranose 
ring in binding affinity towards lectin Concavalin A (Con A).170 These compounds were obtained using the 
strategy of protection/deprotection pattern and inversion (an example is reported below, Fig. 1.67, for the 
synthesis of the β-thio-mannopyranose 1.159), while compound 1.158 can be readily obtained following the 
already known procedure. 171 
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Fig. 1.67 Synthesis of 1-thio-α/β-D-mannopyranose 1.157; the positional thio-α/β-D-mannose derivatives 1.158-1.166 
In the same year (2015), also the work of Shu and co-workers was published that reported a practical strategy 
toward the synthesis of glycosyl thiols by selective S-deacetylation reactions.172 A few years ago, Misra’s 
group also developed an expedient one-step pathway to β-glycosyl thiols by reaction of glycosyl bromides 
with CS2 and Na2S9·H2O,173-174 although some of the thioglycosides, contamined with impurities, resulted 
difficult to purify. Shu and his team instead proposed a method inspired by Native Chemical Ligation (NCL) to 
selective deacetylate anomeric thioacetates with absolute control of the anomeric configuration. The 
classical NCL involves a reversible trans-thio-esterification between a C-terminal peptidyl thioester and 
another peptide that presents an N-terminal cysteine residue (see Fig. 1.68a). This step is then followed by 
the irreversible shift of the acyl group from the sulphur to the nitrogen atom of cysteine, which generates a 
new peptide bond released at the same time the free thiol. The authors of this work applied the same 
strategy to the selective S-deacetylation of glycosyl thioacetates to produce glycosyl thiols. 
 
Fig. 1.68 Selective S-deacetylation reaction inspired by NCL proposed by Shu et al. 
Chapter one 
40 
 
The precedure was optimized on the peracetylated thio-glycoside 1.167 (Fig. 1.69). In the presence of the 
cysteine methyl ester hydrochloride III (quenched by NaHCO3), the reaction proceeded fast and the desired 
product was isolated in 95% yield together with N-acetyl cysteine.  
 
Fig. 1.69 Optimization of selective deacetylation reaction conditions 
Considering that 1,4-dithiothreitol V (DTT) is often used as a scavenger in these reactions to limit the 
formation of the disulphide side product,175-179 it was also tested in this reaction. DTT mediated the S-
deacetylation through a trans-thio-esterification pathway that led the anomeric S-acetyl group to the sulphur 
atom of the DTT. Surprisingly, when DTT in stoichiometric amount was used in combination with NaHCO3 the 
reaction still proceeded smoothly giving the desired deacetylated compound in 90% yield. Since the trans-
thio-esterification step is reversible, in the optimized procedure DTT is used in excess. Furthermore, this 
process is favoured in a weak base environment: a catalytic amount of the base (NaHCO3 or TEA) was proved 
crucial for the performance of the reaction. Dimethylacetamide (DMA) was the best solvent for this 
transformation, because it simplified the purification step (by a simple extraction with toluene the product 
is isolated without needing further purification). The authors described also a protocol to recover and 
regenerate DTT by simply another extraction followed by hydrolysis with K2CO3-MeOH. This procedure can 
facilitate the large-scale synthesis of glycosyl thiols (for an industrial application). 
Finally, the reaction scope was investigated and various S-acetylated glycosides were employed to create a 
library of differently protected sugars bearing conformationally defined anomeric thiols (Fig. 1.70).  
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Fig. 1.70 Library of differently protected sugars bearing anomeric thiols synthesized starting from various S-acetylated glycosides 
The configurations of the anomeric C-S bond was not altered during the process (β-S-acetylated sugars gave 
β-glycosyl thiols while the α-anomers gave the corresponding α-products). 
This method was finally employed for the preparation of the building blocks necessary for the construction 
of the S-linked-trisaccharide 1.175 (Fig. 1.71). 
 
Fig. 1.71 Preparation of the S-linked-trisaccharide 1.175 
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If on one hand 1-thiosugars are being extensively used in the construction of specific thiooligosaccharides 
and thiopeptides, on the other little attention has been devoted to their use for the preparation of 
(hetero)arylthioglycosides. Indeed, thioglycosides could be used as nucleophiles combined with transition 
metal-catalysts (Fig. 1.72), an approach that has been recently reviewed.180 
 
Fig. 1.72 Metal- catalyzed cross-coupling for the construction of functiolized thioglycosides 
Among different examples reported, the Pd catalysed approach of Messaoudi and co-workers stands out as 
an efficient and stereoselective coupling of various unprotected and protected glycosyl thiols with aglycon 
halides in mild conditions, achieved employing G3-XantPhos as the precatalyst (Fig. 1.73).181 
 
Fig. 1.73 Coupling of glycosyl thiols with aglycon halides by using G3-XantPhos as precatalyst 
The reaction is versatile (various aryl, akenyl and alkynyl halides can be used), tolerates several functional 
groups (e.g. –Br, -OTs, -OH, -CN, -CO2Me, -CONR2, C(Me)=NNHTs) and it is reproducible up to a multigram-
scale. The scope was then expanded to (12)-S-linked saccharides and S-linked glycoconjugates.182 The same 
method was also applied to heteroaryl bis-glycosides, where N-glycosyl quinolin-2-ones (general structure 
reported in Fig. 1.74) in which a glycosyl unit is attached to a quinolin-2-one core (one of the most important 
heterocycle in medicinal chemistry).183 
 
Fig. 1.74 General structure of N-glycosyl S-galactosyl quinoli-2-ones 
In addition, the first use of PdG3-WantPhos in a tandem process for the synthesis of unsymmetrical biaryles 
thioglycosides was recently described by the same group.184 The procedure consists of using a single Pd-
catalyst which promotes under the same catalytic cycle, the catalysis of two individual steps: the first is a 
selective coupling reaction between β-thiosugars and di-halogenated arenes (iodo-bromoarenes); the 
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second is based on C-C bond formation between the mono-halogenated thioglycoside intermediate and 
diverse aryl boronic acids (Fig. 1.75). 
 
Fig. 1.75 First use of PdG3-WantPhos for the synthesis of unsymmetrical biaryles thioglycosides 
This procedure showed for the first time the use of PdG3-XantPhos in a multicomponent process under mild 
conditions and it represented one of the most robust methods developed so far in the thioglycoconjugation 
chemistry that could be further explored for range of medicinal chemistry screening programmes. 
1.3.4.2 S-linked oligosaccharides 
As mentioned before, glycosyl thiols represent the main building blocks used for the construction of S-linked 
saccharides.  
In 2012, Marra and Dondoni exploited the thiol-ene coupling reaction for the synthesis of S-disaccharides.155  
The figure below (Fig. 1.76) shows the reaction between tetra-O-acetyl 1-thio-β-D-glucose 1.168 and sugar 
alkenes 1.176, 1.78 and 1.180: these reactions occurr at room temperature under UV irradiation at λmax 365 
nm, using 2,2-dimethoxy-2-phenylacetophenone (DPAP) as initiator, affording 1.177, 1.179 and 1.181 that 
are the corresponding isosteres of 1,6- and 1,5-linked natural O-disaccharides, respectively. 
 
Fig. 1.76 Examples of thiol-ene coupling between sugar thiols and sugar alkenes 
The same process was then applied for the construction of S-linked glycopeptides (Fig. 1.77). 
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Fig. 1.77 Synthesis of alkyl-tethered S-lactosyl glycosides 
 
In 2016 Belz and co-workers proposed a practical synthesis of S-linked glycosides achieved through SN2 
displacement of sugar halides by sugar thiolates.185 This procedure allowed to avoid the isolation of the often 
unstable corresponding thiol compound. 
Two different approaches were proposed by Belz’s group for this process: the first requires an initial insertion 
of the mercapto group into the glycosyl acceptor, with the leaving group on the glycosyl donor (or viceversa) 
and it is for sure the most convenient for the synthesis of β-linked compounds (as α-glycosyl halides can be 
readily prepared). The second one is based on the configurational stability of anomeric thiolates.  This 
strategy is applied for α-linked S-glycosides, installing the sulphur atom into the glycosyl donor with 
stereochemical control at the building block stage. 
Belz’s work focused in particular on the preparation of S-linked α-1,6-oligomannosides. Disaccharide 1.189 is 
obtained thorugh the coupling of iodide 1.187 and thioacetate 1.188 (Fig. 1.78) in the presence of 
diethylamine in dimethylformamide. 
 
Fig. 1.78 Preparation of S-linked α-1,6-oligomannoside 1.189 
The α-mercapto precursor of 1.187 is the isothiouronium bromide 1.188186 that was treated with MeI/Et3N 
in acetonitrile to afford the corresponding thiomethyl glycoside 1.189 (Fig. 1.79). Finally, the deacetylation 
under Zemplén conditions, followed by iodination using I2, PPh3, imidazole and acetylation gave the iodide 
1.187.  
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Fig. 1.79 Synthesis of the iodide α-mercapto compound 1.187 
The temporary protection of the anomeric sulphur allowed the nucleophilic S-glycoside formation. 
Afterwards the latent thiolate precursor can be release to perform the subsequent coupling reaction. 
In summary... 
This overview about the state of the art of glycomimetics highlights the strong interest that these structures 
have raised in the last decades. Although the efforts of the scientific community spent to develope and 
propose increasingly innovative synthetic procedures for the preparation of sugar mimics, the majority of 
them still require multiple steps, complicate reaction conditions that must to be under careful control, 
sometimes expensive and also sensitive reagents. Furthermore, most of the procedures reported so far 
describe the synthesis of mono-saccharide mimics, while, for the preparation of oligosaccharide structures, 
the standard glycosylation protocol is still applied, with all its drawbacks and difficulties.  
My PhD project takes place in this scenario with the aim to design a new class of glycomimetic compounds, 
accessible through a simple and straightforward synthesis involving few steps. With this goal, we started 
from a specific model: the Manα(1,2)Man disaccharide, a natural ligand for DC-SIGN.  
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CHAPTER TWO: carbohydrate binding proteins 
Carbohydrate-protein interactions are involved in many biological recognition phenomena, including 
fertilization, cell–cell recognition, immunological responses and pathogen–host cell attachment processes. 
In order to control these events, significant effort has been focused toward the development of high-affinity 
ligands for various carbohydrate-binding proteins. However, this is a challenging task, also because 
carbohydrate-protein interactions are usually weak, typically in the millimolar to micromolar range. 
Furthermore, the availability of saccharide ligands for carbohydrate-binding proteins is often limited by the 
tedious synthetic protocols required for their preparation. The knowledge on molecular recognition of sugars 
by carbohydrate-binding proteins has been employed for the development of new biomedical strategies. 
Glycans are selectively recognized by certain proteins, called lectins which can be either secreted or 
expressed on cell surface. Lectins, present at the surface of host cells, often recognize pathogen-specific sugar 
moieties, mediating attachment. They typically present binding sites shallow and exposed to the solvent, 
which makes recognition of oligosaccharides an intrinsically low-affinity process. 
Depending on the composition of the binding site and thus of the target sugar specifically recognized, 
mammalian lectins are called galectins (binding pocket specific for the disaccharide lactose or N-
acetylactosamine), SIGLECs (that bind preferentially sialic acid residues) and C-type lectins (which show a 
certain selectivity for mannose- and fucose-containing carbohydrates).1 Despite the huge diversity among 
lectins, they share the presence of a Carbohydrate Recognition Domain (CRD), usually formed by less than 
200 amino acids. 
C-type lectin receptors (CLRs) represent the most abundant class and they are so called because of the 
presence of a calcium ion (Ca2+) into their binding site.  They are largely expressed by animals, viruses and 
parasites. In particular, these proteins play a crucial role in the immune system where they belong to the 
family of receptors expressed by Antigen Presenting Cells (APCs). 
The main function of C-type lectins expressed by Dendritic Cells (DCs) is to interact with certain molecular 
patterns featured by non-self-cells, in order to start the internalization process of pathogens for processing 
and antigen presentation, thereby triggering the information cascade that lead to the immune responses 
against a diversity of microorganisms.  
One of these C-type lectin is DC-SIGN.   
2.1 DC-SIGN: structure and functionality 
DC-SIGN (Dendritic Cell-Specific ICAM-3-Grabbing Non-integrin) is a C-type lectin whose important role in the 
human body was clarified in 2000 by van Kooyk and co-workers.2 It is mainly expressed and displayed on their 
surface by immature DCs located on dermal and mucosal tissues (Fig. 2.1). 
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Fig. 2.1 Picture of a dendritic cell expressing DC-SIGN on its surface 
DC-SIGN is a tetrameric transmembrane protein, composed by an N-terminal cytoplasmic domain, a 
transmembrane domain from which it departs a neck repeat domain formed by hydrophobic amino-acid 
residues (responsible for the tetramerization) that is connected with the CRD exposed in the extracellular 
environment (Fig. 2.2).  
 
Fig. 2.2 Tetrameric and monomeric structure of DC-SIGN 
The CRD of DC-SIGN is selective for mannose- and fucose-containing carbohydrates and includes the calcium 
ion responsible for both sugar binding and structural maintenance (Fig. 2.3).  
 
Fig. 2.3 Binding site of DC-SIGN 
DC-SIGN plays a key role in the immune system. Indeed, it binds self glycoproteins InterCellular Adhesion 
Molecules 2 (ICAM-2) and ICAM-3 and thus mediates the interaction between dendritic cells and T-cells.3 
Furthermore, DC-SIGN is able to recognize several pathogens, like viruses (Hepatitis C, Ebola, Dengue, SARS), 
bacteria (Mycobacterium tuberculosis, Klebsiella pneumonae), yeasts (Candida albicans) and parasites 
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(Leishmania spp, Schistosoma mansoni) by specifically recognizing the glycosylated structures displayed at 
their surface. 
However, several pathogens, such as Human Immunodeficiency Virus type-1 (HIV-1), hijack DCs to 
disseminate the infection in the human body. In particular, DC-SIGN represents the primary target recognized 
by all those pathogens that, as HIV-1, exploit mucosal entry pathways.4 This explains why DC-SIGN has 
become an interesting target for the design of anti-infective agents. 
DC-SIGN interaction with the HIV virus involves the highly mannosylated envelope protein of HIV called gp120 
(Fig. 2.4).5 
 
Fig. 2.4 Highly mannosylated gp120 envelope protein of HIV6 
In particular, the main natural ligand recognized by the CRD of DC-SIGN is the high-mannose glycan 
(Man)9(GlcNAc)2, also known as Man9, that is conjugated to the envelope protein and exposed on the viral 
surface (Fig. 2.5).7 
 
Fig. 2.5 High mannose glycan (Man)9(GlcNAc)2 
HIV-1 
High mannose glycan, Man
9
 
Man1,2)Man 
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2.1.1 DC-SIGN ligands 
Binding assays revealed that a particular portion of Man9 (the Manα(1,2)Man terminal epitope) is directly 
involved in the binding event with the receptor and, when presented on a glycoarray, it is sufficient to reach 
similar affinity value than the entire molecule.8 Therefore, the artificial compounds designed as DC-SIGN 
pathogen antagonists should mimic this framework in order to achieve high activity. With this aim, the 
Bernardi’s group has already developed some mannose-based DC-SIGN monovalent ligands, among which 
the pseudo-dimannoside (2.1) and the so-called Man030 (2.2) have shown interesting affinity towards the 
receptor (with IC50 values of 0.9 mM and 0.3 mM respectively, as measured by SPR inhibition assay) (Fig. 
2.6).8-9 
  
Fig. 2.6 Mannose-based DC-SIGN monovalent ligands 2.1 and 2.2; interaction between –OH in position 3 and 4 of 2.1 and 2.2 and 
the calcium ion of the CRD 
These two compounds contain a mannose ring, whose hydroxyl groups in position 3 and 4 are involved in the 
interaction with the calcium ion in the CRD (Fig. 2.6),10 and a conformationally stable 1,2-trans-diaxial 
cyclohexanediol moiety, which is able to establish additional Van der Waals interactions with residues 
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present in the binding site. This latter moiety replaces the non-pharmacophoric part of the natural ligand 
mimics, the reducing end mannose residue and confers enzymatic stability to the molecule.11 
Below, the synthetic pathways proposed for the preparation of the pseudo-dimannoside 2.1 (Fig.2.7) and 
the Man030 2.2 (Fig. 2.8) are reported. 
 
Fig. 2.7 Retroynthesis of the pseudo-dimannoside 2.1 
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Fig. 2.8 Retroynthesis of the Man030 2.2 
As mentioned before, carbohydrate-protein interactions typically show low affinity, usually in the millimolar 
range. This weak interaction is overcome both in Nature and in the development of new ligands by exploiting 
multivalency. In this way, high affinity is achieved through multiple glycan presentations towards the lectin 
protein. This concept has been exploited also for the development of DC-SIGN antagonists. Four main factors 
are fundamental in the design of such multivalent systems: number of copies of the monovalent ligand, 
overall dimension of the polyvalent construct relative to the size of the polymeric protein and to the 
separation of its binding sites, right balance between flexibility/rigidity, solubility. 
The main strategy followed in our group for the preparation of multivalent systems consists in coupling the 
monovalent ligand, that has to bear at least one azido group, to a polyalkyne dendrimeric core through a 
‘click’ reaction, obtaining dendrimers that show a certain flexibility. In the figure below, two examples of 
dendrimeric scaffolds which have DC-SIGN as target protein are reported:9 
Chapter two 
57 
 
 
Fig. 2.9 Tetravalent and hexavalent dendrimeric scaffolds decorated with 2.1 
Comparing the IC50 values (obtained through an SPR inhibition assay) of the monovalent with the tetra- and 
the hexavalent systems, it is evident how the multiple presentation of the ligand towards the receptor helps 
the affinity (Fig. 2.9). 
More recently, another strategy was developed in the design of these systems in order to further increase 
their activity. This approach rely on a linear rigid central spacer with a proper length, designed to efficiently 
exploit the chelation mechanism. ROD3 was shown to span the required distance (about 4 nm) to chelate 
two DC-SIGN biding sites at the same time (Fig. 2.10).12 
            
Fig. 2.10 ROD-3-divalent structure (on the left); ROD3-divalent/DC-SIGN complex in dynamic simulations performed using an 
implicit GB/SA water model (25 ns) (on the right) 
In this case, the ROD3-divalent system, bearing two copies of pseudo-dimannoside 2.1, was sufficient to 
reach a similar affinity towards DC-SIGN than the hexavalent dendrimer reported in Fig. 2.9. 
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CHAPTER THREE: aim of the work 
Although the pseudo-dimannoside 2.1 and its bis-amide derivative 2.2 represented very promising 
candidates in this field, their structure and preparation still show some drawbacks: the first critical point of 
the synthesis is certainly the glycosylation reaction that requires extremely anhydrous conditions and low 
temperatures; additionally, there are some restrictions about the insertion of the azido linker that has to be 
introduced at a specific point in the synthesis and whose length cannot be easily modified. Finally, although 
2.1 is composed of a sugar moiety connected to an unnatural aglycon through a pseudo-glycosidic bond, the 
pseudo-dimannoside was found to be a substrate of glycosidases, albeit as a low reacting one.1 
The aim of this PhD project was to create a new class of glycomimetic DC-SIGN ligands, starting from all the 
know-how already gathered for compound 2.1. The strategy that we have devised consisted in the 
replacement of the glycosidic oxygen atom of compounds 2.1 and 2.2 with a sulphur atom, in order to further 
improve the metabolic stability of these molecules,2 while maintaining the affinity towards the receptor. 
  
Fig. 3.1 The pseudo-dimannoside 2.1 (on the left) and the corresponding pseudo-thiodimannoside (on the right) 
Furthermore, the presence of the carbon-sulphur bond should help to simplify the synthetic strategy, 
exploiting the lower basicity and the better nucleophilicity of the sulphur atom compared to oxygen: indeed, 
these structures (as already mentioned in the Chapter 1.3.4 of Thioglycosides) are usually prepared from 
sugar-thiolates, which can easily react by an SN2-like mechanism with different substrates.2-3 In addition, 
some examples in literature show that, since the C-S bond is longer than the corresponding C-O bond, these 
structures benefit of an increased conformational flexibility that can allow them to adapt their conformation 
and enable a better fit into a binding pocket, leading sometimes to a better affinity towards the receptor. 
During this thesis, I have developed two novel strategies for the synthesis of pseudo-thiodimannosides, 
leading to either O-linked (X= OCOR) or N-linked (X= NHCOR) products. Both approaches rely on nucleophile 
opening of a 3-membered electrophile ring, either an epoxide or an aziridine of appropriate symmetry 
derived from the cyclohexene diester 4.4, by the α-thioacetyl-tetra-O-acetylmannoside 4.8 (Fig. 3.2). 
 
Fig. 3.2 General approach for the preparation of pseudo-thiodimannosides through nucleophile opening of an epoxide or an 
aziridine ring 
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CHAPTER FOUR: synthesis of O-linked pseudo-thiodisaccharides 
4.1 Results and discussion 
As mentioned in the previous chapter, retrosynthetically, the S-analog of 2.1 (4.9) could be obtained 
through nucleophilic opening of the epoxide 4.5 (Fig. 4.1) by an α-glycosyl thiolate. 
 
Fig. 4.1 The pseudo-dimannoside 2-1 (on the left); retrosynthetic approach to obtain the corresponding pseudo-thiodimannoside 
4.9 
Indeed, the symmetry properties of 4.5 and 4.9, coupled to the stereoelectronic requirements for trans-
diaxial opening of epoxycyclohexanes, allow the formation of a single isomer during this reaction, which has 
the same configuration as 2.1. Precedent literature on thiol alkylation suggests that this reaction could 
actually be performe one-pot, starting from the α-thioacetyl mannopyranose 4.8.1 This has the advantage of 
both streamlining the synthesis of 4.9 and reducing the risk for disulphide formation from the free thiol.  
In this chapter, we show how we set up and optimised the synthesis of 4.9, using the approach described 
above, as well as the properties of this molecule and its use for the synthesis of polyvalent DC-SIGN ligands. 
4.1.1 Synthesis of the epoxide 4.5 
For the synthesis of the epoxide 4.5 the already well-known procedure was followed:2 starting from the 
enantiomerically pure dicarboxylic acid 4.3 ([αD]= +169, custom-made by Alchemy) we performed a Fischer 
esterification with MeOH in standard conditions, followed by  epoxidation of the double bond using m-
chloroperbenzoic acid (m-CPBA) in dichloromethane (Scheme 4.1).2 Both these steps gave the product 
almost in quantitative yield, and no chromatographic purification of the crude reaction mixture was required. 
 
Scheme 4.1 Synthesis of epoxide 4.5  
4.1.2 Synthesis of the 1-S-acetyl-α-mannopyranose 4.8 
The synthesis of the glycosyl donor 4.8 started from peracetylation of mannose 4.6, used as a mixture of α 
and β anomers. Since this reaction was performed in a large scale (on 5 g of the natural sugar), to avoid the 
use of large quantities of pyridine, employed as solvent in standard protocols, an alternative method was 
applied that involved a catalytic amount of a Lewis acid (lanthanum(III) triflate) and acetic anhydride as both 
acylating agent and the solvent (Scheme 4.2).3 
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Scheme 4.2 Synthesis of the α-thioacetate 4.8 
The 1-S-acetyl-2,3,4,6-tetra-O-acetyl-α-mannopyranose 4.8 is a known compound.4-5 It was prepared by 
treating the peracetylated mannose 4.7 with thioacetic acid in the presence of a Lewis acid. However, 
although the α-product is certainly the most favoured one, because of the strong anomeric effect of mannose 
and of the neighbouring group participation of the 2-O-acetyl protecting group, the formation of variable 
amounts of the β-product was observed in our first experiments. Although these amounts remained under 
25% of the mixture, the separation by flash chromatography of the two stereoisomers was difficult and led 
to low yields of the isolated desired α-compound. For this reason, the thio-acetylation reaction was optimized 
and in the table below (Table 4.1) all the experiments carried out with this aim are reported. The critical 
elements necessary to guarantee reproducibility of the process were found to be the quality of the thioacetic 
acid batch, which needs to be freshly distilled before use, and the quality of the Lewis acids employed as 
promoters. 
Table 4.1. Optimization of the synthesis of 4.8. All reactions were performed at room temperature. 
 
a measured on the 1H-NMR spectrum of the crude as the ratio of the anomeric proton signals (CDCl3, α-anomer 5.97 
ppm; β-anomer 5.51 ppm) 
b used for the purification by chromatographic column 
c product isolated through automated chromatography (Biotage, ULTRA column, HP samplet) 
 
In the first experiment, even if the amount of the β anomer measured from the 1H-NMR spectrum of the 
crude was lower than 20%, flash chromatography using 6:4 Hex:EtOAc afforded the thioacetate product as a 
mixture of the two anomers, moreover in low yield (Table 4.1, entry 1; Fig. 4.2). Indeed, this eluent provided 
scant separation of the two isomers also on TLC (6:4 Hex:EtOAc, cerium ammonium molibdate stain) and the 
Entry Solvent time LA [4.7] β anomera y Eluentb 
1  CH2Cl2 24 h BF3 · Et2O 0.25 M 19% 35% (α/β) 6:4 Hex:AcOEt  
2 CH2Cl2 15 h TMSOTf 1.5 M 11% 36% (α only) 8:2 iPr2O:CH2Cl2  
3 
CH2Cl2 : Et2O 
(1 : 1) 
24 h TMSOTf 1.5 M 17 % / / 
4 
Et2O (and 5 
drops of 
CH2Cl2) 
50 h TMSOTf 1.5 M 21 % / / 
5 CH2Cl2 15 h TMSOTf 1.5 M 11% 68% (α only) 8:2 iPr2O:CH2Cl2c 
Chapter four 
63 
 
two spots of the starting α/β mixture and of the α/β mixture of the product were very close to each other’s. 
Additionally, hydrolysis products were visible at the bottom of the plate. 
 
Fig. 4.2 1H-NMR spectrum of the α/β mixture of compound 4.8 of entry 1 (the anomeric proton signals are H1α at 5.97 ppm, and H1β 
at 5.51 ppm) 
In the next trial, the Lewis acid was replaced with trimehtylsilyl trifluoromethanesulfonate (TMSOTf) and the 
concentration of the substrate was increased to 1.5 M (Table 4.1, entry 2). In this case, after only 15 h at 
room temperature TLC (6:4 Hex:EtOAc) showed complete conversion of the starting sugar 4.7. The 
concentration increase allowed to reduce the reaction time; furthermore the 1H-NMR of the crude in this 
case was cleaner than the previous one. Although the amount of the β-product found in the crude was lower 
(11%) and the flash chromatography with 8:2 iPr2O:CH2Cl2 as eluent allowed the isolation of the pure α-
anomer in 36% yield, the separation efficiency was still modest and much of the desired product remained 
contaminated by the β-isomer. 
Since the process follows presumably an SN1-type mechanism (through the formation of the oxocarbenium 
ion intermediate under acidic catalysis conditions), we considered that the solvent could play an active role 
in this reaction. In particular, it is well described in the literature that the participation of ethers in these 
transformations could lead to the generation of an equatorial oxonium ion, which should favour the 
formation of the thermodynamically more stable axial α-product.6 Taking this into account, the thio-
acetylation was performed in a 1:1 mixture of CH2Cl2:Et2O (Table 4.1, entry 3) and in only Et2O (with some 
drops of CH2Cl2 necessary to dissolve completely the starting sugar, entry 4): in both these experiments the 
amount of the β-anomer found in the crude was comparable with the previous results. Moreover, the low 
solubility of the peracetylated compound 4.7 in ether led to an important increment of the reaction time (50 
h for entry 4). In the last attempt, the same conditions of entry 2 were reproduced (CH2Cl2, TMSOTf), but the 
crude purification was performed by automated flash chromatography using 8:2 iPr2O:CH2Cl2 and a high-
performance column (Biotage, ULTRA column, HP samplet): only in this case starting from 1 g of crude (where 
11% of the β was present) 680 mg of the only α-product were isolated, corresponding to 68% yield and thus 
to an increment of more than 30% compared to entry 2 (Table 4.1, entry 5). 
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4.1.3 Synthesis of the pseudo-thiodisaccharide 4.9 
The pseudo-thiodisaccharide 4.9 was obtained through a one-pot ring opening reaction between the α-
thioacetate 4.8 and the epoxide 4.5 (Scheme 4.3).  
 
Scheme 4.3 Ring-opening reaction of epoxide 4.5 by 4.8 to generate the speudo-thiodisaccharide 4.9 
A one-pot procedure implies several advantages: first of all, it allows to improve the efficiency of the process 
whereby the reactants are subjected to successive transformations in the same reaction vessel, 
circumventing purification steps. In this way, a one-pot procedure can minimize chemical waste, save time, 
and simplify practical aspects. Recently, Hayashi gave an accurate definition of “one-pot process”, 
summarizing all the characteristics and the limitations of this synthetic approach, presenting also the concept 
of “pot economy”.7 Furthermore, in the case in our hands, the procedure allowed to avoid the strict 
requirements of the standard glycosylation, such as anhydrous conditions and the low temperatures. 
For the conditions of this process we were inspired by the procedure reported by Belz and co-workers two 
years ago (see chapter 1.3.4 of Thioglycosides), where diethylamine was used to deacetylate in situ the 
anomeric sulphur, generating a thiolate able to displace a sugar halide.1 We decided to adopt their conditions 
to open the epoxide 4.5, but added methanol (7-10 mol equiv) as a supplementary proton source. Below all 
the experiments performed in order to optimize this transformation are summarized and discussed (Table 
4.2). 
Table 4.2 Optimization of the one-pot ring opening reaction conditions. All the experiments were performed at room temperature 
Entry 4.8 (eq) 4.5 (eq) Cfa (M) MeOH t Convb yc Scaled notes 
1 1 1.5 0.2 7 eq 4h 56% 42% 30 mg / 
2 1.2 1 0.2 7 eq 3h 78% 48% 20 mg 
monitored by 
ESI-MS 
3 1 1 0.2 7 eq 3 days 69% 32% 30 mg 
monitored by 
NMR 
4 1+0.5 1 0.35e 7 eq 24 h 71% 30% 24 mg / 
5 1.15 1 0.6 / < 2h ≈100% 61% 12 mg 
increased 
epoxide 
concentration 
6 1.3 1 0.6 / 7 h ≈100% 77% 
scale up 
to 200 mg 
Et2NH 1.9 eq 
a final concentration of the limiting reagent. 
b measured on the 1H-NMR spectrum of the crude by the integration of the signals associated to the starting epoxide 
(2xOMe singlets at 3.68 and 3.67 ppm) and the product (2xOMe singlets at 3.70 and 3.71 ppm); see Fig. 4.4. 
c of the isolated product. 
d referred to the limiting reagent. 
e after the second addition of 4.8 (initial concentration= 0.4 M). 
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Although the epoxide was certainly the most precious reactant, since the starting material is custom made, 
in the first experiment (Table 4.2, entry 1) it was added in excess relative to 4.8 because of all the difficulties 
faced with the synthesis and the purification of the thio-acetyl compound. The reaction was performed in 
anhydrous N,N-dimethylformamide (DMF, 0.2 M concentration of the limiting agent), stirring under nitrogen 
atmosphere for 4 h at room temperature. Even after only 2 h, the TLC (6:4 Hex:EtOAc, cerium ammonium 
molibdate stain) showed the almost complete disappearance of the thio-sugar spot. The NMR of the crude 
showed, besides the unreacted epoxide, the presence of another species that was confirmed to be the 
expected product 4.9 by ESI-MS (m/z= 601, [4.9 + Na]+). Column chromatography (eluent 4:6 Hex:EtOAc) 
allowed to recover unreacted 4.5 (39%) and the pseudo-thiodisaccharide 4.9 in 42% yield. Beside affording 
the product and providing proof of principle for the synthetic concept, this experiment revealed that 
monitoring the reaction by TLC is inefficient, because detection of the epoxide becomes difficult at low 
concentration. For this reason, in the second attempt (Table 4.2, entry 2), the reaction course was followed 
by ESI-MS (Fig. 4.3). In this case, the limiting reagent was the epoxide 4.5. Analysis by ESI-MS of a sample 
collected after 30 min of reaction at room temperature showed the presence of both the epoxide (peak at 
237, [4.5 + Na]+) and the product (peak at 601, [4.9 + Na]+; Fig. 4.3, left panel). After 2 h the epoxide peak 
was no longer visible (Fig. 4.3, right panel) and the reaction was quenched (after 3 h). 
 
Fig. 4.3 Sample analysed by ESI-MS after 30’ (left) and after 2h (right); peak at 601, [4.9 + Na]+, peak at 237, [4.5 + Na]+ 
However, in the NMR spectrum of the crude reaction mixture, some unreacted epoxide was still found (22%, 
Fig. 4.4). This implied that compound 4.5 does not fly well in the mass-spectrometer, compared to the 
reaction product, suggesting to select a different monitoring tool. Anyway, product 4.9 was isolated in 
moderate yield (48% with a conversion of 78%), better than in the previous experiment (42% with a 
conversion of 56%). 
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Fig. 4.4 1H-NMR of the crude where is still visible the unreacted epoxide (pointed by the red arrows, 2xOMe singlets at 3.67 and 
3.68 ppm, and the multiplet of the H2 at 2.62 ppm; NB the ppm values were affected by the presence of still DMF and EtNH2 in the 
mixture) 
The subsequent reaction (Table 4.2, entry 3) was then performed inside an NMR tube, using DMF-d7 as 
solvent. The following signals were used to monitor the concentration of the different species, as the reaction 
proceeded: for the epoxide 4.5 the multiplet at 2.62 ppm of H2, for the thioacetate 4.8 the anomeric proton 
H1 at 5.82 ppm and for the reaction product 4.9 the multiplet at 3.8-3.88 ppm of H1’. In particular, we followed 
the consumption of the H1 of the thioacetate, the disappearance of the epoxide and the appearance of the 
diagnostic signals of the product. Plotting the relative integrations of these signals as a function of time, we 
obtained the graph reported below (Fig. 4.5) following the typical trend of a second order reaction, 
confirming the SN2 pathway. The reaction was very fast at the beginning (see the curve slopes in the first 20 
min), but after 100 min the rate decreased reaching a plateaux. In particular, it seemed that when the epoxide 
has reached a certain (low) concentration, it did not react anymore, while the thioacetate continued to be 
consumed, possibly by formation of the corresponding dithioether. 
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Fig. 4.5 Graph of the one-pot ring opening monitored by NMR spectroscopy, obtained plotting the relative NMR integrations of 
diagnostic signals associated to the reagents (4.5 and 4.8) and the product (4.9) in function of time 
To force the conditions towards a better conversion of epoxide 4.5, the thio-sugar 4.8 was added in two 
portions, starting with a stoichiometric ratio of the reagents. Addition of the second portion of 4.8 (0.5 mol 
equiv) was done after 2 h, when 4.8 was not revealed anymore by TLC, working in a more concentrated 
solution (0.35 M instead of 0.2 M, Table 4.2, entry 4). However, after 4 h, the reaction mixture was analysed 
by NMR spectroscopy revealing again the presence of the epoxide (30%). The work-up was performed after 
24 h; the unreacted epoxide was recovered (25%) after the chromatographic column and the product 4.9 
was isolated in only 30% yield. Better results were obtained by starting with an excess of thioacetate 4.8 (1.2 
mol equiv) and 1.9 equivalents of Et2NH at higher concentration (0.6 M, Table 4.2 entry 5): under these 
conditions yields increased to over 60% after only 2 h. Furthermore, this experiment revealed that the 
additional MeOH was not required and that the epoxide could be reprotonated directly by the ammonium 
salt generated from Et2NH (see Fig. 4.6). Finally, the best conditions were found by further increasing both 
the concentration of the thio-sugar (1.3 mol equiv added) and the reaction time (7 h) (Table 4.2 entry 6). 
Under these conditions, scale up of the process to 200-300 mg of epoxide was allowed with reproducible 
yields.  
Collecting all the information obtained during the optimization phase, we hypothesized a mechanism for the 
one-pot epoxide opening sequence (Fig. 4.6). 
 
Fig. 4.6 Proposed mechanism for the one-pot ring opening reaction of 4.5 by 4.8 
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The first equivalent of diethylamine acts as a nucleophile, selectively deacetylating the sulphur in the 
anomeric position, affording thiol 4.8a that reacts with excess Et2NH in an acid/base equilibrium. The thiolate 
4.8b thus generated can react with 4.5, forming an alkoxide which is protonated by the Et2NH+ salt (or by the 
thiol itself) thus shifting the equilibrium towards the product. The pseudo-thiodisaccharide 4.9 is obtained as 
a single isomer as the product of an exclusively trans-diaxial opening of epoxide 4.5. The tendency of epoxides 
to open trans-diaxially is well known and described in literature.8 Furthermore, starting from an 
enantiomerically pure cyclohexene dicarboxylic acid (compound 4.3) and considering the real conformation 
assumed by the epoxide 4.5 (reported in Fig. 4.7),9 only one isomer can be actually obtained, regardless of 
the carbon that undergoes nucleophilic attack. 
 
Fig. 4.7 Conformation of the epoxide 4.5 
The structure of product 4.9 and the conformation of the cyclohexane ring were confirmed from coupling 
constant analysis of the cyclohexane protons in the 1H-NMR spectrum of the isolated compound: while in 
deuterated chloroform (CDCl3, Fig. 4.8, left panel) the coupling constants could not be accurately measured, 
the spectrum in CD3OD showed a large 11 Hz vicinal spin–spin coupling constant for protons H4’ and H5’ (Fig. 
4.8, right panel) indicating a trans-diaxial orientation. 
     
Fig. 4.8 1H-NMR spectrum of 4.9 in in CDCl3 (left panel) and in CD3OD (right panel); numbering of the ring is unconventional and 
used to simplify comparison with the natural Manα(1,2)Man disaccharide 
The locked conformation (populated by ≥90%) of the cyclohexane moiety is due to the presence of the 
carbomethoxy groups, which preferentially assume the equatorial position: this feature is characteristic of 
vicinal trans-cyclohexanedicarboxylic acid derivatives, including the pseudo-dimannoside 2.1, and it allows 
the distal substituents in 4.9 to occupy the axial position, thus mimicking the 3D features of an α-
mannopyranose residue.10 
Once the ring opening reaction was optimized and the mechanism of the process was rationally defined, we 
tried to further improve the reaction conditions by employing different techniques. The same process was 
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initially performed in a flow micro-reactor. At the beginning, we were inspired by all the potential advantages 
of this technology, compared to batch vessels. Some of them are reported below: 
· improved heat transfer and mixing processes (that means a better control on the reaction 
parameters) 
· the possibility to change the reaction conditions while the reactor is operational (that means fast 
optimization) 
· the possibility to rapidly obtain several chemical information from mg quantities of starting material 
· the opportunity to transfer the process to a large scale production by exploiting an automated flow 
process (interesting for an industrial application, for example) 
In particular, we used the kit supplied by Chemtrix, reported in Fig. 4.9, that is composed by: 
· gas-tight syringes, where the reactants are charged, dissolved in the reaction solvent 
· a thermal controller, that allow to set the required reactor temperature 
· a micro-reactor within a thermostated reaction platform 
· a back-pressure regulator (optional), that prevents boiling of reactants or solvent when the reaction 
temperature is above their boiling points 
  
Fig. 4.9 Kit supplied by Chemtrix for flow-processes 
In particular, the micro-reactor is a glass device containing channels in which reagent solutions can first be 
brought to the reaction temperature before they are mixed and allowed to react. The main components of 
a micro-reactor are listed below: 
· Mixer: where reactants are combined 
· Residence time unit: a thermally regulated micro channel in which the reaction takes place 
· Quench inlet: where the reaction products are mixed with a quench agent before collection 
· Outlet: where reaction products are collected 
There are different micro-reactors specifically designed for various processes. In Fig. 4.10 some of them are 
reported and the reaction type for which they are used is indicated. 
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Fig. 4.10 Examples of micro-reactors (supplied by Chemtrix) 
Flow reactions are performed by pumping reagent solutions into the reactor (via capillary tubing) where they 
are mixed and reacted. At the μm length scale, high viscous forces dominate and the flow is laminar. As a 
result, diffusion processes dominate and determine the mixing time, which is typically in the sec range. 
Compared to batch processes, the reaction time in a flow reactor is dependent on the reactant flow rate and 
the reactor volume, through the equation reported below: 
 
Keeping in mind the mechanism of the one-pot ring opening (illustrated and discussed before, see Fig. 4.6), 
for the first trial we selected the set-up depicted below (Fig. 4.11). 
Table 4.3 Conditions used for the first trial, in terms of final 
concentration of 4.5 (into the reactor) and equivalents of 
the other reagents 
[4.5]f 4.8 Et2NH 
0.3 M 1.3 eq 1.9 eq 
 
 
 
 
 
𝐑𝐞𝐬𝐢𝐝𝐞𝐧𝐜𝐞 𝐓𝐢𝐦𝐞 =
Reactor Volume (μl)
Overall Flow Rate (μl min−1)
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This reactor was designed for a reaction like A+B= P1+C= P2+Q= P, where A+B were thioacetate 4.8 and 
diethylamine (pushed through the first two inlet channels, dissolved in anhydrous DMF) that had to form the 
thiolate in situ (P1). At this point, the epoxide was charged into the third inlet channel (C) to be opened by 
the thiolate and give the final product 4.9 (P), which left the system through the output channel (keeping 
close the quench inlet, Q). For the first experiments, we decided to fix the flow rate, varying the temperature. 
The final concentration of the epoxide was 0.3 M and the molar equivalents of each reactant the same as in 
the optimized batch conditions (Table 4.3, N.B: a concentration of 0.3 in the reactor means that the reactants 
were previously charged into the syringe pumps as 0.6 M solutions). Finally, the crude collected outside the 
reactor was analysed by 1H-NMR spectroscopy to measure the conversion of the epoxide 4.8 into the 
product, using the same signals mentioned above. The preliminary results are reported in the table below 
(Table 4.4). 
Table 4.4 Results obtained (in terms of conversion) performing the one-pot reaction in the micro-reactor 3224 with different flow 
rates of the reactants at different temperatures 
Entry Flow T 
Residence 
time 
Conversion 
1 7.5 μl/min 60°C 2 min 13% 
2 7.5 μl/min 70°C 2 min 17% 
3 7.5 μl/min 80°C 2 min 13% 
In these conditions, the conversions were always below 20% and the sugar appeared degraded in the crude’s 
spectrum, whereas the unreacted epoxide was found still intact (Fig. 4.12).  
 
Fig. 4.12 1H-NMR spectrum of the crude of entry 2 of Table 4.4 
The crude of each reaction was also checked by TLC: numerous spots with low Rf were found, presumably 
derived from the sugar. We concluded that the formation of the thiolate was very fast and it occurred 
immediately when the thioacetate encountered the diethylamine. Probably, in the time between the first 
Fig. 4.11 Micro-reactor used for the first trials (on the right); the reaction conditions (Table 4.3 on the left) 
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mixer and the inlet of the epoxide, the sugar underwent degradation and the reaction ended up with a low 
conversion. 
The micro-reactor was then replaced with the one depicted below (Fig. 4.13). In the first syringe pump the 
thioacetate 4.8 and the epoxide 4.5 dissolved in DMF were charged (since they could not react with each 
other without the amine); in the second one the diethylamine in DMF. In this way, when the thiolate was 
formed, the epoxide was already present, ready to be opened.  
Table 4.5 Conditions used in terms of final 
concentration of 4.5 (into the reactor) and 
equivalents of the other reagents  
[4.5]f 4.8 Et2NH 
0.3 M 1.3 eq 1.9 eq 
 
 
 
 
 
 
 
Keeping the same residence time (2 minutes) than in the previous experiments (and thus decreasing the flow 
rate to 2.5 μl/min), we immediately observed better results in terms of conversion, even at 40°C (Table 4.6, 
entry 1, 29% conversion). However, increasing the temperature did not lead to any improvement, neither 
did changing the flow rates. 
Table 4.6 Optimization of the conditions for the one-pot reaction performed in micro-reactor 3222 
Entry Flow Temperature 
Residence 
time 
Conversion 
1 2.5 μl/min 40°C 2 min 29% 
2 2.5 μl/min 50°C 2 min 28% 
3 2.5 μl/min 60°C 2 min 
not 
detectable 
4 2.5 μl/min 70°C 2 min / 
Only when the concentration into the reactor was doubled (from 0.3 M to 0.6 M) and the residence time 
increased, better results were observed (Table 4.7, entry 1 and 2), until conversion reached 69% (Fig. 4.14) 
with 30 min of residence time (entry 4).  
Table 4.7 Best results obtained for the one-pot reaction performed in the flow micro-reactor 3222 
Entry Flow Temperature 
Residence 
time 
Conversion 
1 0.5 μl/min 25°C 10 min 45% 
Fig. 4.13 Micro-reactor 3222 employed (on the right); the reaction conditions (Table 4.5 on the left) 
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2 0.5 μl/min 40°C 10 min 55% 
3 0.25 μl/min 50°C 20 min 65% 
4 0.17 μl/min 60°C 30 min 69% 
 
Fig. 4.14 1H-NMR spectrum of the crude of entry 4, Table 4.7 
However, the low flow rate, required to obtain reasonable results in terms of conversion, made these 
conditions clearly not competitive with the batch ones and the use of this technique was not further pursued. 
When the reaction was performed under micro-wave irradiation at 60°C, reproducing the optimized batch 
conditions, complete consumption of the starting epoxide 4.5 was observed after 1h, giving the final product 
4.9 in 75% yield and allowing the scale up of the reaction from 50 mg to 200 mg, with reproducible yields. 
Below all the results obtained for the one-pot reaction are summarized: 
· Batch conditions: room temperature, 7 h, conversion= 89%, y= 77% 
· Flow conditions: 60°C, 30 min (residence time), conversion= 69% (scale up not allowed) 
· MW conditions: 60°C, 1 h, conversion= 90%, y= 75% (scale up allowed) 
4.1.4 Deacetylation of 4.9 and conformational analysis of 4.10 
The pseudo-thiodisaccharide 4.9 underwent deacetylation in standard Zemplén conditions (methoxide 
solution in anhydrous methanol, at room temperature) giving quantitatively compound 4.10 after only 10 
minutes (Scheme 4.4). 
 
Scheme 4.4 Zemplén deacetylation of compound 4.9 
To predict the three-dimensional structure of compound 4.10, we followed the same approach already used 
for the original pseudo-dimannoside 2.1. NMR studie had revealed that 2.1 has a conformational distribution 
similar to the natural disaccharide Manα(1,2)Man. Two conformations, dubbed E (for Extended) and S (for 
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Stacked), in fast equilibrium around the (pseudo)glycosidic bond, are characterized by two mutually exclusive 
NOE contacts: the H1-H1’ contact for the S conformer, and the H1- H3’eq contact for the E conformer (Fig. 4.15, 
the unconventional numbering of the cyclohexane ring was adopted for easier comparison with natural 
sugars).10 
 
Fig. 4.15 E and S conformations found at lowest energy for the pseudo-dimannoside 2.1 and their typical NOE contacts 
A qualitative analysis of the NOE data allowed deducing that the E conformer of 2.1 is the preferred 
conformation in solution (D2O). Interestingly, the E conformation was also the one observed in the X-ray of 
the DC-SIGN:2.1 complex.11 
The conformation of 4.10 was investigated by NOESY experiments (in D2O, 500 MHz) performed in 
collaboration with prof. Vasile and prof. Sattin. The experimental data were then compared with the results 
obtained for the pseudo-dimannoside 2.1. This analysis showed an intense H1-H3’eq cross-peak, while the H1-
H1’ contact was revealed as a weak cross-peak, using 800 ms of mixing time (Fig. 4.16).  
  
Fig. 4.16 NOESY spectrum (500 MHz, D2O, 300 K, 800 ms of mixing time) of compound 4.10 performed with solvent suppression 
These results suggested that compound 4.10 assumes preferentially an extended-like conformation (that is 
also the one found at the lowest energy for the pseudo-dimannoside 2.1). 
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A conformational search of 4.10 (performed with the MM3* force field, by the prof. S. Sattin) supported the 
existence of both S and E conformers of similar strain energy (Fig. 4.17). However, due to the increased length 
of the C-S bond relative to the C-O bond, the calculated H1-H1’ distance in the S conformation of 4.10 is 3.1 
Å, as opposed to 2.6 Å in 2.1, in qualitative agreement with a reduced intensity of the H1-H1’ cross-peak.  
 
Fig. 4.17 Stacked (S) and Extended (E) conformations of the pseudo-1,2dimannoside 2.1 (on the top), and the pseudo-thio-1,2-
dimannoside 4.10 (on the bottom). The mutually exclusive NOE contacts defining the conformation are indicated by arrows. 
Overall, the data are consistent with both the pseudo-dimannoside 2.1 and the pseudo-thiodimannoside 
4.10 populating the same conformational space and mimicking the conformational features of the native 
Manα(1,2)Man sugar.12 
4.1.5 Functionalization of 4.10 with an azido-linker 
To allow the synthesis of multivalent derivatives of 4.10, we planned the functionalization of the free alcohol 
function of the cyclohexane moiety with an azido-terminated linker (Fig. 4.18).  
 
Fig. 4.18 General plan for the functionalization of 4.10 with an azido-linker 
To check the ability of this molecule to undergo esterification, the coupling conditions were tested initially 
between the peracetylated-pseudo-thiodisaccharide 4.9 and pivaloyl chloride 4.11, to give the pivaloate 
ester 4.12 in 59% yield (Scheme 4.5). 
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Scheme 4.5 Functionalization of 4.9 with pivaloyl chloride 4.11 and subsequent deacetylation to obtain compound 4.13 
This compound could be selectively deacetylated under Zemplén conditions (using a 0.02 M solution of 
MeONa in anhydrous MeOH), affording the final mimic 4.13 in quantitative yield and confirming that the 
pivalic framework was bulky enough to allow selective hydrolysis of the acetyl groups. 
Having tested the resistance of a bulky ester, we looked for something similar: a simple molecule, possibly 
disubstituted in α-position, with an azide at the end of a short aliphatic chain. 
In 2010 Sewald and co-workers reported the synthesis of a β-azidopivalic acid 4.15, starting from the β-
chloropivalic acid 4.14 (Scheme 4.6).13 
 
Scheme 4.6 Conditions reported by Sewald et al.13 for the synthesis of 4.15 
The reaction is performed in refluxing water, using excess of NaN3 and worked-up by acidifying the cooled 
mixture to pH 2-3 by addition of concentrated aqueous hydrochloric acid. We deemed this procedure unsafe, 
since highly toxic and explosive HN3 is produced. Additionally, the product 4.15 itself is to be considered with 
caution, since the rule of thumb to gauge the safety of organic azides is the one reported below: 
(𝑁𝐶𝑎𝑟𝑏𝑜𝑛 +  𝑁𝑂𝑥𝑦𝑔𝑒𝑛)
𝑁𝑁𝑖𝑡𝑟𝑜𝑔𝑒𝑛
 ≥ 3 
The sum of the total number of carbon atoms plus the total number of oxygen atoms divided by the total 
number of nitrogen atoms should not exceed (or be equal at least) 3. The calculated ratio for the azido pivalic 
acid 4.15 is 2.3, meaning that this compound must be handled very carefully. 
For these reasons, the reaction conditions of the ClN3 exchange reported by Sewald were modified and 
the work-up procedure made safer, starting from the same β-chloropivalic acid 4.14 (commercially available 
at low cost, 5 g/ 21,60 €). The process was performed in N,N-dimehtylformamide, at 60°C for 3 days (Scheme 
4.7) and finally the crude was diluted with non-flammable dichloromethane and filtered over celite, which 
removed the excess sodium azide, avoiding acidification of the mixture. 
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Scheme 4.7 Our conditions for the preparation of 4.15 
The formation of the azido compound 4.15 was confirmed by the up-field shift of the methylene group 
observed in the 1H-NMR of the crude from 3.63 ppm in the chloride to 3.43 ppm in the azide (Fig. 4.19). 
 
Fig. 4.19 1H-NMR (CDCl3) spectra of 4.14 (in blue) and 4.15 (in red) superimposed: see the shift of the CH2 signal next to the Cl in 
4.14 from 3.63 to 3.43 ppm. 
For the coupling between 4.15 and 4.9 we took inspiration again from Sewald’s work who described the 
esterification of a secondary alcohol with the acyl chloride of 4.15, freshly prepared in situ (Scheme 4.8).13 
 
Scheme 4.8 Conditions for the esterification of the carboxylic function of 4.15 proposed by Sewald et al.13  
These conditions were reproduced in our laboratory, increasing the temperature to 40°C (boiling point of the 
solvent, Scheme 4.9). This transformation occurred by using oxalyl chloride, a catalytic amount of DMF in 
dichloromethane for 3 h.  
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Scheme 4.9 Esterification coupling between 4.9 and the corresponding acyl chloride of 4.15 to generate 4.17 
In this process, the real chlorinating agent is the imidoyl chloride generated in situ from the reaction between 
DMF and the oxalyl chloride (Fig. 4.20). Then the reaction proceeds as reported below, regenerating the DMF 
catalyst and affording the product as the acyl chloride 4.16. 
 
Fig. 4.20 Mechanism for the synthesis of the acyl chloride 4.16 using DMF and oxalyl chloride 
In the next step (Scheme 4.9), after testing milder conditions for the esterification process (pyridine as 
solvent and dimethylaminopyridine, at different temperatures) without obtaining yields above 40%, the 
protocol of Sewald was followed: it involved the use of DMAP and triethylamine (equimolar to 4.16, used in 
excess compared to 4.9) for the esterification of a secondary bulky alcohol. In our case, the process occurred 
at room temperature (after the addition of 4.16 as last reactant at 0°C) and proceeded for 2.5 h, affording 
the ester 4.17 in good yield (89%, Scheme 4.9). 
Finally, the pseudo-thiodisaccharide 4.17 underwent Zemplén deacetylation in the conditions previously 
tested for the pivaloate ester 4.12 (Scheme 4.10). 
 
Scheme 4.10 Deacetylation of 4.17 
In the first experiment, this hydrolysis reaction was performed in a very small scale (8 mg, Table 4.8 entry 1) 
and the yield of the isolated product was quantitative. However, when the reaction was scaled up to 50 mg, 
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50% of fully hydrolysed compound 4.10 was found in the 1H-NMR of the crude (entry 2). 4.18 was anyway 
isolated from the mixture, confirming its stability under chromatographic conditions. 
Table 4.8 Optimization of the deacetylation conditions of 4.17 
Entry Scale [MeONa/MeOH] [4.17]f T Reaction time 4.10a y 
1 8 mg 0.02 M 0.02 M r.t. 10 min 
not 
observed 
quant. 
2 50 mg 0.02 M 0.02 M r.t. 10 min 50% 29 %b 
3 50 mg 0.02 M 0.02 M 0°C 12 min 51% / 
4 30 mg 0.01 M 0.02 M 0°C 20 min 
not 
observed 
quant. 
5 50 mg 0.01 M 0.02 M 0°C 25 min 27% / 
a (hydrolyzed product) measured by 1H-NMR spectrum of the crude 
b isolated product by chromatographic column, CH2Cl2:MeOH (95:5) 
The process performed at 0°C did not lead to any improvements (entry 3). At this point, we came back to a 
smaller scale (30 mg), decreasing the concentration of the methoxide solution (to 0.01 M, entry 4) and 
maintaining the lower temperature. The reaction was quenched after 20 min, when the spot of the starting 
peracetylated sugar disappeared on the TLC (95:5 CH2Cl2:MeOH, cerium ammonium molibdate stain). In this 
case, no product of hydrolysis was observed in the crude and compound 4.18 was isolated in quantitative 
yield. The attempt to reproduce these conditions on a bigger scale was useless (entry 5).  
In conclusion, although the pivalic azido linker was rationally selected to survive in hydrolytical conditions, 
the Zemplén deprotection had to be performed very carefully and in mild conditions to limit the formation 
of the hydrolysed compound. 
Although this approach was efficient enough to allow the synthesis of multivalent compounds (see Chapter 
4.1.8), the results obtained made prohibitive the scale up of the process and forced us to reconsider the 
synthetic strategy for the preparation of these mimetics (see Chapter 5 of Aziridines). 
4.1.6 Surface Plasmon Resonance (SPR) inhibition studies with DC-SIGN 
In order to investigate the biological activity of these new thio-glycomimetics and to compare their affinity 
towards DC-SIGN to the original pseudo-dimannoside 2.1, compounds 4.10 and 4.13 were tested by Surface 
Plasmon Resonance (SPR) inhibition assays from Franck Fieschi’s group, in Grenoble. In particular, through 
these tests, the ability of the glycomimetics to inhibit DC-SIGN ECD (Extra Cellular Domain) binding to 
immobilized mannosylated Bovine Serum Albumin (Man-BSA) on a SPR sensor chip was measured. The IC50 
values (obtained from the same campaign) are reported below (Fig. 4.21). 
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Fig. 4.21 IC50 values obtained through SPR inhibition assay for the final pseudo-thiodisaccharides 4.10 and 4.13, compared to that 
of the pseudo-dimannoside 2.1 
The biological results revealed that, replacing the glycosidic oxygen atom of 2.1 with a sulphur, the activity 
remained perfectly comparable with the corresponding O-linked glycomimetics and also the presence of a 
bulky substituent connected to the cyclohexane ring did not affect the affinity for the receptor. 
4.1.7 Mannosidase stability 
As mentioned before, these new thio-mimetics were designed to be first of all more metabolically stable than 
the original pseudo-dimannoside 2.1. The stability of 2.1 to enzymatic hydrolysis was previously investigated: 
the molecule is a substrate of jack-bean mannosidase, but it appeared to be significantly more resistant (8-
fold) than the natural disaccharide.10 The experiment consisted of an incubation of the glycomimetic (for 30 
min at 37°C) with increasing concentrations of the enzyme (from 0.5 µg/mL to 10 µg/mL); afterwards the 
mixture was lyophilized and the products analyzed by GC. The extent of the hydrolysis was evaluated by 
integration of the peaks relative to 2.1 and to the aglycon part (found as product of the hydrolysis). 
To compare the stability of the pseudo-thiodisaccharide 4.10 to the O-analog 2.1, we set up a different 
experiment: the test was performed into an NMR tube, in a buffer solution of KH2PO4 in deuterium oxide 
(D2O) at pH 4.5 (maximum activity pH for the α-mannosidase employed), where the substrate was added first 
and finally the enzyme. In these experiments the concentration of the enzyme was more than 10-fold higher 
(140 μg/mL) compared to the previous tests performed in 2004. The enzyme utilized for this experiment was 
the α-mannosidase from Canavalia ensiformis (Jack bean) that is commercially available as an ammonium 
sulfate suspension (3 M) at pH 7.5. The extent of hydrolysis was evaluated by NMR spectroscopy, by recording 
proton spectra over time. 
In Fig. 4.22 are reported the spectra recorded at different time for compound 2.1. We followed the 
disappearance of the H1 proton of the pseudo-dimannoside (4.95 ppm) and the appearance of the H1 of free 
mannose (5.10 ppm) that is released when the glycosidic bond is cleaved by the enzyme. After only 85 min, 
complete hydrolysis of 2.1 was observed: indeed the last spectrum (bottom trace) revealed only the presence 
of the anomeric proton of the free mannose unit. 
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Fig. 4.22 Hydrolysis of 2.1 over the time monitored by 1H-NMR spettroscopy; highlighted in blue the H1 signal of 2.1 at 4.95 ppm, in 
yellow the H1 signal of the free mannose at 5.10 ppm  
The same experiment performed for the thio-glycomimetic confirmed the higher resistance of this compound 
towards enzymatic hydrolysis, since no degradation of 4.10 was observed, even after 24 h (see the last 
spectrum on the bottom where 4.10 appeared clearly intact, Fig. 4.23). 
 
Fig. 4.23 Experiment performed for 4.10 that did not show any hydrolysis; highlighted in red the H1 signal og 4.10 at 5.33 ppm 
4.1.8 Creation of multivalent systems 
As mentioned in the Introduction, multivalent carbohydrate presentations can be exploited to overcome the 
low affinity typical for the interaction between sugars and lectins. During my visit in Sevilla, at the “Instituto 
de Investigaciones Químicas-IIQ” under the supervision of Dr. F.  Javier Rojo, I worked on the synthesis of 
multivalent scaffolds, such as dendrimers and glyconanogels, both decorated with the pseudo-
thiomannoside 4.18 to be used as DC-SIGN antagonists. 
4.1.8.1 As dendrimers 
The dendrimer core 4.19 (Scheme 4.11) bearing three terminal alkyne functions had already been 
synthetized by Rojo’s group; it was then coupled with two commercially available spacers of different length, 
the chloroethyl ether 4.20 and the tetraethylene glycol dichloride 4.21.  
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Scheme 4.11 Synthesis of the dendrimer cores 4.22 and 4.23 starting from commercially available chloroethyl ether 4.20 and 
tetraethylene glycol dichloride 4.21 
The processes were set up in the same conditions, using NaOH and tetrabutylammonium hydrogensulfate at 
45°C for one day, employing a very large excess of the chlorinated peg chains. In both cases the final 
compounds (4.22, 4.23) were obtained in about 80% yield of the isolated products.  
Afterwards, the Cu(I)-catalyzed azido-alkyne cycloaddition (CuAAC) was performed with the azido compound 
4.18 on 4.22 and 4.23 under micro-wave irradiation, at 60°C, using CuSO4 as copper source, sodium ascorbate 
as reductant specie and TBTA as stabilizer of the active form of the metal-catalyst (Scheme 4.12).  
 
Scheme 4.12 Synthesis of dendrimers 4.26 and 4.27 decorated with thio-glycomimetic 4.18 
The trivalent systems 4.24 and 4.25 were purified through size exclusion chromatography (using a Sephadex 
LH-20 column in methanol) and the clean compounds, obtained in excellent yields, analyzed by ESI-MS and 
NMR spectroscopy. Subsequently, the chloride of 4.22 and 4.23 was replaced with an azide in standard 
conditions to afford the final products 4.26 and 4.27 in quantitative yield (after another purification by 
Sephadex). 
At this point, 4.26 and 4.27 could be exploited directly as multivalent DC-SIGN ligands or incorporated in a 
more complex structures (like glyconanogels) to further raise the multivalency, thanks to the presence of 
that terminal azides. 
4.1.8.2 As glyconanogels 
Nanogels (NGs) are a type of cross-linked, nanometric-sized hydrogel particles with a tunable size and an 
interior network that is typically used for the incorporation of therapeutics. NGs are soft, flexible and quite 
stable.14-16 These structures require an easy preparation and they have been mainly employed as drug and 
gene delivery system. Recently (in 2011), Haag and his team highlighted the potential of these nanostructures 
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as antiviral agents.17 Later on, Rojo’s group developed a straightforward preparation of glycoNGs specifically 
designed to inhibit viral infections by multivalent interaction with the cellular receptor DC-SIGN, mimicking 
the virus dimension (Fig. 4.24). In particular, their glyconanogels have been decorated with multiple copies 
of mannose that are exposed on the nano-particle surface (results not published yet). The antiviral activity 
towards pseudo-Ebola virus of these structures are under investigations. 
 
Fig. 4.24 Antiviral activity of glycoNGs by multivalent interaction with DC-SIGN receptors 
With the aim to further improve the activity of these structures, we decided to prepare glycoNGs 
incorporating the thio-glycomimetic 4.18.  
Below the preparation of the glyconanogels  is reported schematically (Fig. 4.25). 
 
Fig. 4.25 General procedure for the preparation ofglyconanogels decorated with glycomimetic 4.18 
The preparation of the glyconanogels starts with a commercially available polyethylene glycol (PEG-3000), 
chosen since the presence of PEG moieties in the molecule should result in an enhanced biocompatibility and 
longer circulation times in the blood stream (stealth properties). This structure undergoes some 
modifications (synthesis developed and optimized by Noelia de la Cruz, PhD student, and Ana Sousa-Herves, 
Post-doc of Rojo’s group; results not published yet) until the formation of the alkyne 4.28. Personally, I 
performed the subsequent CuAAC coupling between 4.28 and mimetic 4.18 to generate the polymerizable 
building block 4.29 as “carbohydrate-derivate monomer” (Scheme 4.13). 
 
Scheme 4.13 Click reaction between 4.28 and 4.18 to generate the carbohydrate-derivative monomer 4.29 
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4.29 was purified by Sephadex LH-20 column in MeOH and then analysed and characterized by NMR 
spectroscopy. The next step was the creation of the glyconanogels, through free-radical polymerization 
process, using inverse miniemulsion to template NGs formation. Miniemulsion technique allowed the 
creation of stable nanodroplets (typically with size range in 50-500 nm) in a continuous phase by applying 
ultrasonication.18-19 The formation of the miniemulsion was followed and confirmed by Dynamic Light 
Scattering (DLS). The procedure was optimized by Rojo’s group (results not published yet).  
 
Fig. 4.26 DLS analysis of the miniemulsion that showed the presence of only one population of nanoparticles 
The DLS analysis (Fig. 4.26) showed that the miniemulsion was composed by only one population of nano-
particles (diameter average= 200 nm), with a relatively narrow polydispersity (PdI < 0.2). 
Subsequently the polymerization took place inside the nanodroplets with the addition of an initiator and  
finally, an extensive purification afforded the desired glycoNGs, which were characterized by DLS. The DLS 
analysis revealed the presence of particles with a hydrodynamic diameter around 100 nm and narrow size 
distribution (Fig. 4.27). 
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Fig. 4.27 DLS analysis of the final NGs (on the left); comparison between hydrodinamic diameters of our NGs and the HIV 
The diameter of these NGs was very similar to that of HIV (90-120 nm).20 We are currently waiting for the 
biological activity results obtained for these particles. 
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4.3 Conclusions 
A straightforward one-pot ring opening reaction between tetra-O-acetylmannose-1-thioacetate 4.8 and 
epoxide 4.5 was proposed and optimized for the synthesis of the pseudo-thiodisaccharide 4.9, designed to 
mimic the pseudo-dimannoside 2.1 and thus the natural disaccharide.  
   
Fig. 4.28 General scheme for the preparation of the corresponding pseudo-thiodimannoside 4.10 of 2.1 
Conformational analysis of the corresponding deacetylated product 4.10 by NMR-NOESY studies, supported 
by molecular modelling, strongly suggested that the molecule is a mimic of the natural Mana(1,2)Man sugar 
and shares the conformational features of the O-linked analog 2.1. Interaction studies with DC-SIGN, 
performed by Surface Plasmon Resonance (SPR) confirmed that the molecule acts as a DC-SIGN antagonist 
and has the same potency of analog 2.1. These results were all collected and recently published.1  
The mannosidase stability of 4.10 was tested against hydrolysis by a commercially available α-mannosidase 
and was found to be significantly higher than that of 2.1.  
4.10 was finally equipped with an azido-terminated ester tether (giving compound 4.18) which survived 
Zemplén deprotection conditions. However, the scale-up of the deacetylation process was prohibitive for 
this compound that was observed to undergo hydrolysis of the ester bond.  
The azido group of 4.18 allowed the creation of multivalent systems (dendrimers and glyconanogels, Fig. 
4.29) and this work was carried out in Sevilla, under the supervision of Dr. Javier Rojo.  
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Fig. 4.29 Multivalent scaffolds decorated with the pseudo-thiodimannoside 4.18 synthesized in Sevilla 
1) A. Tamburrini; S. Achilli; F. Vasile; S. Sattin; C. Vives; C. Colombo; F. Fieschi; A. Bernardi, Bioorg Med Chem 
2017, 25, 5142-5147. 
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4.3 Experimental section 
General methods and procedures for the monovalent ligands 
Chemicals were purchased from commercial sources and used without further purification, unless otherwise 
indicated. When anhydrous conditions were required, the reactions were performed under nitrogen or argon 
atmosphere. Anhydrous solvents were purchased from Sigma-Aldrich® with a content of water ≤0.005%. 
Triethylamine (TEA), methanol and dichloromethane were dried over calcium hydride, THF was dried over 
sodium/benzophenone and freshly distilled. N,N-dimethylformamide (DMF) was dried over 4Å molecular 
sieves.  Reactions were monitored by analytical thin-layer chromatography (TLC) performed on Silica Gel 60 
F254 plates (Merck), and TLC Silica gel 60 RP-18 F254s (Merck) with UV detection (254 nm and 365 nm) and/or 
staining with ammonium molybdate acid solution, potassium permanganate alkaline solution or ninhydrin. 
Flash column chromatography was performed according to the method of Still and co-workers1 using silica 
gel 60 (40-63 μm, Merck). Automated flash chromatography was performed with Biotage Isolera Prime 
system, Biotage SNAP ULTRA cartridges were employed. Microwave irradiation was performed by a Biotage 
Initiator+ system. The kit for the flow processes was supplied by Chemtrix (Labtrix® Start system). NMR 
experiments were recorded on a Bruker AVANCE-400 MHz instrument at 298 K. Chemical shifts (δ) are 
reported in ppm. The 1H and 13C NMR resonances of compounds were assigned with the assistance of COSY, 
HSQC and in some cases NOESY experiments. Multiplicities are assigned as s (singlet), d (doublet), t (triplet), 
q (quartet), quint (quintet), m (multiplet). The NOESY spectra of 4.10 were acquired using a Bruker 500 MHz 
instrument at 300 K. Spectra (8 scans and 256 increments) were collected using three mixing times (300, 600 
and 800 ms). Water suppression was achieved by excitation−sculpting pulse sequence. Mass spectra were 
recorded on Apex II ICR FTMS (ESI ionization-HRMS), Waters Micromass Q-TOF (ESI ionization-HRMS) or 
ThermoFischer LCQ apparatus (ESI ionization. Specific optical rotation values were measured using a Perkin-
Elmer 241, at 589 nm in a 1 dm cell. The following abbreviations are used: DCC (N,N’-
dicyclohexylcarbodiimide), DCM (CH2Cl2 dichloromethane), m-CPBA (meta-chloroperoxybenzoic acid), DMF 
(N, N’-dimethylformamide), DMAP (4-dimethylaminopyridine), TBTA (tris[(1-benzyl-1H-1,2,3-triazol-4-
yl)methyl]amine), TFA (trifluoroacetic acid). 
SPR (Surface Plasmon Resonance) studies were carried out using a ProteOn XPR36 Protein Interaction Array 
Apparatus (Bio-Rad Laboratories, Hercules, CA). The instrument is characterized by six parallel flow channels 
that can immobilize up to six ligands on the same sensor chip.2 Mannosylated Bovine Serum Albumin (Man-
BSA, Dextra Laboratories, Reading, UK) was immobilized, as a reference, in a parallel different channel. 
Immobilization levels were typically 3000 and 4000 resonance units (RU, 1RU 1 pg protein/mm2), 
respectively. 
The epoxide 4.5 was prepared as previously described3 2,3,4,6-Tetra-O-acetyl-1-S-acetyl-α-D-
mannopyranose 4.8 was prepared from penta-O-acetylmannopyranose 4.7 following a reported procedure4 
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and 2,2-dimethyl-3-azido-propanoylchloride 4.16 was synthesized from commercially available 2,2-dimethyl-
3-chloro-propanoic acid according to Sewald,5 with modifications. 
Synthesis of O-linked pseudo-thiodisaccharides 
(1S,2S)-dimethyl cyclohex-4-ene-1,2-dicarboxylate 4.4 
 
To a solution of diacid 4.3 (3 g, 17.6 mmol) in fresh distilled MeOH (58 mL), sulphuric acid (188 μL), was added 
at room temperature. The mixture was then heated to reflux (60-65°C) and stirred overnight, under nitrogen 
atmosphere. The reaction was monitored by TLC (Hex:EtOAc 1:1, potassium permanganate stain). The 
solvent was evaporated at reduced pressure to half the starting volume and then the mixture diluted with 
EtOAc and washed with NaHCO3 and H2O. The organic phases were dried over anhydrous Na2SO4 and the 
solvent was evaporated under vacuum to afford product 4.4 (3.17 g, 16 mmol) as a colourless oil in 91% yield. 
1H-NMR (400 MHz, CDCl3): δ = 5.71-5.66 (m, 2H, H4, H5), 3.69 (s, 6H, 2xOCH3), 2.91-2.81 (m, 2H, H1, H2), 2.47-
2.36 (m, 2H, H3eq, H6eq), 2.24-2.12 (m, 2H, H3ax, H6ax). 
1H-NMR (400 MHz, CDCl3): 
 
 
  
Experimental section  
91 
 
(3S-4S)-dimethyl 7-oxabicyclo[4.1.0]heptane-3,4-dicarboxylate 4.5 
 
Compound 4.4 (180 mg, 0.91 mmol) was dissolved in fresh distilled CH2Cl2 (2 mL) under nitrogen atmosphere 
and mCPBA (225 mg, 1.27 mmol) was added. The mixture was stirred at room temperature for 2 h. The 
reaction was monitored by TLC (Hex:EtOAc 7:3, cerium ammonium molibdate stain). The mixture was then 
diluted with CH2Cl2 and washed with Na2CO3 (x2) and H2O. The organic phase was dried over anhydrous 
Na2SO4 and the solvent was removed at reduced pressure, affording product 4.5 (181 mg, 844 mmol) in 93% 
yield. The spectral data of the compound corresponded to those reported3 and no further purification was 
required. 
1H-NMR (400 MHz, CDCl3): δ = 3.68 (s, 3H, OMe), 3.67 (s, 3H, OMe), 3.26-3.23 (m, 1H, H4), 3.20-3.17 (m, 1H, 
H5), 2.86 (dt, J1-6eq= 4.8 Hz, J1-2= J1-6ax= 10.7 Hz, 1H, H1), 2.62 (dt, J2-3eq= 4.8 Hz, J2-3ax=10.7 Hz, 1H, H2), 2.42 (ddd, 
J6eq-5= 1.8 Hz, J6eq-6ax= 15 Hz, 1H, H6eq), 2.27 (ddd, J3eq-4= 6.7 Hz, J3eq-3ax= 15.5 Hz, 1H, H3eq), 2.06-2.02 (m, 1H, 
H3ax), 1.90 (ddd, J6ax-5=2.2 Hz, 1H, H6ax). 
1H-NMR (400 MHz, CDCl3): 
 
1,2,3,4,6-Tetra-O-acetyl-α-D-mannopiranose 4.7 
 
To a solution of mannose (5 g, 27.7 mmol) in acetic anhydride (13 mL, 138.5 mmol) under nitrogen 
atmosphere, La(OTf)3 (49 mg, 0.083 mmol) was added at 0°C. Then the mixture was stirred at room 
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temperature overnight. The reaction was monitored by TLC (1:1 Hex:EtOAc, cerium ammonium molibdate 
stain). A saturated water solution of NaHCO3 was finally added till neutral pH; the product was extracted with 
CH2Cl2 and the organic phase dried over Na2SO4. After removal of the solvent under reduced pressure, 
compound 7 (10.8 g, 27.7 mmol) was isolated in quantitative yield. 
1H-NMR (400 MHz, CDCl3): δ = 6.08 (d, J1α-2α= 1.8 Hz, 1H, H1α), 5.85 (d, J1β-2β= 1.0 Hz, 1H, H1β), 5.48 (dd, J2α-3α= 
3.25 Hz, J2α-1α= 1.2 Hz, 1H, H2α),  5.35-5.23 (m, 4H, H2β, H4β, H4α, H3α), 5.12 (dd, J3β-4β= 10.1 Hz, J3β-2β= 3.3 Hz, 
1H, H3β), 4.33-4.24 (m, 2H, H6α), 4.16-4.07 (m, 2H, H6β), 4.07-4.01 (m, 1H, H5α), 3.82-3.76 (m, 1H, H5β), 2.21-
1.99 (m, 30H, 10xOAc). 
2,3,4,6-Tetra-O-acetyl-1-S-acetyl-α-D-mannopyranose 4.8 
 
To a solution of penta-O-acetylmannopyranose 4.7 (1.021 g, 2.62 mmol) in dry CH2Cl2 (1.75 mL), thioacetic 
acid (558 μL, 7.85 mmol) was added under nitrogen atmosphere. TMSOTf (473 μL, 2.62 mmol) was added 
dropwise at 0 °C and the resulting mixture was stirred at room temperature overnight. After 15 h, TLC (2:8 
CH2Cl2:iPr2O) showed complete conversion of the starting material. The reaction mixture was diluted with 
CH2Cl2 and washed with satd aq NaHCO3 and H2O. The organic phase was dried over anhydrous Na2SO4, 
filtered and concentrated in vacuo. The crude material was purified by automated flash chromatography 
(Biotage, ULTRA column, HP samplet) (2:8 CH2Cl2:iPr2O) to afford 4.8 (723 mg, 1.78 mmol) in 68% yield. TLC: 
Rf = 0.35 (CH2Cl2:iPr2O 2:8); 1H-NMR (400 MHz, CDCl3): δ = 5.93 (d, J1-2= 1.6 Hz, 1H, H1), 5.35-5.27 (m, 2H, H4, 
H2), 5.08 (dd, J3-4= 10 Hz, J3-2= 3.2 Hz, 1H, H3), 4.26 (dd, J6a-6b= 12.4 Hz, J6a-5= 4.8 Hz, 1H, H6a), 4.05 (dd, J6b-6a= 
12.4 Hz, J6b-5= 2.4 Hz, 1H, H6b), 3.91 (ddd, J5-4= 10 Hz, J5-6a= 4.8 Hz, J5-6b= 2.4 Hz, 1H, H5), 2.41 (s, 3H, SAc), 2.16, 
2.06, 2.02, 1.97 (4 s, 4xOAc); 13C-NMR (100 MHz, CDCl3): δ = 190.3 (CO), 170.5 (CO), 169.8 (CO), 169.7 (CO), 
169.4 (CO), 80.1 (C1), 72.4 (C2), 70.9 (C3), 69.8 (C4), 65.6 (C5), 62.1 (C6), 31.2 (SAc), 20.8 (OAc), 20.6 (OAc), 
20.6 (OAc), 20.5 (OAc). 
1H-NMR (400 MHz, CDCl3): 
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13C-NMR (100 MHz, CDCl3): 
 
Synthesis compound 4.9 
 
Diethylamine (185 μL, 1.77 mmol) was added to a solution of thioacetate 4.8 (493 mg, 1.21 mmol) and 
epoxide 4.5 (200 mg, 0.93 mmol) in dry DMF (1.55 mL). The reaction mixture was stirred for 1 h, at 60°C 
under micro-wave irradiation, then diluted with EtOAc, washed with 1 M HCl and H2O. The organic phase was 
dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The crude material was purified by flash 
chromatography (4:6 Hex:EtOAc) to afford 4.9 (414 mg, 0.72 mmol) in 77% yield. TLC: Rf = 0.3 (4:6 Hex:EtOAc); 
[α]D14 (CHCl3, c 1.03)= +68; 1H-NMR (400 MHz, CDCl3): δ = 5.36 (dd, J2-3 = 3.2 Hz, J2-1= 1.5 Hz, 1H, H2), 5.33 (d, 
J1-2= 1.3 Hz, 1H, H1), 5.26 (t, J4-3= J4-5= 9.9 Hz, 1H, H4), 5.19 (dd, J3-4= 9.9 Hz, J3-2= 3.2 Hz, 1H, H3), 4.40–4.34 (m, 
1H, H5), 4.24 (dd, J6a-6b= 12 Hz, J6a-5= 6.4 Hz, 1H, H6a), 4.11 (dd, J6b-6a= 12.3 Hz, J6b-5= 2.6 Hz, 1H, H6b), 3.86–3.78 
(m, 1H, H1’), 3.71 (s, 3H, OMe), 3.69 (s, 3H, OMe), 3.22–3.14 (m, 1H, H5’), 3.10–2.98 (m, 2H, H4’, H2’), 2.40-2.30 
(m, 1H, H3’eq), 2.20–2.10 (m, 1H, H6’eq), 2.15 (s, 3H, OAc), 2.09 (s, 3H, OAc), 2.05 (s, 3H, OAc), 1.98 (s, 3H, OAc), 
Experimental section  
94 
 
1.93–1.76 (m, 2H, H3’ax, H6’ax); 1H-NMR (400 MHz, CD3OD): δ = 5.45 (d, J1-2= 1.3 Hz, 1H, H1), 5.37 (dd, J2-3 = 3.2 
Hz, J2-1= 1.5 Hz, 1H, H2), 5.24 (t, J4-3= J4-5= 9.9 Hz, 1H, H4), 5.19 (dd, J3-4= 9.9 Hz, J3-2= 3.2 Hz, 1H, H3), 4.38–4.32 
(m, 1H, H5), 4.25 (dd, J6a-6b= 12 Hz, J6a-5= 6.4 Hz, 1H, H6a), 4.12 (dd, J6b-6a= 12.3 Hz, J6b-5= 2.6 Hz, 1H, H6b), 4.0 
(m, 1H, H1’), 3.68 (s, 6H, 2xOMe), 3.20 (m, 1H, H2’), 3.05 (dt, J5’-4’= 11 Hz, J5’-6’= 5.5 Hz, 1H, H5’), 2.92 (dt, J4’-5’= 
11 Hz, J4’-3’= 3.8 Hz, 1H, H4’), 2.22–2.32 (m, 1H, H3’eq), 2.15 (s, 3H, OAc), 2.06 (s, 3H, OAc), 2.05 (s, 3H, OAc), 
2.00–2.06 (m, 1H, H6’eq) 1.97 (s, 3H, OAc), 1.88–1.97 (m, 2H, H3’ax, H6’ax); 13C-NMR (100 MHz, CDCl3): δ = 174.1 
(CO), 173.8 (CO), 170.6 (CO), 169.9 (CO), 169.7 (CO), 169.6 (CO), 82.6 (C1), 71.1 (C2), 69.5 (C5), 69.3 (C1’), 69.1 
(C3), 66.3 (C4), 62.5 (C6), 52.2 (OMe), 52.1 (OMe), 48.7 (C2’), 40.3 (C4’), 39.6 (C5’), 31.3 (C6’), 28.6 (C3’), 20.8 
(OAc), 20.6 (OAc), 20.6 (OAc), 20.5 (OAc); MS (ESI) calcd for C24H34O14S [M+Na]+ m/z: 601.16, found 601.42; 
HR-MS (ESI) calcd for C24H34O14S [M+Na]+ m/z: 601.15615, found 601.15571. 
1H NMR (400 MHz, CDCl3): 
 
1H NMR (400 MHz, CD3OD): 
 
13C NMR (100 MHz, CDCl3): 
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One-pot epoxide ring opening performed into a flow micro-reactor 
Below, only the conditions that led to the best results are reported (see Table 4.7, entry 4). 
175 mg (0.43 mmol, 1.3 equiv) of thioacetate 4.8 and 77 mg (0.36 mmol, 1 equiv) of the epoxide 4.5 were 
dissolved together in a previously sonicated dry DMF (300 μL; initial epoxide concentation 1.2 M), and 
charged into a gas-tight syringe of 500 μL, while the Et2NH (71 μL, 0.68 mmol, 1.9 equiv) dissolved in a 
previously sonicated dry DMF (300 μL) was withdrew with the second syringe. 
Micro-reactor 3222 (volume of 5 μL, depicted in the figure below) was employed: the gas-tight syringes were 
connected with the two inlet channels. The quench inlet was kept closed for all the process and the product 
4.9 was collected outside the reactor where was analysed by 1H-NMR spectroscopy, after the removal of the 
solvent under reduced pressure.  
 
Experimental details: 
concentration of the epoxide inside the micro-reactor= 0.6 M 
flow of the reactants= 0.17 μl/min 
temperature of the micro-reactor platform= 60°C 
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residence time of the reactants inside the reactor= 30 min 
conversion of 4.5 into 4.9 detected by 1H-NMR spectroscopy= 69% 
Synthesis of compound 4.12 
 
To a solution of compound 4.9 (40 mg, 0.069 mmol) in dry pyridine (150 μL), DMAP (8 mg, 0.069 mmol) and 
pivaloyl chloride (43 μL, 0.35 mmol) were added. The mixture was stirred at room temperature under 
nitrogen atmosphere. After 5 h, a second aliquot of pivaloyl chloride (25 μL, 0.21 mmol) was added. After 
reaction completion (24 h, monitored by TLC, 6:4 Hex:EtOAc) the mixture was diluted with EtOAc, washed 
with 1 M HCl, H2O and satd aq NaHCO3. The organic layer was dried over anhydrous Na2SO4 and concentrated 
under reduced pressure. Flash chromatography (6:4 Hex:EtOAc) yielded product 4.12 (27 mg, 0.041 mmol) 
in 59% yield. TLC= Rf 0.3 (6:4 Hex:EtOAc); [α]D22 (CHCl3, c 1.61)= +75; 1H-NMR (400 MHz, CDCl3): δ = 5.38 (d, 
J1-2= 1.5 Hz, 1H, H1), 5.35 (dd, J2-3= 3.2 Hz, J2-1= 1.6 Hz, 1H, H2), 5.29 (t, J4-3= 9.7 Hz, 1H, H4), 5.18 (dd, J3-4= 10.0 
Hz, J3-2= 3.3 Hz, 1H, H3), 5.08–5.04 (m, 1H, H1’), 4.36–4.27 (m, 2H, H5, H6a), 4.16–4.07 (m, 1H, H6b), 3.7 (s, 3H, 
OMe), 3.69 (s, 3H, OMe), 3.34–3.29 (m, 1H, H2’), 3.01–2.87 (m, 2H, H4’, H5’), 2.15 (s, 3H, OAc), 2.13–2.00 (m, 
10H, H3’eq, H6’eq, H3’ax, H6’ax, 2xOAc), 1.99 (s, 3H, OAc) 1.2 (s, 9H, tBu); 13C-NMR (100 MHz, CDCl3): δ = 177.0 
(CO), 174.2 (CO), 174.1 (CO), 170.5 (CO), 169.8 (CO), 169.7 (CO), 169.5 (CO), 82.9 (C1), 70.8 (C2), 69.7 (C1’), 
69.6 (C5), 69.2 (C3), 65.9 (C4), 62.3 (C6), 52.0 (OMe), 52.0 (OMe), 43.6 (C2’), 39.6 (C4’), 39.5 (C5’), 38.8 (C IV), 
28.7 (C3’), 27.9 (C6’), 27.0 (3xMe, tBu), 20.8 (OAc), 20.6 (OAc), 20.5 (OAc), 20.5 (OAc); MS (ESI) calcd for 
C29H42O15S [M+Na]+ m/z: 685.21, found 685.29. 
1H NMR (400 MHz, CDCl3): 
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13C NMR (100 MHz, CDCl3): 
 
3-Azido-2,2-dimethylpropanoyl chloride 4.16 
 
2,2-dimethyl-3-chloro-propanoic acid 4.14 (400 mg, 2.97 mmol) was dissolved in dry DMF (14.6 mL) and NaN3 
(990 mg, 15.2 mmol) was added. The mixture was stirred at 50°C under nitrogen atmosphere. After 3 days, 
the reaction was allowed to reach room temperature. The mixture was diluted with CH2Cl2 and filtered over 
a celite pad to remove unreacted NaN3 and the generated salts (NaCl). The solvent was evaporated at reduced 
pressure giving 3-azido-2,2-dimethylpropanoic acid 4.15 in quantitative yield (425 mg). 1H-NMR (400 MHz, 
CDCl3): δ = 3.42 (s, 2H, CH2), 1.25 (s, 6H, 2xCH3). 
1H NMR (400 MHz, CDCl3): 
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Acid 4.15 was used without further purification: the crude azide (143 mg, 1.00 mmol) was dissolved in fresh 
distilled CH2Cl2 (3.3 mL) and oxalyl chloride (254 μL, 2.00 mmol) was added drop wise to the solution. After 
the addition of one drop of dry DMF, the mixture was refluxed for 3 h. The solution was cooled to room 
temperature and the solvent was carefully removed in vacuo to yield 3-azido-2,2-dimethylpropanoyl chloride 
4.16. The complete conversion was confirmed by NMR analysis and the product was used in the next step 
without further purification. 1H-NMR (400 MHz, CDCl3): δ = 3.53 (s, 2H, CH2), 1.35 (s, 6H, 2xCH3).  
1H NMR (400 MHz, CDCl3): 
 
Synthesis of compound 4.17 
 
To a solution of compound 4.9 (209 mg, 0.36 mmol) in dry CH2Cl2 (2.7 mL) and Et3N (112 μL, 0.81 mmol), 
DMAP (98 mg, 0.8 mmol) was added. The solution was cooled to 0°C and the acylchloride 4.16 (131 mg, 0.81 
mmol) was added. The mixture was stirred at room temperature under nitrogen atmosphere. After reaction 
completion (2.5 h, monitored by TLC, 1:1 Hex:EtOAc) the mixture was diluted with CH2Cl2, washed with satd 
aq NaHCO3 and 1 M HCl. The organic layer was dried over anhydrous Na2SO4 and concentrated under reduced 
pressure. Flash chromatography (6:4 Hex:EtOAc) yielded product 4.17 (226 mg, 0.32 mmol) in 89% yield. TLC: 
Rf 0.5 (1:1 Hex:EtOAc); [α]D16 (CHCl3, c 1.08)= +67; 1H-NMR (400 MHz, CDCl3): δ= 5.39 (m, 1H, H1), 5.37–5.34 
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(m, 1H, H2), 5.30 (t, J4-3= 9.5 Hz, 1H, H4), 5.19 (dd, J3-4= 9.7 Hz, J3-2= 3.6 Hz, 1H, H3), 5.14–5.11 (m, 1H, H1’), 
4.37–4.30 (m, 2H, H5, H6a), 4.15– 4.07 (m, 1H, H6b), 3.71 (s, 3H, OMe), 3.71 (s, 3H, OMe), 3.42 (s, 2H, CH2N3), 
3.36–3.33 (m, 1H, H2’), 3.03–2.89 (m, 2H, H4’, H5’), 2.17 (s, 3H, OAc), 2.14–2.06 (m, 4H, H3’eq, H6’eq, H3’ax, H6’ax), 
2.18 (s, 3H, OAc), 2.05 (s, 3H, OAc), 2.00 (s, 3H, OAc), 1.23 (s, 3H, CH3), 1.23 (s, 3H, CH3); 13C-NMR (100 MHz, 
CDCl3): δ= 174.6 (CO), 174.5 (CO), 174.3 (CO), 170.8 (CO), 170.2 (CO), 170.0 (CO), 169.9 (CO), 83.3 (C1), 71.1 
(C2), 70.9 (C1’), 70.0 (C5), 69.6 (C3), 66.3 (C4), 62.6 (C6), 59.9 (CH2N3), 52.4 (2xOMe), 44.2 (C IV), 43.8 (C2’), 40.0 
(C4’), 39.9 (C5’), 29.1 (C3’), 28.2 (C6’), 23.3 (CH3), 23.3 (CH3), 21.1 (OAc), 20.9 (OAc), 20.9 (OAc), 20.9 (OAc); MS 
(ESI) calcd for C29H41N3O15S [M+Na]+ m/z: 726.2; found 726.8. 
1H NMR (400 MHz, CDCl3): 
 
 
13C NMR (100 MHz, CDCl3): 
 
General procedure for the Zemplén deacetylation 
A MeONa/MeOH solution was added to the substrate dissolved in freshly distilled MeOH under nitrogen 
atmosphere (substrate and MeONa final concentration 0.02 M) and the reaction mixture was stirred at room 
temperature. After completion, (approx. 10 min, monitored by TLC) the reaction was quenched with 
AMBERLITE IR-120 H+ till neutral pH, the resin was filtered off and the solvent was evaporated at reduced 
pressure, obtaining the pure product. 
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Synthesis of the pseudo-thio-1,2-dimannoside 4.10 
 
TLC: Rf 0.4 (8:2 CH2Cl2:MeOH); [α]D19 (MeOH, c 0.51)= +155; 1H-NMR (400 MHz, D2O): δ=  5.38 (d, J1-2= 1.5 Hz, 
1H, H1), 4.12–4.07 (m, 1H, H1’), 4.06 (dd, J2-3= 3.2 Hz, J2-1= 1.5 Hz, 1H, H2), 3.95 (ddd, J5-4= 9.0 Hz, J5-6a= 6.2 Hz, 
J5-6b= 1.9 Hz, 1H, H5), 3.85 (dd, J6a-6b= 12.4 Hz, J6a-5=  2.2 Hz, 1H, H6a), 3.77–3.71 (m, 2H, H6b, H3), 3.70 (s, 3H, 
OMe), 3.69 (s, 3H, OMe), 3.64 (t, J4-3= 9.8 Hz, 1H, H4), 3.25–3.19 (m, 1H, H2’), 3.06–2.95 (m, 2H, H5’, H4’), 2.27–
2.16 (m, 1H, H3eq), 2.11–2.03 (m, 1H, H3ax), 2.00– 1.92 (m, 2H, H6eq, H6ax); 13C-NMR (100 MHz, D2O): δ= 177.3 
(CO), 177.0 (CO), 84.9 (C1), 73.4 (C5), 71.7 (C2), 71.0 (C3), 67.7 (C1’), 67.0 (C4), 60.8 (C6), 52.6 (2xOMe), 45.4 
(C2’), 40.0 (C5’), 39.0 (C4’), 29.9 (C3’), 27.5 (C6’); HR-MS (ESI) calcd for C16H26O10S [M+Na]+ m/z: 433.11389; found 
433.11346. 
1H NMR (400 MHz, D2O): 
 
13C NMR (100 MHz, D2O): 
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Synthesis of compound 4.13 
 
TLC: Rf 0.24 (9:1 CH2Cl2:MeOH); [α]D20 (MeOH, c 1.01)= +128; 1H-NMR (400 MHz, D2O): δ= 5.41 (d, J1-2= 1.1 Hz, 
1H, H1), 5.11–5.08 (m, 1H, H1’), 4.08 (dd, J2-3= 3.3 Hz,  J2-1= 1.5 Hz, 1H, H2), 3.95 (ddd, J5-4= 9.4 Hz, J5-6a= 5.8 Hz, 
J5-6b= 2.4 Hz, 1H, H5), 3.85 (dd, J6a-6b= 12. 5 Hz, J6a-5= 2.4 Hz, 1H, H6a), 3.79–3.72 (m, 2H, H6b, H3), 3.71 (s, 3H, 
OMe), 3.70 (s, 3H, OMe), 3.69– 3.63 (m, 1H, H4), 3.42–3.38 (m, 1H, H2’), 3.05–2.92 (m, 2H, H4’, H5’), 2.23–2.01 
(m, 4H, H3’eq, H3’ax, H6’eq, H6’ax), 1.21 (s, 9H, tBu); 13C-NMR (100 MHz, D2O): δ= 180.3 (CO), 176.8 (CO), 176.8 
(CO), 85.3 (C1), 73.6 (C5), 71.7 (C2), 71.0 (C1’), 70.6 (C3), 66.8 (C4), 60.6 (C6), 52.7 (OMe), 52.7 (OMe), 42.8 (C2’), 
39.9 (C4’), 39.6 (C5’), 38.7 (C IV), 28.4 (C3’), 27.3 (C6’), 26.2 (tBu); HR-MS (ESI) calcd for C21H34O11S [M+Na]+ m/z: 
517.17140; found 517.17166. 
1H NMR (400 MHz, D2O): 
 
 
13C NMR (100 MHz, D2O): 
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Synthesis of compound 4.18 
 
TLC: Rf 0.37 (9:1 CH2Cl2:MeOH); [α]D20 (MeOH, c 0.81)= +112; 1H-NMR (400 MHz, MeOD): δ= 5.40–5.36 (m, 
1H, H1), 5.17–5.12 (m, 1H, H1’), 3.95 (dd, J2-3= 3.2 Hz, J2-1= 1.6 Hz, 1H, H2), 3.88–3.81 (m, 2H, H5, H6a), 3.75 (dd, 
J6b-6a= 12.2 Hz, J6b-5= 6.0 Hz, 1H; H6b), 3.72–3.68 (m, 1H, H4), 3.69 (s, 3H, OMe), 3.67 (s, 3H, OMe), 3.62 (dd, J3-
4= 9.2 Hz, J3-2= 3.2 Hz, 1H, H3), 3.50 (s, 2H, CH2N3), 3.43–3.38 (m, 1H, H2’), 3.00–2.89 (m, 2H, H4’, H5’), 2.19–
2.02 (m, 4H, H3’eq, H6’eq, H3’ax, H6’ax), 1.24 (s, 6H, 2xCH3); 13C-NMR (100 MHz, MeOD): δ = 176.1 (CO), 176.0 
(CO), 176.0 (CO), 87.1 (C1), 75.7 (C5), 73.6 (C2), 73.1 (C3), 72.4 (C1’), 68.5 (C4), 62.5 (C6), 60.8 (CH2N3), 52.6 
(OMe), 52.6 (OMe), 44.1 (C2’), 41.1 (C4’), 40.9 (C5’), 30.0 (C3’), 29.0 (C6’), 23.3 (CH3), 23.3 (CH3); HR-MS (ESI) 
calcd for C21H33N3O11S [M+Na]+ m/z: 558.17280; found 558.17371. 
1H NMR (400 MHz, CD3OD): 
 
 
 
13C NMR (100 MHz, CD3OD): 
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Surface Plasmon Resonance (SPR) analysis of 4.10 and 4.13 
The extracellular domain (ECD) of DC-SIGN (residues 66-404) was overexpressed and purified.6 The SPR 
experiments were performed on a BIAcore T200 using a CM3 sensor chip. Flow cells were activated as 
described.7 Flow cell one was functionalised with BSA and blocked with ethanolamine and subsequently used 
as a control surface. Flow cells 2 and 3 were treated with BSA-Mana1-3[Mana1-6]Man (Dextra) (60 lg/ml) in 
10 mM NaOAc pH 4 to reach different binding densities and blocked with ethanolamine. The final densities 
on flow cells 2 and 3 were 2579 and 2923 RU, respectively. The affinity of the various compounds for DC-
SIGN ECD were evaluated via an established inhibition assay35 in which DC-SIGN ECD was injected at 20 lM 
alone or in the presence of increasing concentration of inhibitors (ranging from 0 to 5 mM). Injections were 
performed at 5 lL/min using 25 mM Tris-HCl pH 8, 150 mMNaCl, 4 mMCaCl2, 0,05% P20 surfactant as running 
buffer. The surface was regenerated by the injection of 50 mM EDTA. 
Synthesis of multivalent systems 
Materials and methods 
Solvents were HPLC grade and used as received unless otherwise stated. Size exclusion chromatography was 
done with Sephadex LH-20 (GE Healthcare). Thin-layer chromatography (TLC) was done on silica plates. NH2-
PEG-NH2 (Mn 2135, Mp 2153 [M+Na+], Mw 2184, PDI 1.01, By MALDI-TOF), PEG di-acrylate (Mn 575), 2-[2-
(2-azidoethoxy)ethoxy]ethanol,  di-tert-butyl dicarbonate (Boc2O), 1-[bis(dimethylamino)methylene]-1H-
1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate (HATU), acryloyl chloride, 4-
Dimethylaminopyridine (DMAP), Quadrasil® MP, Tween® 80, Span® 80, ammonium persulfate (APS) and 
tetramethylethylenediamine (TEMED) were purchased from Sigam-Aldrich. Amicon Ultra-15 centrifugal 
filters (MWCO 100 KDa) were obtained from Millipore. NMR experiments were performed in a Bruker 
Advance DRX 400 instrument. NMR chemical shifts (δ) are reported in ppm downfield from the CDCl3 signal 
or the HOD peak (D2O). 2D experiments (COSY and HSQC) were performed when necessary. NMR spectra 
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were analysed with MestreNova software. Mass spectra (ESI) were recorded with an Esquire 6000 ESI-Ion 
Trap from Bruker Daltonics. 
Synthesis of compounds 4.22 and 4.23 
 
Compound 4.19 (600 mg, 2.40 mmol) was dissolved in tetraethylene glycol dichloride 4.21 (7 mL, 35.95 
mmol). Then a solution of NaOH (50%) was added (7 mL) dropwise to the mixture and tetrabutylammonim 
hydrogensulfate (NBu4HSO4, 1.63 g, 4.79 mmol) under stirring. Finally the reaction was heated up to 45°C. 
After 24 h, the mixture was allowed to reach room temperature; afterwards it was diluted with CH2Cl2, 
washed with H2O. The organic layer was recovered and dried over MgSO4, filtered and the solvent removed 
under vacuo. The purification through chromatographic column (2:1 Hex/EtOAc) afforded compound 4.23 
(1.065 g, 2.39 mmol) in 80% yield. 
The same procedure was followed for the preparation of compound 4.22 (already synthetized by the host 
group), starting from alkyne 4.19 and using the chloroethyl ether 4.20.  
1H NMR (400 MHz, CDCl3) of compound 4.23: 
 
δ= 4.12 (d, J2D-1D= 2.4 Hz, 6H, 3x2D), 3.75 (t, J7D-6D= 5.8 Hz, 2H, 7D), 3.71-3.56 (m, 14H, 3xDa, 3x5Db, 6D), 
3.52 (s, 6H, 3x3D), 3.45 (s, 2H, 4D), 2.40 (t, J=2.3 Hz, 3H, 3x1D).  
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Synthesis of compounds 4.24 and 4.25 
 
4.22 (9.5 mg, 0.027 mmol) was dissolved in 1:1 DMSO/milliQ H2O (Vf= 1.08 mL). Then TBTA (8.6 mg, 0.0162 
mmol), CuSO4·H2O (2 mg, 0.008 mmol) and Na ascorbate (4.8 mg, 0.024 mmol) and finally the 
thioglycomimetic 4.18 (50 mg, 0.093 mmol) were added in this order. The reaction proceeded under MW 
irradiation at 50°C for 30 minutes, then at room temperature over night under nitrogen atmosphere. 
Quadrasil MP was added and the mixture was stirred for 20 minutes and afterwards directly charged into a 
Sephadex LH-20 column (in MeOH) without previous filtration. The fractions were analysed by TLC 7:3 
AcCN/H2O. Compound 4.24 (45 mg, 0.023) was isolated in 87% yield. 
The same procedure was followed for the preparation of dendrimer 4.25, isolated (35 mg, 0.017 mmol) in 
85% yield.  
1H NMR (400 MHz, MeOD) of compound 4.24: 
 
δ= 7.95 (s, 3H, triazole ring), 5.42-5.39 (m, 3H, 3xH1), 5.22-5.18 (m, 1H, H1’), 4.63-4.52 (m, 12H, 3x1D, 3xCH2 
linker), 4.02-3.98 (3H, 3xH2’), 3.91-3.82 (m, 6H, 3xH6a, 3xH5), 3.81-3.41 (m, 46H, 3xH6b, 3xH4, 3x(2xOMe), 3xH3, 
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3xH2, 4x2D, 3Da, 3Db, 4D, 5D), 3.0-2.81 (m, 6H, 3xH4’, 3xH5’), 2.19-2.0 (m, 12H, 3xH3’eq, 3xH6’eq, 3xH3’ax, 3xH6’ax), 
1.30 (s, 9H, 3xCH3 linker), 1.27 (s, 9H, 3xCH3 linker). 
ESI-MS of compound 4.24: 
 
1004.64 [4.24+2Na]2+; 1986.27 [4.24+Na]+ 
1H NMR (400 MHz, MeOD) of compound 4.25: 
 
δ= 7.94 (s, 3H, triazole ring), 5.42-5.39 (m, 3H, 3xH1), 5.22-5.18 (m, 1H, H1’), 4.65-4.50 (m, 12H, 3x1D, 3xCH2 
linker), 4.01-3.93 (3H, 3xH2’), 3.91-3.81 (m, 6H, 3xH6a, 3xH5), 3.81-3.39 (m, 54H, 3xH6b, 3xH4, 3x(2xOMe), 3xH3, 
3xH2, 4x2D, 3x3Da, 3x3Db, 4D, 5D), 2.99-2.79 (m, 6H, 3xH4’, 3xH5’), 2.19-1.98 (m, 12H, 3xH3’eq, 3xH6’eq, 3xH3’ax, 
3xH6’ax), 1.29 (s, 9H, 3xCH3 linker), 1.25 (s, 9H, 3xCH3 linker). 
ESI-MS compound 4.25: 
 
1048.16 [4.25+2Na]2+; 2074.22 [4.25+Na]+ 
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Synthesis of compounds 4.26 and 4.27 
 
For both compounds 4.26 and 4.27 was followed the same protocol: the chlorinated molecule (scale about 
60 mg) was dissolved in anhydrous DMF (0.06 M). Then the NaN3 (10 eq) was added and mixture heated up 
to 60°C and stirred for 3 days. Both azido-products 4.26 and 4.27 were obtained in quantitative yield. 
ESI-MS of compound 4.26: 
 
1007.8 [4.26+2Na]2+; 1992.21 [4.26+Na]+ 
ESI-MS of compound 4.27: 
 
1051.62 [4.27+2Na]2+; 2082.31 [4.27+Na]+ 
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Preparation of the glyconanogels 
Synthesis of the “carbohydrate-derivate monomer” 4.29 
 
To a solution of the alkyne 4.28 (70 mg, 0.022 mmol) in 1:1 milliQ H2O:tBuOH (Vf= 440 μL), the other reactants 
were added in the following order: TBTA (14 mg, 0.026 mmol), CuSO4·H2O (3.3 mg, 0.013 mmol), Na ascorbate 
(13 mg, 0.066 mmol) and finally the glycomimetic 4.18 (30 mg, 0.056 mmol). The reaction proceeded at room 
temperature for 48 h under nitrogen atmosphere. Then Quadrasil MP was added and after 20 minutes under 
stirring the mixture was filtered and the solvents removed in vacuo. The final product 4.29 was isolated (58 
mg, 0.016 mmol) through Sephadex LH-20 column (in MeOH) in 72% yield. 
1H NMR (400 MHz, MeOD):  
 
δ= 7.93 (s, 1H, triazole ring), 7.45-7.3 (signals of residual TBTA), 5.57 (s, 2H, 10P), 5.41 (d, J1-2= 1.3 Hz,1H, H1), 
5.21-5.15 (m, 1H, H1’), 4.0-3.95 (m, 1H, H2), 3.92-3.81 (m, 2H, H6a, H5), 3.80-3.62 (m, H6b, H4, 2xOMe, H3, H2, 
1P, 2P, 3P, 4P, 5P, 6Pa, 6Pb, 7P, 8P), 3-52 (s, 2H, CH2N3), 3.43-3.38 (m, 1H, H2’), 3.01-2.90 (m, 2H, H4’, H5’), 
2.19-1.98 (m, 4H, H3’eq, H6’eq, H3’ax, H6’ax), 1.26 (s, 6H, 3xCH3 linker). 
The next step was the creation of the glyconanogels, through free-radical polymerization process, using 
inverse miniemulsion to template NGs formation. The formation of the miniemulsion was followed and 
confirmed by Dynamic Light Scattering (DLS). The procedure was optimized by Rojo’s group (results not 
published yet).  
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DLS analysis of the miniemulsion that showed the presence of only one population of nanoparticles 
The DLS analysis showed that the miniemulsion was composed by only one population of nano-particles, with 
a relatively narrow polydispersity. 
The polymerization took place inside the nanodroplets with the addition of an initiator and  finally, an 
extensive purification afforded the desired glycoNGs, which were characterized by DLS. The DLS analysis 
revealed the presence of particles with a hydrodynamic diameter around 100 nm and narrow size 
distribution. 
 
DLS analysis of the final NGs (on the left); comparison between hydrodinamic diameters of our NGs and the HIV 
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The diameter of these NGs was very similar to that of HIV (90-120 nm).8 We are currently waiting for the 
biological activity results obtained for these particles. 
1) W. C. Still; M. Kahn; A. Mitra, The Journal of Organic Chemistry 1978, 43, 2923-2925. 
2) T. Bravman; V. Bronner; K. Lavie; A. Notcovich; G. A. Papalia; D. G. Myszka, Analytical Biochemistry 2006, 
358, 281-288. 
3) J. J. Reina; S. Sattin; D. Invernizzi; S. Mari; L. Martinez-Prats; G. Tabarani; F. Fieschi; R. Delgado; P. M. Nieto; 
J. Rojo; A. Bernardi, ChemMedChem 2007, 2, 1030-6. 
4) P. Shu; J. Zeng; J. Tao; Y. Zhao; G. Yao; Q. Wan, Green Chemistry 2015, 17, 2545-2551. 
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CHAPTER FIVE: aziridines 
As discussed before (see Chapter 4.1.5), the pseudo-thiodisaccharide 4.10 was functionalized with a 
particularly bulky azido-linker with the aim to stabilize it against hydrolysis.1 However, the ester linkage 
remains a weak point of the molecule, as demonstrated by the partial hydrolysis of the linker under Zemplén 
conditions. For this reason, we decided to modify our synthetic strategy and examine the ring opening 
reaction of an aziridine rather than an epoxide, in order to generate an N-linked glycomimetic much more 
resistant towards hydrolysis. 
O-linked pseudo-thiodimannoside: 
 
N-linked pseudo-thiodisaccharide: 
 
The new synthetic pathway includes the formation of a free aziridine on the double bond of 4.4, followed by 
N-functionalization with an acylating agent. Finally, the one-pot trans-diaxial ring opening by α-thioacetate 
4.8 can be performed to generate the final pseudo-thiodimannoside with an amide linker.  
However, although aziridines are the nitrogen analogues of epoxides, the direct aziridation of olefins is more 
difficult and less described than the corresponding epoxidation. A key feature responsible for this situation 
is the comparative inertness of N-O and N-N bonds compared to the peroxide linkage. Aziridines have raised 
less interest amongst synthetic organic chemists than their oxygenated counterparts, because of objective 
difficulties faced not only in their synthesis, but also for their critical stability. Furthermore, oxiranes and 
aziridines show quite different reactivity and physical properties.  
In the next chapter, the chemistry of aziridines will be introduced and discussed: their structural and physical 
features will be described, as well as their biological properties, the main synthetic methods reported in 
literature, their reactivity and the most important transformations in which they have been involved so far 
(some attractive examples will be reported). 
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5.1 Aziridines: the main structural and chemical features 
Aziridines are the simplest structures belonging to the class of three-membered saturated nitrogen-
containing heterocycles. As analogues to epoxides, they are strategic precursors for the synthesis of more 
complex structures, as exemplified in Fig. 5.1.2-8 
 
Fig. 5.1 Examples of elaborations of aziridines 
Compared to acyclic aliphatic amines, the lone pair of the nitrogen of aziridines shows a greater s-character 
and this makes them less basic and weaker species as π-donors (Fig. 5.2).  
 
Fig. 5.2 Comparison between the pKa of a N-H aziridine and of an acyclic aliphatic amine 
Furthermore, the bond strain caused by the geometric constraints of the 3-membered ring makes the barrier 
to inversion at nitrogen considerably higher than in acyclic analogues. Indeed, the activation enthalpy of the 
N-inversion of an N-H aziridine is approximately 70 kJ mol-1, considerably greater than that of a typical 
secondary amine but at the same time not enough to prevent racemization at room temperature. However, 
when the nitrogen bears an electronegative substituent, that inversion barrier’s energy increases up to 112 
kJ mol-1 and two diastereomers, stable at room temperature, can be separated (Fig. 5.3).3 
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Fig. 5.3 Difference in inversion barrier’s energy between N-H aziridines (on the left) and N-Cl aziridines (on the right) 
Conventionally, depending on the nature of the N-substituent, aziridines are classified as activated, when the 
nitrogen is protected as a carbamate, a sulfonyl-amide or an amide, and non-activated, when the aziridine is 
a secondary (N-H) or a tertiary amine (N-alkyl) (Fig. 5.4).9  
 
Fig. 5.4 Examples of activated (on the left) and non-activated (on the right) aziridines 
5.2 Biological properties of aziridines 
Aziridines were found in various biologically active natural products (Fig. 5.5).10-11  
 
Fig. 5.5 Some biological compounds bearing aziridine ring 
Their in vivo potency have raised in the last 25 years an increased interest for both their synthesis and 
chemical applications.12 
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For example, an important class of these natural products is that of Mitosanes, in which the aziridine ring 
was found to be essential for the anti-tumour activity (Fig. 5.6).13-15  
 
Fig. 5.6 General structure of Mitosane, where Z is H or Me 
Another structure that presents a potent antitumoral and antibiotic activity is the Azinomycin (Fig. 5.7).16-18 
These natural products are of synthetic interest because of the unprecedented and densely functionalized 
aziridino-pyrrolidine ring system. 
 
Fig. 5.7 Structure of Azinomycin 
The activity of all of these compounds lies in their ability to act as DNA cross-linking agents through 
nucleophilic opening of the aziridine ring.  
5.3 Elaborations and applications of aziridines in organic chemistry 
From a synthetic point of view, aziridines have been studied widely in the last decades because of their 
versatility in myriad regio- and stereo-selective transformations, like ring openings, isomerizations, ring 
expansions, 1-3 dipolar cycloadditions, etc. …3, 19-25  
5.3.1 Nucleophilic ring-opening of aziridines 
The most widely exploited and studied elaboration of aziridines is their opening by nucleophilic species for 
the formation of 1,2-difunctional ring-opened products that represent common motifs in many organic 
molecules of interest. The reactivity of aziridines in ring opening reactions depends on both the ring strain 
(upon ring opening approximately 105 kJ/mol are released) and the nature of the N-substituent. Indeed the 
nitrogen atom is often modified with electron-withdrawing groups that promote ring opening through 
polarization of the C-N bond (Fig. 5.8).3 In particular, sulphonamides stand out as the most commonly utilized 
aziridine protecting groups for these kind of processes. 
 
Fig. 5.8 Polarization of the C-N bond in the presence of an EWG as N-substituent 
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In 2004 Eric Hu published a very accurate summary of all the new methodologies (developed until that 
moment) for the nucleophilic ring opening of aziridines.26 In this review, interesting and peculiar examples 
were reported, including carboanions, enamines, olefins, cyanides, alcohols, hydroxyl and carboxylate 
anions, sulphide anions, amines, azides as nucleophiles, concluding with some cases of halogen, hydrogen 
and other heteroatom nucleophilic addition of aziridines. Just to provide an idea of the huge versatility of 
this process, some examples described in Hu’s work are reported in the figure below (Fig. 5.9). 
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Fig. 5.9 Example of nucleophilic ring opening reactions of aziridines 
In almost all the cases illustrated in Hu’s review, N-acyl or N-tosyl aziridines were employed. Indeed un-
activated aziridines emerged as significantly less reactive in ring opening reactions, because of their lack of 
substituents capable to stabilize the intermediate anion formed after the nucleophilic attack.  
In 2006, Watson and co-workers reported ring opening reactions of a range of alkyl aziridines catalysed by 
tris-(pentafluorophenyl)borane (Fig. 5.10).27 The procedure worked with a variety of amines and thiols, giving 
the corresponding trans-diamines and α-aminosulphides in good yields. On the contrary, the reaction with 
alcohols under similar conditions failed to give trans-1,2-aminoethers. They also observed that the activation 
of the substrate in the absence of nucleophiles afford adducts of polymerization.  
 
Fig. 5.10 Ring opening of un-activated aziridines catalysed by B(C6F5)3 proposed by Watson et al.27 
The mechanism was also investigated: the process occurs through the formation of an aziridinium adduct 
(confirmed by NMR analysis), due to the interaction between the nitrogen atom and the borane, finally 
followed by the attack of the nucleophile (Fig. 5.11). 
 
Fig. 5.11 Mechanism proposed by Watson et al.27 for the ring opening of unactivated aziridines catalysed by B(C6F5)3  
Recently (in 2016), the regioselective aziridine opening was employed in the synthesis of β-substituted 
tryptamines, molecules that are known in pharmacology as important neurotransmitters and that contain an 
indole ring structure.28 In particular, this work described the addition of a series of indoles to 4-nitrobenzyl 
carbamate (PNZ)-protected aziridines to produce a library of tryptamine derivatives (Fig. 5.12). 
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Fig. 5.12 Addition of a series of indoles to 4-nitrobenzyl carbamate (PNZ)-protected aziridines to produce a library of tryptamine 
derivatives 
5.3.2 Possible rearrangements of the aziridine ring 
5.3.2.1 Rearrangement by ring expansion: synthesis of oxazolines 
Another chemical property of aziridines, recently exploited in the organic synthesis of heterocycles, is their 
ability to undergo rearrangement by ring expansion through an addition/elimination mechanism, producing 
oxazolines. In this process, known as “Heine’s reaction”, the attack by a nucleophilic specie on the least 
hindered carbon of the aziridine leads to the intermediate opened product that can undergo intramolecular 
ring closure generating an oxazoline (Fig. 5.13).  
 
Fig. 5.13 General scheme for the Heine’s rearrangement 
Heine originally reported a series of intramolecular aziridine rearrangements that took place in the presence 
of nucleophilic inorganic salts, such as sodium iodide.29-31 Specifically, the rearrangement of N-acylaziridines 
to oxazolines is known to occur under a range of Lewis acid and Lewis base-catalyzed conditions.32-42  
However, Heine reaction led only to a mixture of products due to the lack of regio-control during the process 
(Fig. 5.14).   
 
Fig. 5.14 Regio-selectivity problem of Heine reaction  
In 2011 (more than 50 years later than Heine’s work) Morgan and co-workers reported the regioselective 
rearrangement of N-acylaziridines to oxazolines catalysed by electron-rich phopshines (Fig. 5.15).43  
 
Fig. 5.15 Nucleophile-catalysed rearrangement of aziridines 
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The proposed mechanism for this process is reported in the figure below (Fig. 5.16). 
 
Fig. 5.16 Proposed mechanism for the nucleophile-catalysed rearrangement of aziridines 
The aziridine 5.1 undergoes nucleophilic attack at the least hindered carbon by the phosphine 5.4. The 
phosphine catalyst must be small enough to efficiently open the aziridine, but additional steric bulk around 
phosphorus may prevent non-productive decomposition of the intermediate specie 5.2. Intramolecular 
displacement of the phosphine, acted by the oxygen, leads to ring closure and to the formation of the 
oxazoline 5.3 as a single regioisomer. 
The authors of this paper demonstrated that, employing enantioenriched phosphines with the role of both 
the catalyst and the nucleophilic specie in the Heine reaction, it was possible to reach very high yields and 
levels of regioselectivity, generating a wide range of differently functionalized heterocycles (an example is 
reported in Fig. 5.17). 
        
Fig. 5.17 Application of Heine reaction for the preparation of the heterocycle 5.7 
Recently, Morgan has also proposed the first example of direct catalytic, highly enantioselective Heine 
reaction.44 In this work, highly enantioenriched oxazoline products were synthetized in a palladium(II)-
diphosphine catalysed process (Fig. 5.18). Furthermore, acylisoxazoles were identified as a novel directing 
group to generate isoxazole-based oxazoline products. 
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Fig. 5.18 Synthesis of highly enantioenriched oxazolines through the palladium(II)-diphosphine catalysed process proposed by 
Morgan et al.44 
The isomerization of aziridines was deeply investigated also by Lectka and co-workers in the early nineties. 
This work took inspiration from a previous study on the effect of metal ions on the rotational barrier in 
amides, which explained the cis-trans conformational isomerization of amides catalysed by late transition 
metals through the coordination of the nitrogen atom (Fig. 5.19).45 
 
Fig. 5.19 Cis-trans conformational isomerization of amides catalysed by late transition metals through the coordination of the 
nitrogen atom proposed by Lectka et al.45 
According to the literature available until the nineties, Lewis acids should raise the isomerization barrier 
coordinating the oxygen, which reinforces the double-bond character of the C-N bond.46 Starting from this 
assumption, for Leckta and co-workers it was reasonable to believe that the coordination of the metal to the 
nitrogen atom instead should disrupt the amide resonance and catalyse the isomerization. To prove that, 
they started screening different metal salts (such as Cu(II)), taking into account that late transition metals 
should be less oxophilic, thus favouring coordination of the N atom.  
Once this hypothesis was demonstrated, they applied the same theory to acylaziridines.41 In particular, they 
demonstrated that azaphilic Lewis acids (able to coordinate the amide nitrogen) catalysed the rearrangement 
of aziridines to the corresponding oxazolines, whereas oxophilic Lewis acids (through the coordination of the 
oxygen atom) activated the substrates towards external nucleophilic attack (Fig. 5.20).  
 
 
Fig. 5.20 Rearrangement of aziridine ring in the presence of azaphilic LAs; ring opening of acylaziridines promoted by oxophilic LAs 
For example, they observed that the TMSN3 promoted the conversion of the N-functionalized aziridines 
towards the opened product when a Lewis acid, such as oxophilic Yb(2,2’-biphenol)OTf, was present. 
Complexes of Zr and Ti were also found to catalyse the nucleophilic attack of TMSN3. When metals that are 
usually classified as more azaphilic, such as Zn, Cu and Sn were investigated, addition of the nucleophile was 
not observed, but rearrangement of acylaziridines to 2-aryloxazolines occurred. In particular, the authors 
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observed that this process proceeded smoothly at room temperature and that electron-donating N-
substituents increased the rate of reaction.  
A few years later, the same approach was employed in the synthesis of a biologically active compound by 
Tolomelli and co-workers.47 In particular, they exploited the aziridine rearrangement to build a crucial 
framework for the synthesis of the antibiotic Lysobactin. In agreement with the observations of Lectka’s 
team, the azaphilic Lewis acid BF3 led to the spontaneous ring expansion of the aziridine of 5.8 to the 
corresponding oxazoline 5.9 in almost quantitative yield (Fig. 5.21). 
 
Fig. 5.21 Spontaneous ring expansion of the aziridine of 5.8 to the corresponding oxazoline 5.9 in the presence of an azaphilic LA 
5.3.2.2 Thermal rearrangement of aziridines 
N-acylaziridines can undergo thermal rearrangement to allylamides at high temperatures (usually around 80-
90°C).48-49 The thermal behaviour of these structures was also investigated by Stogryn and Brois.50 In 
particular, they reported that divinylaziridines can be thermally ring-expanded to generate the azepine 
structure in high yields (Fig. 5.22). 
 
Fig. 5.22 Stogryn’s work (1965)50 
Stogryn noted that, upon exposure to thermal/basic conditions, the corresponding trans-divinylaziridine was 
unreactive. Explorations of thermal vinylaziridine ring expansions revealed that the nature of the nitrogen 
substituent was critical for this process. Rees51 and Lwowski52 reported that the thermolysis of N-substituted 
vinylaziridines at high temperatures yielded pyrroline products (Fig. 5.23).  
 
Fig. 5.23 Rees’work (1967, on the left)51; Lwowski’s (1968, on the right)52 
Heine demonstrated that a p-nitrobenzyl carbamate substituted aziridine afforded a 2-pyrroline product, 
presumably proceeding through an ylide intermediate.53  Heine also observed that alternate acyl groups 
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(benzoyl and thiourea) resulted in strain-assisted aza-Claisen rearrangements to form seven membered ring 
products (Fig. 5.24).54 
 
Fig. 5.24 Heine’s work53-54 
Finally, also Scheiner55 revealed that N-aryl- and N-vinyl-substituted aziridines both undergo thermal Claisen 
rearrangement to form azepine structures (Fig. 5.25).  
 
Fig. 5.25 Scheiner’s work (1967)55 
5.3.2.3 The base-promoted isomerization of aziridines to allyl amines 
In 2001 Müller and co-workers described the base-promoted desymmetrization of meso-sulfonyl aziridines 
(5.10) to generate allyl amines (5.12).56  
 
Fig. 5.26 Example of base-promoted isomerization of aziridines to allyl amines and enamines 
However, in those conditions the isomerization was not regioselective, giving a mixture of the desired allyl 
amine 5.12 and the enamine 5.11, due to an α-deprotonation (Fig. 5.26).  
Mordini and co-workers investigated the same process one year later.57 They treated a series of N-substituted 
aziridines (5.13) with superbasic mixtures (butyllithium/potassium tert-butoxide, LICKOR or lithium 
diisopropylamide/potassium tert-butoxide, LIDAKOR; Fig.5.27). 
 
Fig. 5.27 Different behaviour of N-substituted aziridines under treatment with superbasic mixtures 
While the two sulfonyl aziridines 5.13c and 5.13d underwent a regioselective rearrangement to the 
corresponding allylic sulfonyl amide 5.15c and 5.15d by treatment with LIDAKOR, the Boc- and pivaloyl 
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aziridines 5.13a and 5.13b were simply deprotected to N-H compound. After this screening, the tosyl group 
revealed to be certainly the best N-substituent in promoting the base-induced rearrangement. 
5.4 Synthesis of aziridines 
Despite all the advantages of working with aziridines, from their important role in biological processes to 
their versatility as building blocks, they have received limited application in synthesis due to several 
difficulties in their preparation and handling. 
The first example of synthesis of aziridines was reported by Wenker in 1935: he described the cyclization of 
amino alcohols to generate the three-membered ring. However his procedure afforded the free aziridine in 
low yields (Fig. 5.28).58 
 
Fig. 5.28 Wenker’s synthesis (1935)58 
Afterwards, other chemists proposed different procedures, like Hoch and Campbell with their study about 
the conversion of oximes to free-aziridines (Fig. 5.29).59-60 
 
Fig. 5.29 Hoch-Campbell synthesis 59, 61 
In subsequent years, various synthetic pathways were reported in the literature for the formation of 
aziridines. 
The main available routes involve transfer of a nitrogen atom from an aminating agent to an olefin, carbene 
and ylid addition to imines, or cyclization of 1,2-aminohalides and 1,2-azidoalcohols (Fig. 5.30).58, 61-64 
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Fig. 5.30 Various synthetic pathways for the preparation of aziridines 
So far, the most studied process is the aziridination of olefins, that is typically accomplished via metal-
mediated transfer of nitrene fragments or by 1,4-addition of nitrogen transfer reagents to electron-deficient 
olefins followed by elimination.65-71  
Nitrenes are those intermediates whose reactivity is comparable to carbenes. The nitrogen atom can present 
two free electron lone pairs (singlet electrophilic state), or the four electrons in three different orbitals, one 
filled and two semi-filled (triplet state) showing a diradical behaviour.72 
One of the most widely used nitrene source are iminoiodinanes (e.g. PhI=NTs) for the synthesis of N-sulfonyl 
aziridines. However, the main problem correlated to this reagent is the need to isolate the nitrene 
precursor.12 To overcome this issue, novel in situ procedures for the generation of the metal-nitrene active 
species have emerged, also changing the nitrogen donor with sulphonamides, sulfonimidamides and 
sulfamates in a metal-catalyzed aziridination of olefins in the presence of an oxidant (Fig. 5.31).  
 
Fig. 5.31 Metal-catalysed aziridination of olefins in the presence of an oxidant 
Recently, several tricks to make this process stereoselective have been also proposed, involving the use of 
external controller such as a catalyst, or a ligand or a simple chiral agent.12 
The N-protecting tosyl moiety has sometimes even an active role in some stereoselective aziridination 
reactions: with a bulky N-substituent, minimization of the steric repulsion could be the driving force of the 
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process, when the metal-nitrene, the ligand and the olefin are very close to each other, and thus the 
discrimination of one face/site of the olefin from the other for the formation of the aziridine can be possible.  
However, all of these procedures showed various drawbacks, such as the need for new nitrene sources to 
improve the versatility of the method and the often problematic removal of the N-substituent (usually N-
sulfonyl groups) at the end of the synthesis. In addition, the mechanisms of most of these processes are not 
completely clear yet.  
Another organic source of nitrogen are azido compounds. They can be synthetized from the corresponding 
amines and they are tolerant to a wide range of functional groups. Azides can afford the required nitrenoid 
species by simply dissociating, releasing molecular nitrogen. The only drawbacks of these compounds are in 
their preparation, that could involve several synthetic steps, and in their often low reactivity, overcome by 
using high temperatures or UV irradiation in some cases. An example of this chemistry is reported below in 
Fig. 5.32:73-75 
 
Fig. 5.32 Synthesis of aziridines by using azides as nitrogen sources 
Recently, a metal-free visible-light induced decarboxylative aza-Darzens reaction between N-aryl glycines and 
diazo compounds was reported, to generate a series of mono-substituted aziridines (Fig. 5.33).76   
 
Fig. 5.33 Metal-free visible-light inducing decarboxylative aza-Darzen reaction; the photocatalyst is the Rose Bengal (RB), the 
solvent is MeOH 
The aziridine-2-carboxylate generated represents a very interesting electrophilic scaffold for the design of 
cysteine protease inhibitors.77-83 
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Fig. 5.34 Mechanism for the aza-Darzen process, where RB is the Rose Bengal photocatalyst 
A mechanism for the aza-Darzen process was proposed (Fig. 5.34): the photoexcitacion of the rose bengal 
(RB) by visible light generates excited RB* that is quenched by N-aryl glycine to afford the cation radical 
intermediate A. The decarboxylation of A leads to the α-amino alkyl radical B which is further oxidized to give 
the iminium ion C. Deprotonation of C affords the active imine D and finally the nucleophilic addition of the 
diazo specie on the C=N bond, followed by an intramolecular nucleophilic attack (E), leads to the final 
aziridine product. 
The authors of this work investigated also the versatility and the functional group tolerance of this procedure, 
that was found to be significantly sensitive to the N-aryl glycine substituent: while EDGs, such as methoxy, 
and EWGs, such as fluoro, chloro and bromo were well tolerated (even located in different positions on the 
ring), other EWGs such as NO2 or Boc, Ts and Ac resulted not compatible with this transformation. 
5.4.1 Synthesis of N-acylaziridines 
In activated aziridines, such as N-tosyl and N-acyl aziridines, the electron-withdrawing group on the nitrogen 
facilitates the ring opening reaction, increasing the electrophilicity of the two adjacent carbons and stabilizing 
the negatively charged intermediate, generated after the nucleophilic attack. 
N-acylaziridines are considered strategic organic intermediates, deserving many efforts for the discovery and 
the optimization of new synthetic methodologies for their production. Indeed, the traditional methods 
present several drawbacks, like all the challenges associated to the possible thermal rearrangement of these 
molecules (see Chapter 5.3.2.2),84 but also the formation of by-products due to the undesired ring-opening 
processes that complicates the purification step. 
In 2013, Morgan and co-workers published a procedure that allows the gram scale synthesis of N-
acylaziridines by deprotection of N-tosylaziridines and reprotection with N-hydroxysuccinimide derivatives 
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(Fig. 5.35).85 They also demonstrated the advantage of having an electro-deficient aziridine (bearing the 3,5-
dinitrobenzoyl (DNB) as nitrogen protecting group, for example) in order to favour the ring opening by a wide 
range of nucleophiles. 
 
Fig. 5.35 Gram scale synthesis of N-acylaziridines by deprotection of N-tosylaziridines and reprotection with N-hydroxysuccinimide 
derivatives proposed by Morgan et al.85 
As described above, most of the procedures reported so far in literature have described the synthesis of N-
tosylaziridine and for this reason Morgan’s method revealed to be so efficient and useful. Furthermore, it 
allows to functionalize N-tosylaziridines directly, avoiding the isolation of the intermediate free-aziridine, 
whose stability is quite variable and thus not predictable.  
In summary… 
All of these examples demonstrate the recent efforts and the interest in the preparation of aziridines. Most 
of these methods are still limited to the synthesis of N-activated aziridines that usually bear strongly electron-
withdrawing groups on the nitrogen atom. In particular, without question N-sulfonyl activated aziridines are 
the most widely-employed class used in organic chemistry because of their relatively easy preparation and 
because of their significantly greater stability compared to the corresponding N-H compounds. The only 
significant drawback to the use of such aziridines as synthetic intermediates is the reluctance of the N-
substituent bond (sulfonammide or carbamate) to undergo cleavage using mild conditions: strongly acidic or 
reductive conditions must often be employed to liberate the amine product, which is inevitably the desired 
target of the synthetic sequence. The harsh conditions usually necessary for the deprotection could lead to 
a loss of valuable material or to the disruption of the sensitive three-membered ring. In addition to this 
additional step with all its risks and complications correlated, most of the synthetic methodologies in 
literature involves nitrogen sources generated by using strong oxidants. 
For all of these reasons, the development of new methodologies for the direct synthesis of N-H aziridines 
remains a very attractive and challenging task. 
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5.4.2 Synthesis of N-H aziridines 
Unprotected aziridines are important compounds due to their presence in various pharmacologically active 
natural products and other pharmaceutical agents with antitumor activity. 27, 86-88 They are also important 
intermediates in organic chemistry thanks for their reactivity and versatility. However, as already mentioned, 
until 2014 there were no examples available for the direct synthesis of N-H aziridines. There were instead 
some methods that describe the preparation of these compounds in more than one step. 
In 2010, Lebel and co-workers proposed a method for the stereoselective synthesis of N-H aziridines through 
copper catalysis using a chiral bis-oxazoline as the ligand.89-92  This procedure requires an electron deficient 
styrene as the starting olefin, used in large excess, and it involves tosyloxycarbamate as a cheap and stable 
nitrogen source, avoiding the use of additional oxidant (Fig. 5.36). The N-protecting group can be removed 
at the end in mild conditions (by using 5 equivalents of LiOH). 
 
Fig. 5.36 Stereoselective synthesis of N-H aziridines through copper catalysis using a chiral bis-oxazoline 5.17 as the ligand 
The carbamoyl moiety used as a protecting group could also be useful to promote nucleophilic opening of 
the aziridine ring upon N-deprotection, giving an amino-alcohol as final product (Fig. 5.37).  
 
Fig. 5.37 Nucleophilic opening of aziridine ring upon N-deprotection to give an amino-alcohol 
Katsuki and co-workers demonstrated that SESN3 is an ideal as nitrogen source, due to the easy removal of 
the corresponding SES moiety nitrogen protective group (by simple treatment with the 
tris(dimethylamino)sulfonium difluorotrimethylsilicate, TASF) (Fig. 5.38).73-75Errore. Il segnalibro non è 
definito. 
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Fig. 5.38 SESN3 used as nitrogen source in the aziridine synthesis; follows the removal of SES nitrogen protective group to give the 
free-aziridine 
Another quite old procedure is the three-step sequence proposed initially by Sweeney and by Tanner later, 
which leads to N-H aziridines from alkenes through epoxidation, ring opening with an azide and reductive 
ring closure with triphenylphosphine (Fig. 5.39).93-95 
 
Fig. 5.39 Three-step synthesis of N-H aziridines proposed by Sweeney and Tanner93-95 
Although this methodology usually provided high yields, the multi-step pathway was long and tedious.  
Only in 2014 the first procedure was published for the direct aziridination of diverse mono-, di-, tri- and tetra-
substituted olefins, through homogeneous rhodium catalysis.96 This method does not require external 
oxidants and involves the use of an hydroxylamine (the O-(2,4-dinitrophenyl)hydroxylamine, DPH) as 
aminating agent that is commercially available and quite stable when exposed to air.97 Furthermore, for this 
process the authors proposed the Du Bois’ catalyst (Rh2(esp)2), which is a dimeric rhodium dicarboxylate 
complex that can be handled in air without any special precautions and is not so expensive (100 mg/63.90 €) 
considering the low loadings required in the procedure.  After screening different reaction media (like MeCN, 
MeOH, etc. …) they selected 2,2,2-trifluoroethanol (TFE) as highly polar, hydroxylic and non-nucleophilic 
solvent (Fig. 5.40). 
 
Fig. 5.40 N-H aziridation process catalysed by Du Bois’ catalyst proposed by Falck et al.96 
In order to demonstrate the efficiency of the method, the authors explored the versatility of the N-H 
aziridation conditions and its tolerance for many functional groups located in different regions in the starting 
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materials. The procedure was found to be suitable for aliphatic substrates, bearing terminal or less accessible 
unfunctionalized double bonds, and for cyclic olefins like cyclohexene, with good yields (60-90%). 
They also examined the possible mechanisms of the process, with quantum mechanical density-functional 
theory (DFT) calculations: the most plausible pathway goes through the formation of a metal-nitrene species 
as intermediate (Fig. 5.41). Indeed, in the first step the hydroxylamine (DPH) coordinates the metal centre of 
the catalyst loosing dinitrophenol (ArO-H), giving the nitrene in a triplet-spin state (which calculations 
evaluated at 8 kcal/mol lower in energy than the open-shell singlet). However, since the catalyst and the final 
aziridine product have singlet-spin ground states, a spin interconversion is necessary after the formation of 
the first C-N bond with the alkene, generating a diradical intermediate. Afterwards, the second C-N bond is 
formed by coupling of the two free electrons without energy barriers and leading directly to the final N-H 
aziridine.  
 
Fig. 5.41 The most plausible pathway for the N-H aziridation catalysed by Du Bois’ catalyst, using DPH as aminating agent 
Although the method revealed to be really versatile, operationally simple, scalable and involving mild 
conditions and low catalyst loading, a drawback remains the nitrogen source: although DPH is air stable and 
not so expensive (1g/34 €), it is required in stoichiometric amount and its commercial sources are still limited. 
Other problems are related to its relatively short shelf life, reason why DPH has to be stored in the fridge, 
and to the toxicity of both DPH and the by-product (the 2,4-dinitrophenol released during the process) that 
could be a serious issue from an industrial application point of view. 
In 2017, Kürti (one of the authors of the above mentioned work96) and co-workers proposed an alternative 
aminating agent: hydroxylamine-O-sulfonic acid HOSA (Fig. 5.42).98  
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Fig. 5.42 Hydroxylamine-O-sulfonic acid HOSA 
This reagent presents a robust thermal stability, it is widely available and is even cheaper than DPH (5g/47 
€). Moreover, the only by-product derived from HOSA is an inorganic sulphate produced during the work-up 
that can be easily removed through aqueous extraction. Besides having solved the problems correlated to 
DPH, compared to the previous procedure this method provides shorter reaction times and a wider substrate 
scope, including cyclic and acyclic olefins that bear various functional groups, like esters, silyl ethers and 
alcohols. 
5.5 References 
1) A. Tamburrini; S. Achilli; F. Vasile; S. Sattin; C. Vives; C. Colombo; F. Fieschi; A. Bernardi, Bioorg Med Chem 
2017, 25, 5142-5147. 
2) A. Padwa; C. Murphree, Chapter 4.1 Three-membered ring systems, Elsevier: 2003; 15. 
3) J. B. Sweeney, Chem. Soc. Rev. 2002, 31, 247-258. 
4) U. M. Lindström; P. Somfai, Synthesis 1998, 1998, 109-117. 
5) J. B. Sweeney, Georg Thieme Verlag: Stuttgart: Germany, 2008; 40. 
6) B. Zwanenburg; P. ten Holte, Curr. Chem. 2001, 216, 93. 
7) P. Somfai; J. Ahman, Targets Heterocycl. Syst. 1999, 3, 341. 
8) A. Padwa, Aziridines and Azirines: Monocyclic, Elsevier: Oxford, 2008. 
9) G. E. Ham, The Journal of Organic Chemistry 1964, 29, 3052-3055. 
10) F. M. D. Ismail; D. O. Levitsky; V. M. Dembitsky, European Journal of Medicinal Chemistry 2009, 44, 3373-
3387. 
11) C. J. Thibodeaux; W.-c. Chang; H.-w. Liu, Chemical Reviews 2012, 112, 1681-1709. 
12) L. Degennaro; P. Trinchera; R. Luisi, Chem Rev 2014, 114, 7881-929. 
13) M. Kasai; M. Kono, Synlett 1992, 1992, 778-790. 
14) W. A. Remers, The Chemistry of Antitumor Antibiotics, Vol. 1, Wiley-Interscience: 1979; 1, 242. 
15) W. A. Remers; R. T. Dorr, Alkaloids: Chemical and Biological prespectives, Wiley: New York, 1988; 6, 1. 
16) T. J. Hodgkinson; M. Shipman, Tetrahedron 2001, 57, 4467-4488. 
17) R. S. Coleman; J.-S. Kong; T. E. Richardson, Journal of the American Chemical Society 1999, 121, 9088-
9095. 
18) R. S. Coleman; J. Li; A. Navarro, Angew Chem Int Ed Engl 2001, 40, 1736-1739. 
19) W. McCoull; F. A. Davis, Synthesis 2000, 2000, 1347-1365. 
20) W. Hao; X. Wu; J. Z. Sun; J. C. Siu; S. N. MacMillan; S. Lin, J Am Chem Soc 2017, 139, 12141-12144. 
21) R. Chawla; A. K. Singh; L. D. S. Yadav, RSC Advances 2013, 3, 11385-11403. 
22) J. T. Njardarson, Synlett 2013, 24, 787-803. 
23) P. Dauban; G. Malik, Angew Chem Int Ed Engl 2009, 48, 9026-9. 
24) C. Botuha; F. Chemla; F. Ferreira; A. Perez-Luna, Aziridines in natural product synthesis, Wiley-VCH: 
Weinheim, Germany, 2011;  3-39. 
25) S. Kobayashi; C. Ogawa, Science of Synthesis, Water in Organic Synthesis, Thieme, Stuttgart: 2012;  579-
599. 
26) X. E. Hu, Tetrahedron 2004, 60, 2701-2743. 
27) I. D. Watson; L. Yu; A. K. Yudin, Acc Chem Res 2006, 39, 194-206. 
28) J. Kidd; K. Maiden; J. B. Morgan, Tetrahedron 2016, 72, 3802-3807. 
29) H. W. Heine; M. E. Fetter; E. M. Nicholson, Journal of the American Chemical Society 1959, 81, 2202-2204. 
30) H. Heine; H. Bender, The Journal of Organic Chemistry 1960, 25, 461-463. 
31) H. W. Heine; D. C. King; L. A. Portland, The Journal of Organic Chemistry 1966, 31, 2662-2665. 
32) P. Thyrum; A. R. Day, Journal of Medicinal Chemistry 1965, 8, 107-111. 
Chapter five 
133 
 
33) H. W. Heine; M. S. Kaplan, The Journal of Organic Chemistry 1967, 32, 3069-3074. 
34) J. W. Lown; T. Itoh; N. Ono, Canadian Journal of Chemistry 1973, 51, 856-869. 
35) F. W. Eastwood; P. Perlmutter; Q. Yang, Journal of the Chemical Society, Perkin Transactions 1 1997, 35-
42. 
36) B. F. Bonini; M. Fochi; M. Comes-Franchini; A. Ricci; L. Thijs; B. Zwanenburg, Tetrahedron: Asymmetry 
2003, 14, 3321-3327. 
37) H. Heine; Z. Proctor, The Journal of Organic Chemistry 1958, 23, 1554-1556. 
38) T. Nishiguchi; H. Tochio; A. Nabeya; Y. Iwakura, Journal of the American Chemical Society 1969, 91, 5835-
5841. 
39) T. Nishiguchi; H. Tochio; A. Nabeya; Y. Iwakura, Journal of the American Chemical Society 1969, 91, 5841-
5846. 
40) K. Hori; T. Nishiguchi; A. Nabeya, The Journal of Organic Chemistry 1997, 62, 3081-3088. 
41) D. Ferraris; W. J. Drury; C. Cox; T. Lectka, The Journal of Organic Chemistry 1998, 63, 4568-4569. 
42) G. Cardillo; L. Gentilucci; M. Gianotti; A. Tolomelli, Tetrahedron 2001, 57, 2807-2812. 
43) A. Martin; K. Casto; W. Morris; J. B. Morgan, Organic Letters 2011, 13, 5444-5447. 
44) M. Punk; C. Merkley; K. Kennedy; J. B. Morgan, ACS Catal 2016, 6, 4694-4698. 
45) C. Cox; D. Ferraris; N. N. Murthy; T. Lectka, Journal of the American Chemical Society 1996, 118, 5332-
5333. 
46) R. Fussenegger; B. M. Rode, Chemical Physics Letters 1976, 44, 95-99. 
47) Giuliana Cardillo; Luca Gentilucci; Massimo Gianotti; A. Tolomelli, Eur J Org Chem 2000, 2489. 
48) P. E. Fanta; E. N. Walsh, The Journal of Organic Chemistry 1966, 31, 59-62. 
49) G. Szeimies; K. Mannhardt; M. Junius, Chemische Berichte 1977, 110, 1792-1803. 
50) E. L. Stogryn; S. J. Brois, The Journal of Organic Chemistry 1965, 30, 88-91. 
51) R. S. Atkinson; C. W. Rees, Chemical Communications (London) 1967, 1232a-1232a. 
52) A. Mishra; S. N. Rice; W. Lwowski, The Journal of Organic Chemistry 1968, 33, 481-486. 
53) H. W. Heine; P. G. Mente, The Journal of Organic Chemistry 1971, 36, 3076-3078. 
54) P. G. Mente; H. W. Heine; G. R. Scharoubim, The Journal of Organic Chemistry 1968, 33, 4547-4548. 
55) P. Scheiner, The Journal of Organic Chemistry 1967, 32, 2628-2630. 
56) P. Müller; C. Boléa, Helvetica Chimica Acta 2002, 85, 483-494. 
57) A. Mordini; F. Russo; M. Valacchi; L. Zani; A. Degl'Innocenti; G. Reginato, Tetrahedron 2002, 58, 7153-
7163. 
58) H. Wenker, Journal of the American Chemical Society 1935, 57, 2328-2328. 
59) J. Hoch, Compt. Rend. 1934, 198, 1865. 
60) K. N. Campbell; B. K. Campbell; J. F. McKenna; E. P. Chaput, J. Org. Chem. 1943, 8, 103. 
61) K. N. Campbell; B. K. Campbell; E. P. Chaput, The Journal of Organic Chemistry 1943, 08, 99-102. 
62) J. Jiang; H. Liu; C. D. Lu; Y. J. Xu, J Org Chem 2017, 82, 811-818. 
63) K. N. Campbell; J. F. McKenna, The Journal of Organic Chemistry 1939, 04, 198-205. 
64) Gabriel, Ber. deut. Chem. Ges. 1888, 21, 1049. 
65) Z. Li; K. R. Conser; E. N. Jacobsen, Journal of the American Chemical Society 1993, 115, 5326-5327. 
66) D. A. Evans; M. T. Bilodeau; M. M. Faul, Journal of the American Chemical Society 1994, 116, 2742-2753. 
67) P. Müller; C. Baud; Y. Jacquier, Tetrahedron 1996, 52, 1543-1548. 
68) L. A. Carpino; R. K. Kirkley, Journal of the American Chemical Society 1970, 92, 1784-1786. 
69) R. S. Atkinson; M. J. Grimshire; B. J. Kelly, Tetrahedron 1989, 45, 2875-2886. 
70) R. S. Atkinson; G. Tughan, Journal of the Chemical Society, Perkin Transactions 1 1987, 2797-2802. 
71) R. S. Atkinson; J. R. Malpass; K. L. Skinner; K. L. Woodthorpe, Journal of the Chemical Society, Perkin 
Transactions 1 1984, 1905-1912. 
72) S. Fantauzzi; A. Caselli; E. Gallo, Dalton Trans 2009, 5434-43. 
73) K. Omura; M. Murakami; T. Uchida; R. Irie; T. Katsuki, Chemistry Letters 2003, 32, 354-355. 
74) K. Omura; T. Uchida; R. Irie; T. Katsuki, Chemical Communications 2004, 2060-2061. 
75) H. Kawabata; K. Omura; T. Katsuki, Tetrahedron Letters 2006, 47, 1571-1574. 
76) Y. Liu; X. Dong; G. Deng; L. Zhou, Science China Chemistry 2016, 59, 199-202. 
77) G. Callebaut; T. Meiresonne; N. De Kimpe; S. Mangelinckx, Chem Rev 2014, 114, 7954-8015. 
Chapter five 
134 
 
78) L. Morodor; H. J. Musiol; R. Scharf, FEBS Letters 1992, 299, 51-53. 
79) D. P. Galonić; N. D. Ide; W. A. van der Donk; D. Y. Gin, Journal of the American Chemical Society 2005, 
127, 7359-7369. 
80) H. Helten; T. Schirmeister; B. Engels, The Journal of Physical Chemistry A 2004, 108, 7691-7701. 
81) T. Ishikawa, Heterocycles 2012, 85, 2837. 
82) G. Cardillo; L. Gentilucci; A. Tolomelli, Aldrichimica Acta 2003, 36, 39. 
83) W. K. Lee; H.-J. Ha, Aldrichimica Acta 2003, 36, 57. 
84) H. Heine, Mech. Mol. Migr. 1971, 3, 145-176. 
85) H. Rubin; J. Cockrell; J. B. Morgan, J Org Chem 2013, 78, 8865-71. 
86) M. Sasaki; A. K. Yudin, Journal of the American Chemical Society 2003, 125, 14242-14243. 
87) P. A. S. Lowden, Aziridine natural products - discovery, biological activity and biosynthesis, Wiley-VCH: 
WEinheim, 2006;  399-442. 
88) V. H. Dahanukar; L. A. Zavialov, Curr. Opin. Drugs. Dis. Dev. 2002, 5, 918-927. 
89) H. Lebel; M. Parmentier, Copper-catalyzed enantioselective aziridination of styrenes. In Pure and Applied 
Chemistry, 2010; Vol. 82, p 1827. 
90) H. Lebel; K. Huard; S. Lectard, Journal of the American Chemical Society 2005, 127, 14198-14199. 
91) H. Lebel; M. Parmentier; O. Leogane; K. Ross; C. Spitz, Tetrahedron 2012, 68, 3396-3409. 
92) H. Lebel; S. Lectard; M. Parmentier, Organic Letters 2007, 9, 4797-4800. 
93) H. M. I. Osborn; J. Sweeney, Tetrahedron: Asymmetry 1997, 8, 1693-1715. 
94) D. Tanner, Angewandte Chemie International Edition in English 1994, 33, 599-619. 
95) D. Tanner; P. Somfai, Tetrahedron 1988, 44, 619-624. 
96) J. L. Jat; M. P. Paudyal; H. Gao; Q. L. Xu; M. Yousufuddin; D. Devarajan; D. H. Ess; L. Kurti; J. R. Falck, 
Science 2014, 343, 61-5. 
97) Z. Yang, Synlett 2014, 25, 1186-1187. 
98) Z. Ma; Z. Zhou; L. Kurti, Angew Chem Int Ed Engl 2017, 56, 9886-9890. 
 
Chapter six 
135 
 
CHAPTER SIX: synthesis of N-linked pseudo-thiodisaccharides 
6.1 Results and discussion 
The first step of the new synthetic pathway developed to generate more hydrolytically stable thio-
glycomimetics (Fig. 6.1) consists in the N-H aziridation of the double bond of 4.4. 
 
Fig. 6.1 General approach to synthesize N-linked pseudo-thiodisaccharides: highlighted in yellow the first step of the N-H 
aziridiation of 4.4 
The method published in 2014 by Falck and co-workers was applied and optimized for olefin 4.4. Because of 
structural similarities, the procedure for cyclohexene 6.1 reported in the substrate scope of this work 
represented our starting point (Scheme 6.1).1 
 
Scheme 6.1 N-H aziridation of cyclohexene 6.1 performed by Falck et al.1 
In particular, the authors obtained aziridine 6.2 in 71% yield, after 3 hours at room temperature (25°C). No 
traces of allylic C-H amination, that would lead to the formation of 1-amino-2-cyclohexene, were detected 
by 1H-NMR analysis, in contrast with other examples reported in the literature about metal nitrene-based 
aziridiation methods.2  
6.1.1 N-H aziridation reaction of 4.4 
 
Scheme 6.2 N-H aziridation of 4.4 
Table 6.1 Optimization of the N-H aziridation conditions 
Entry [4.4] DPH Rh2(esp)2 T (C°) t 
SM:Dimer:Product 
(ratio) 
ya Notes 
1 0.1 M 1.2 eq 1 mol% 30 (rt)b 2 h 1: 1: 3.5 (36 %)  
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2 0.1 M 1.2 eq 1 mol% 25 4 h 1: 1: 6 39 %  
3 0.1 M 1.2 eq 1 mol% 20 8 h 1: 15: 51 58 %  
4 0.1 M 1.2 eq 2 mol% 24 6h 30’ 1: 12.5: 36.5 54 %  
5 0.1 M 1.2 eq 5 mol% 10-13 8 h 1: 4.5: 19.5 60 %  
6 0.1 M 1.2 eq 1 mol% 20 8 h / 36% 
scale up 
(entry 3x4) 
7 0.1 M 1.2 eq 1 mol% 10-13 8 h / 68% 
scale up 
(entry 5x4) 
a measured on the isolated product 6.3 by chromatographic column 95:5 CH2Cl2:MeOH 
b experiment performed in July (temperature not really measured) 
In the first experiment with our substrate 4.4 (entry 1), Falck’s procedure was faithfully reproduced: since 
olefin 4.4 was no more detected on the TLC plate (ninhydrin stain) after only 2 hours, the work up was done 
and the crude analysed by NMR spectroscopy. Although the main product was the desired aziridine 6.3 (as 
shown by the 1H-NMR spectrum and confirmed by MS spectroscopy) the starting material was still present 
(recognized through the identification of its diagnostic doublet of the olefinic hydrogens at 5.7 ppm). 
Furthermore, other signals associated to an unexpected side product were found and the presence of this 
impurity was also confirmed by TLC analysis (a spot of a more polar compound appeared clearly after the 
work-up). The purification step by chromatography on silica gel in 95:5 CH2Cl2: MeOH was not trivial: despite 
the slow gradient, the product was isolated as a mixture with the side product, as the NMR spectrum reported 
below (Fig. 6.2) confirmed (so the yield reported in Table 6.1, entry 1 refers to a mixture and not to the 
perfectly clean product). 
 
Fig. 6.2 1H-NMR spectrum of entry 1; highlighted in blue the diagnostic signals of the dimer (dt at 3.21 ppm and the m at 3.08 ppm), 
in red the diagnostic signals of the product (dt at 2.8 ppm and dt at 2.6 ppm) 
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After analysis of the ESI-MS data, it was hypothesized that the second specie could be the dimeric form 6.4, 
generated upon opening of the aziridine ring by a second molecule of aziridine, working as a nucleophile (Fig. 
6.3). This hypothesis could also explain the greater polarity of the new by-product spot observed on the TLC 
plate, as due to the presence of a free amine function. 
 
 
Fig. 6.3 ESI-MS spectrum of 6.4; peak at m/z= 427.59 [6.4+ H]+; peak at m/z= 874.93 [2x6.4+Na]+ 
The hypothesis was later confirmed by isolation and characterization of 6.4 using NMR spectroscopy (see 
below).   
In the original article, the authors did mention the formation of dimerization side products only as a 
possibility, without reporting any issues faced during the work-up procedure or the purification step.  
In summary, three main problems were highlighted by this first trial: the difficulty in following the 
consumption of the starting olefin, that can not be detected by TLC when its concentration becomes low. As 
a consequence (second issue), it becomes difficult to judge the reaction end point and to avoid misleading 
interpretations of the monitoring data, such as the assumption that the conversion is complete while starting 
material is still available. Finally, the third problem is in the formation of the dimer that has to be limited, 
keeping temperature, concentration and reaction time under careful control. In the second experiment 
(Table 6.1, entry 2), the temperature was maintained at 25°C and monitored until the end of the reaction. 
Furthermore, the reaction time was increased to 4 hours, trying to achieve a better conversion of the starting 
material. In this case, the consumption of the olefin was larger than before, but not complete yet. Instead, 
formation of the dimer was considerably reduced, even if in small amount (17%) it appeared again in the 
NMR of the crude. A more careful and slow chromatographic separation (95:5 CH2Cl2:MeOH) allowed the 
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isolation of both the product 6.3 (with 39% yield, Fig. 6.4) and the dimeric compound 6.4 (Fig.6.5), which, at 
this point, was fully characterized (see Experimental Section).  
 
 
Fig. 6.4 1H-NMR of the isolated product 6.3 
 
Fig. 6. 5 1H-NMR of the isolated dimer 6.4 
In the subsequent experiment (entry 3), working at lower temperature (20°C, kept with a cold-water bath) 
and leaving the reaction under stirring for 8 hours (rather than 4 h), we finally observed complete 
consumption of the olefin 4.4 (disappearance of the doublet at 5.7 ppm), while the dimer continued to be 
present, even if in a further decreased amount (15%) compared to the previous trial. However, when these 
conditions were applied in a larger scale process (entry 6, scale-up by 4-fold) the yield of aziridine 6.3 dropped 
again to 36%, while the 1H-NMR spectrum revealed the presence of the starting material and the dimer in 
1:1 ratio, besides the product. 
We went back to the small scale (about 50 mg of 4.4, 0.25 mmol), looking for reproducible conditions for this 
reaction. In entries 4 and 5, the amount of the catalyst was increased up to 2 and 5 mol% respectively, 
because the authors of this procedure, exploring the substrate scope, had noticed that a small increment of 
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the catalyst loading led to more rapid conversions at room temperature of some olefins. Taking into account 
this consideration, we tried also to decrease the reaction time (entry 4), without noticeable improvements. 
However, using 5 mol% of the catalyst, maintaining the temperature at 10-13°C (by using a bath of dry ice in 
dioxane) and quenching the reaction after 8 hours (time found to be necessary for the total conversion of 
the olefin 4.4, see entry 3), a promising yield was obtained (60%, see entry 5). 
Finally, with entry 7 we proved that the key factor affording good yields of aziridine 6.3 and avoiding product 
dimerization 6.4 is the reaction temperature, which must be kept at 10°C for 8h to achieve full conversion, 
while an increment of catalyst loading does not influence the process. Furthermore, because of the evident 
instability of the final aziridine toward dimerization, a fast and carefully work up was adopted, avoiding NMR 
analysis of the crude and performing directly the chromatographic purification. In this case, the best yield of 
the isolated product was achieved (68%) and the scale up was allowed (by 3-fold) with reproducible yields. 
6.1.2 N-acylation of the free aziridine 6.3 
One of the main advantages of working with free aziridines is their versatility, because the N atom can be 
functionalized with a wide range of organic frameworks and finally, of course, the three-membered ring can 
be opened by a variety of nucleophiles (as already described in Chapter five).  
The second step of the synthetic pathway that we developed consists in an N-acylation reaction of 6.3 (Fig. 
6.6). 
 
Fig. 6.6 General approach to synthesize N-linked pseudo-thiodisaccharides: highlighted in yellow the second step of the N-acylation 
of the free aziridine 6.3 
First of all, we tried the Boc-protection of the free nitrogen of 6.3, following the procedure reported by 
Mordini and co-workers for a similar substrate (Boc2O, TEA, DMAP at room temperature in CH2Cl2; Scheme 
6.3).3 However, in their conditions, the formation of product 6.5 was not observed.  
 
Scheme 6.3 Boc-protection of the free aziridine 6.3 
Instead, the spectrum of the crude revealed the almost complete decomposition of the starting aziridine 
(evident also on TLC), while the ESI-MS analysis suggested the presence of the dimeric form 6.6 depicted in 
Fig. 6.7. 
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Fig. 6.7 ESI-MS spectrum of the Boc-protection reaction’s crude: peak at 549.52 [6.6+Na]+; at 1074.92 [2x6.6+Na]+ 
The procedure was optimized by halving the substrate concentration (from 0.7 M to 0.35 M), decreasing the 
reaction time (from 3 to only 1 hour) and keeping the temperature at 0°C for the all process. In this way, the 
N-Boc aziridine 6.5 was obtained in 68% yield. 
To introduce an azido linker, which could allow the creation of multivalent systems, we tried acylation of 6.3 
with a commercially available acyl chloride, the 5-chlorovaleryl chloride 6.7, bearing a terminal chlorine that 
could be converted into an azide later on. The reaction was performed in standard conditions for the 
synthesis of amides, using pyridine as solvent (Scheme 6.4). 
 
Scheme 6.4 N-acylation of 6.3 with acyl chloride 6.7 
However, the desired amide product 6.8 was not observed in the crude mixture, but ESI-MS analysis allowed 
to identify the presence of compound 6.9 (Fig. 6.8) resulting from opening of the aziridine by nucleophilic 
attack of the chloride ions released during the acylation process. 
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Fig. 6.8 ESI-MS spectrum of the N-acylation of 6.3 with 6.7: peak at 390.28 [6.9+Na]+ 
The formation of similar side-products was previously reported in various literature examples (Fig. 6.9).4-6 
 
Fig. 6.9 Side opening reaction of N-acylated aziridine by nucleophilic species present in solution  
To avoid this unwanted reaction, we changed acylating agent, employing carboxylic acid 6.10 in standard 
coupling conditions (Scheme 6.5), using dicyclohexylcarbodiimide (DCC) as condensing agent.   
 
Scheme 6.5 Coupling reaction between free aziridine 6.3 and carboxylic acid 6.10 
The acylated aziridine 6.11 was isolated in 75% yield and then employed in the subsequent opening reaction 
(see below).   
To prove the validity of the method and to optimize the coupling conditions, the N-acylation reaction was 
also performed using propionic acid 6.12 (Scheme 6.6). This compound turned out to be less reactive than 
6.10 and full consumption of the starting material 6.3 required 4 h at room temperature. However, yields 
could not be established, since the N-propanoyl-aziridine 6.13 could not be fully purified by flash 
chromatography from diclyclohexylurea (DCU) that is formed in stoichiometric amount during the process. 
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Scheme 6.6 Coupling reaction between free aziridine 6.3 and carboxylic acid 6.12 
The same acylation conditions were also adopted for the reaction between 6.3 and 6.14 (Scheme 6.7), which 
is the same linker used in the synthesis of the O-linked pseudo-thiodisaccharide 4.17 (see chapter 4.2.5).  Cl-
N3 exchange at the end of the synthesis would afford the required linker. 
 
Scheme 6.7 Coupling reaction between free aziridine 6.3 and carboxylic acid 6.14 
Also in this case, the reaction led smoothly to the corresponding N-acylaziridine 6.15, that was isolated 
through flash chromatography on silica gel (1:1 Hex:EtOAc) in 67% yields.  
The olefin aziridination and acylation reactions could also be performed in “telescoped” way7, starting from 
4.4 and avoiding the isolation of the free-aziridine 6.3, but performing the acylation with 6.14 directly on the 
crude. This multistep approach  limited the decomposition of the free aziridine 6.3 (Scheme 6.8) and resulted 
in a satisfactory 52% yield over the two steps, as opposed to 40% obtained upon isolation of 6.3.  
 
Scheme 6.8 Telescoped approach for the N-H aziridation of 4.4 and the N-acylation reaction of 6.3 
This procedure allowed to scale up the transformation to 200 mg of starting alkene (by 4-fold).  
To improve the convergence of the synthetic approach, we also performed the chlorine-azide exchange at 
the beginning directly on carboxylic acid 6.14, as described in the previous chapter 4.2.5 (Scheme 6.9).  
 
Scheme 6.9 Chlorine-azide exchange on 6.14; follows the N-acylation of 6.3 through the coupling with carboxylic acid 6.16 
The resulting β-azido-acid 6.16 was then employed in the N-acylation of aziridine 6.3 using the same 
conditions developed for 6.14. DCC-coupling of 6.16 with 6.3 was sluggish, possibly because the absence of 
the strongly electronegative chlorine atom in the acylating compound reduces its reactivity. The slower 
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reaction rate also favoured the ring-opening side reaction and the presence of the dimeric form of 6.17 was 
detected by ESI-MS.  
We tried to improve the acylation process increasing the reactivity of 6.16 through activation of the 
carboxylic function as p-nitrophenyl ester 6.19 (Scheme 6.10). 
 
Scheme 6.10 Synthesis of the activated ester 6.19 
Reaction of 6.16  with  p-nitrophenol 6.18 using EDC·HCl as condensing agent afforded the activated ester 
6.19 only in 50%  yield; however 6.19  was obtained in 76% yield by reaction of 6.16 with the 4-nitrophenyl 
trifluoroacetate 6.20 (Scheme 6.11).  
 
Scheme 6.11 Optimization of the activated ester 6.19 synthesis; follows the N-acylation of 6.3 with 6.19 
Acylation of 6.3 with 6.20 afforded amide 6.17 in 60% yield with a considerable improvement compared to 
the previous experiment (Scheme 6.9). 
6.1.3 One-pot ring opening reactions 
 
Fig. 6.10 General approach to synthesize N-linked pseudo-thiodisaccharides: highlighted in yellow the one-pot ring opening of the 
N-acylated aziridines by α-hioacetate 4.8 
Opening of the N-acylaziridines 6.5, 6.11, 6.13, 6.15 and 6.17 with the mannosyl α-thioacetate 4.8 (Fig. 6.10) 
was examined using the one-pot conditions optimized for the epoxide ring opening reaction described in the 
previous chapter (4.1.3).  
The reaction performed with the N-Boc-aziridine 6.5 in DMF using an excess of Et2NH led smoothly to the 
pseudo-thiodisaccharide 6.21, isolated in excellent yield (Scheme 6.12).    
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Scheme 6.12 One-pot ring opening of aziridine 6.5 by the α-hioacetate 4.8 
On the contrary, reaction of aziridine 6.11 with 4.8 in the same conditions did not afford the expected 
glycomimetic 6.22 (Scheme 6.13).  
 
Scheme 6.13 One-pot ring opening of aziridine 6.11 by the α-hioacetate 4.8 
Rather, another specie was identified by NMR spectroscopy and with the help of the ESI-MS analysis product, 
deriving from nucleophilic displacement of the terminal chloride of 6.11 by the thiolate anion generated in 
situ from 4.8 (compound 6.23, Fig. 6.11).  
 
Fig. 6.11 ESI-MS of the crude of the ring opening reaction depicted in Scheme 6.13; peak at 1018.77 [6.23+ Na]+ 
Indeed, reaction of glycosyl thioacetates with Et2NH in DMF was used in the literature to conduct an SN2 
reaction between the thiolate anion deriving from 4.8 and primary alkyl bromides and iodides (Fig. 6.12).8 
 
Fig. 6.12 SN2 reaction between the thiolate anion deriving from 4.8 and primary alkyl iodides reported by Belz et al.8 
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As reported before, the N-propanoyl aziridine 6.13 was not completely purified from dicyclohexylurea (DCU) 
formed during the acylation process (Scheme 6.6).  However, aziridine 6.13 was successfully submitted to 
ring opening reaction with 4.8. The process allowed the formation and isolation of the thio-glycomimetic 
6.24 in 36% yield over two steps (acylation and ring opening; Scheme 6.14).  
 
Scheme 6.14 One-pot ring opening of aziridine 6.13 by the α-hioacetate 4.8 
The ring opening of 6.15 with 4.8 afforded the corresponding pseudo-thiodisaccharide 6.25 in almost 
quantitative yield (Scheme 6.15). 
 
Scheme 6.15 One-pot ring opening of aziridine 6.15 by the α-hioacetate 4.8 
This excellent result confirmed that the presence of a strong EWG, such as the terminal chlorine on the N-
substituent of 6.15, has a beneficial effect on the reactivity of the acylated aziridine toward the nucleophilic 
attack. However, treatment of thio-glycomimetic 6.25 with sodium azide in DMF, in order to replace the 
chlorine atom with the azido function, was unsuccessful and the starting material was completely recovered 
(Scheme 6.16). 
 
Scheme 6.16 Cl -> N3 exchange reaction on 6.25 
The same reaction was attempted upon deacetylation of 6.25 to afford 6.28, but neither in this case the 
formation of the desired azide was observed (Scheme 6.17). 
Chapter six 
146 
 
 
Scheme 6.17 Cl -> N3 exchange reaction on 6.27 
However, after work-up and reverse phase chromatography (1:1 H2O:MeOH) a stable new product was 
isolated in 38% yield along with unreacted starting material.  The reaction product was identified by NMR 
and MS analysis as the β-lactam 6.29 (Fig. 6.13), presumably formed upon deprotonation of the amide 
nitrogen of 6.27 by NaN3 followed by intramolecular displacement of the chlorine, leading to the four-
membered ring formation. 
 
Fig. 6.13 1H-NMR spectrum in MeOD of the β-lactam 6.29 
Performing the reaction in water, rather than DMF, the basicity of the azide anion should be dampened.  
However, also in these conditions, nucleophilic displacement of the chlorine by sodium azide did not take 
place and again the presence of the β-lactam 6.29 was observed in the ESI-MS analysis of the crude. 
Since the Cl->N3 exchange on both compounds 6.25 and 6.27 turned out not to be feasible, aziridine 6.17, 
which already carried the azido group, was employed in the one-pot reaction with thioacetate 4.8. 
Compared to the excellent reactivity observed in the same process of the corresponding chlorinated 
compound (6.15), aziridine 6.17 revealed to be much less reactive. Indeed the conversion was not complete 
(even increasing the time from 4 up to 7 hours) and the yield of the isolated product 6.26 was lower than 
50%. Furthermore, the slower reaction rate allowed the formation of the dimeric form of 6.17 that was 
identified through ESI-MS analysis of the crude mixture. 
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Scheme 6.18 One-pot ring opening of aziridine 6.17 by the α-hioacetate 4.8 performed under MW irradiation 
An improvement of the ring opening yield was observed only when the same reaction was performed under 
MW irradiation for 2 hours (68% yield, Scheme 6.18). 
Finally, an alternative pathway to exploit the versatility of these compounds was developed: indeed 
deprotection of the N-Boc thio-glycomimetic 6.21 leads to free amine 6.30 that can be functionalized with a 
wide range of different frameworks. Coupling with the activated ester 6.19 was performed and is reported 
in Scheme 6.19 as an example. 
 
Scheme 6.19 Deprotection of 6.21 by treatment with TFA and subsequent coupling with the activated ester 6.19 
Compound 6.30 could represents an interesting building block in the construction of glyco-peptido mimetics. 
6.1.4 Deacetylation of the sugar moiety and isolation of the final thioglycomimetics 
The last step of the synthesis consists in the deacetylation of the sugar moiety (Fig. 6.14). 
 
Fig. 6.14 General approach to synthesize N-linked pseudo-thiodisaccharides: highlighted in yellow the last step of selective 
deacetylation 
In the first experiment, Zemplén conditions ([6.25]f= 0.12 M, MeONa/MeOH 0.2 M) were reproduced for 
deacetylation of 6.25 (Scheme 6.20). However, this trial led to complete decomposition of the starting 
compound. ESI-MS analysis of the crude allowed to identify among the products the same β-lactam obtained 
in the azide/chlorine exchange reaction described above (Scheme 6.17). Likely this degradation was due to 
the basicity of the solution (pH range= 8.5-9.5)9 and to the proximity in pKa values between MeOH (about 
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16) and the amide function (about 15), that could lead to detrimental equilibria in solution and activate 
intramolecular nucleophilic substitution of the primary chloride.  
 
Scheme 6.20 Zemplén deacetylation of 6.25 
Base-promoted side reactions under Zemplén conditions have been frequently reported for glycopeptides10 
and milder conditions have been developed for sugar deacetylation in these situations. In particular, we  
found that treatment with a 4M MeNH2 solution in EtOH11 allowed smooth deacetylation of  6.21, 6.24, 6.25 
and 6.26 affording the final deprotected compounds 6.31, 6.32, 6.27 and 6.28 in acceptable yields (to be 
optimized; Fig. 6.15). 
 
Fig. 6.15 SPR results obtained for the final deprotected N-linked pseudo-thiodisaccharides (nd= not detectable, 6.31 completely 
insoluble) 
The DC-SIGN affinity of the final thio-glycomimetics 6.31, 6.32, 6.27 and 6.28 was tested through SPR 
inhibition assay in the same laboratory that performed the previous tests (see Chapter 4.2.6). The results 
revealed that all of these structures share very similar IC50 values compared to the analogues obtained 
through epoxide ring opening and compared also to the original pseudo-dimannoside 2.1.  
6.2 Conclusions and outlook  
A new synthetic approach was devised for the synthesis of N-linked pseudo-thiodimannnoside mimics 
designed to be stable against enzymatic and chemical hydrolysis. The general structure is shown in Fig. 6.16: 
a mannose residue is linked through a thioglycosidic bond to an aglycon, mimicking the 3D structure and 
conformation of a second mannose residue; the pseudo-anomeric position of the aglycon is functionalized 
with a nitrogen atom, which allows to tether the glycomimetic structure to linkers/scaffolds/peptide residues 
using a non-labile amide linkage.  
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Fig. 6.16 General structure of N-linked pseudo-thiodisaccharides 
The molecule was synthesized in a simple and effective way making use of an N-H aziridine substrate, as 
more reactive and versatile compounds, compared to the corresponding epoxides. 
The N-H aziridiation process through homogeneous rhodium catalysis was optimized for olefin 4.4. 
Afterwards, different solutions for the N-acylation of the free aziridine were proposed and discussed. 
The one-pot ring opening reaction of the N-acylaziridines with mannosyl α-thioacetate 4.8 was optimized, 
obtaining the corresponding pseudo-thiodisaccharides in good yields. An optimized procedure was necessary 
for the deacetylation of the sugar moiety of the all the glycomimetics to afford the final compounds ready 
for the biological tests. 
SPR inhibition assays measuring the ability of compounds 6.31, 6.32, 6.27 and 6.28 differing for the nature 
of the amide linker, to inhibit binding of DC-SIGN to immobilized Man-BSA, revealed that all of them share a 
similar DC-SIGN affinity than the previous O-linked pseudo-dimannosides reported by our laboratory. 
An attractive application for this class of molecules will be the synthesis of glicopeptido mimetics. Possible 
strategies are reported below (Fig. 6.17), where the peptide coupling can be performed at different stages 
in the synthesis: at the beginning, on the free aziridine 6.3 (there are some example in literature of this 
process, like the work of Garner and co-workers12) or in the last step on the free amine function of 6.30. 
 
Fig. 6.17 Possible alternative applications of this strategy 
Furthermore, the versatility of this methodology will be investigated, changing the sugar portion and possibly 
also the cyclohexene moiety, to generate a library of thio-glycomimetics resistant towards enzymatic activity 
and chemical hydrolysis, with the possibility of targeting other lectins than DC-SIGN. 
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6.4 Experimental section 
General methods 
Chemicals were purchased from commercial sources and used without further purification, unless otherwise 
indicated. When anhydrous conditions were required, the reactions were performed under nitrogen or argon 
atmosphere. Anhydrous solvents were purchased from Sigma-Aldrich® with a content of water ≤0.005%. 
Triethylamine (TEA), methanol and dichloromethane were dried over calcium hydride, THF was dried over 
sodium/benzophenone and freshly distilled. N,N-dimethylformamide (DMF) was dried over 4Å molecular 
sieves.  Reactions were monitored by analytical thin-layer chromatography (TLC) performed on Silica Gel 60 
F254 plates (Merck), and TLC Silica gel 60 RP-18 F254s (Merck) with UV detection (254 nm and 365 nm) and/or 
staining with ammonium molybdate acid solution, potassium permanganate alkaline solution or ninhydrin. 
Flash column chromatography was performed according to the method of Still and co-workers1 using silica 
gel 60 (40-63 μm, Merck). Automated flash chromatography was performed with Biotage Isolera Prime 
system, Biotage SNAP ULTRA cartridges were employed. Microwave irradiation was performed by a Biotage 
Initiator+ system. NMR experiments were recorded on a Bruker AVANCE-400 MHz instrument at 298 K. 
Chemical shifts (δ) are reported in ppm. The 1H and 13C NMR resonances of compounds were assigned with 
the assistance of COSY, HSQC and in some cases NOESY experiments. Multiplicities are assigned as s (singlet), 
d (doublet), t (triplet), q (quartet), quint (quintet), m (multiplet). Mass spectra were recorded on Apex II ICR 
FTMS (ESI ionization-HRMS), Waters Micromass Q-TOF (ESI ionization-HRMS) or ThermoFischer LCQ 
apparatus (ESI ionization. Specific optical rotation values were measured using a Perkin-Elmer 241, at 589 
nm in a 1 dm cell. The following abbreviations are used: DCC (N,N’-dicyclohexylcarbodiimide), DCM (CH2Cl2 
dichloromethane), m-CPBA (meta-chloroperoxybenzoic acid), DMF (N, N’-dimethylformamide), DMAP (4-
dimethylaminopyridine), TBTA (tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine), TFA (trifluoroacetic acid), 
DPH (2,4-dinitrophenylhydroxylamine), Rh2(esp)2 (Du Boi’s catalyst). 
SPR (Surface Plasmon Resonance) studies were carried out using a ProteOn XPR36 Protein Interaction Array 
Apparatus (Bio-Rad Laboratories, Hercules, CA). The instrument is characterized by six parallel flow channels 
that can immobilize up to six ligands on the same sensor chip.2 Mannosylated Bovine Serum Albumin (Man-
BSA, Dextra Laboratories, Reading, UK) was immobilized, as a reference, in a parallel different channel. 
Immobilization levels were typically 3000 and 4000 resonance units (RU, 1RU 1 pg protein/mm2), 
respectively. 
Synthesis of aziridine 6.3 
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The reaction was performed in a previously well-dried glassware after flushing with Ar. Olefin 4.4 (150 mg, 
0.76 mmol) was dissolved in CF3CH2OH (7.6 ml, 0.1 M) and transferred to the flask under Ar. Then the catalyst 
(5.8 mg, 1 mol%) and finally the DPH (181 mg, 1.2 mmol) were added to the solution at 10-13°C. This 
temperature was kept using a dioxane-dry ice bath for all the reaction time (8 h). Afterwards, the mixture 
was diluted with CH2Cl2 (10 mL) and then washed with a 15% NaHCO3 solution (10 mL). After two extraction 
with CH2Cl2 the organic phase was collected, washed with brine and finally dried over Na2SO4, filtered and 
concentrated under reduced pressure. Chromatographic purification (95:5 CH2Cl2:MeOH) afforded aziridine 
6.3 (110 mg, 0.52 mmol) in 68% yield. TLC: Rf 0.2 (95:5 CH2Cl2:MeOH, ninhydrin stain). MS (ESI) calcd for 
C10H15NO4 [M + H]+ m/z: 214.11; found: 214.11. 
1H NMR (400 MHz, CDCl3): = 3.66 (s, 3H, OMe), 3.64 (s, 3H, OMe), 2.78 (dt, J1-6ax= J1-2=  11.6 Hz, J1-6eq= 4.6 
Hz, 1H, H1), 2.54 (dt, J2-3ax= 11.4 Hz, J2-3eq= 6.5 Hz, 1H, H2), 2.39-2.33 (m, 4H, H3eq, H6eq, H4, H5), 1.86-1.72 (m, 
2H, H3ax, H6ax); 13C NMR (100 MHz, CDCl3): = 175.9 (C=O), 175.0 (C=O ), 51.9 (OMe), 51.9 (OMe), 41.3 (C2), 
38.2 (C1), 29.7 (C4), 28.0 (C6), 27.5 (C3), 27.2 (C5). 
1H NMR (400 MHz, CDCl3): 
 
13C NMR (100 MHz, CDCl3): 
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Characterization of the dimer 6.4 
 
Table 6.1, entry 2 (Chapter 6.1.1): 6.4 was isolated by chromatographic column (9:1 CH2Cl2:MeOH; TLC: Rf 
0.4, ninhydrin stain). 
1H NMR (400 MHz, CDCl3): = 3.71-3.64 (m, 12H, OMe), 3.21 (dt, J1-6ax= J1-2=  9.9 Hz, J1-6eq= 4.4 Hz, 1H, H1), 
3.10-3.01 (m, 2H, H2, H4), 2.80 (dt, J10-9ax= J10-11=  10.3 Hz, J10-9eq= 5 Hz, 1H, H10), 2.52 (dt, J11-12ax= J11-12=  10.3 
Hz, J11-12eq= 6.3 Hz, 1H), 2.34-2.14 (m, 3H, H12eq, H9eq, H3eq), 1.96-1.66 (m, 3H, H12ax, H6eq, H6ax, H9ax, H3ax), 1.66-
1.60 (m, 1H, H7), 1.37-1.31 (m, 1H, H5); 13C NMR (100 MHz, CDCl3): = 175.9 (CO), 175.70 (CO), 175.3 (CO), 
174.9 (CO), 69.4 (C5), 52.2 (2xOMe), 52.1 (2xOMe), 50.0 (C4), 41.1 (C1), 40.1 (C10), 39.5 (C2), 39.0 (C11), 38.6 
(C7), 34.5 (C8), 31.7 (C6), 28.4 (C3), 27.9 (C9), 27.2 (C12). TLC: Rf 0.39 (9:1 CH2Cl2:MeOH, permanganate stain); 
MS (ESI) calcd for C20H30N2O8 [M + H]+ m/z: 427.21; found: 427.59. 
1H NMR (400 MHz, CDCl3): 
 
13C NMR (100 MHz, CDCl3): 
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Synthesis of the Boc-aziridine 6.5 
 
To a solution of the free aziridine 6.3 (22 mg, 0.1 mmol) dissolved in freshly distilled CH2Cl2 under N2 
atmosphere, DMAP (a few crystals) was added. The mixture was cooled to 0°C and Et3N (freshly distilled, 85 
μl, 0.62 mmol) and Boc2O (118 μL, 0.516 mmol) were added. After 1 h under stirring at 0°C, the reaction was 
allowed to reach room temperature, then quenched with H2O. The resulting mixture was diluted with a 
saturated solution of NH4Cl; the aqueous phase extracted twice with Et2O. The organic layers were washed 
with saturated solutions of KHSO4, Na2CO3 and NaCl in this order and finally dried over Na2SO4, filtered and 
concentrated in vacuum. Purification by flash chromatography (7:3 Hex:EtOAc)  afforded the t-
butylcarbamate 6.5 (22 mg, 0.07 mmol) as a yellow liquid in 68% yield. TLC: Rf 0.33 (7:3 Hex:EtOAc, 
permanganate stain). MS (ESI) calcd for C15H23NO6 [M + Na]+ m/z: 336.14; found: 336.18. 
1H NMR (400 MHz, CDCl3): = 3.66 (s, 3H, OMe), 3.65 (s, 3H, OMe), 2.82 (dt, J1-6ax= J1-2=  11.2 Hz, J1-6eq= 4.5 
Hz, 1H, H1), 2.71-2.67 (m, 1H, H5),  2.64-2.59 (m, 1H, H4), 2.54 (dt, J2-3ax= 11.6 Hz, J2-3eq= 6.5 Hz, 1H, H2), 2.45 
(ddd, J6eq-6ax= 14.2 Hz, J6eq-1= 4.6 Hz, J6eq-5= 1.6 Hz, 1H, H6eq), 2.35 (dt, J3eq-3ax= 14.9 Hz, J3eq-2= 6.7 Hz, 1H, H3eq), 
1.95 (ddd, J3ax-3eq= 15 Hz, J3ax-4= 11.8 Hz, J3ax-2= 0.6 Hz, 1H, H3ax), 1.74 (ddd, J6ax-6eq= 14.5 Hz, J6ax-5= 11.4 Hz, J6ax-
1= 2.9 Hz, 1H, H6ax), 1.43 (s, 9H, H7); 13C NMR (100 MHz, CDCl3): = 175.4 (CO), 174.5 (CO), 162.3 (CO, 
carbamate), 52.0 (2xOMe), 40.8 (C2), 38.3 (C1), 37.0 (C5), 34.5 (C4), 28.0 (tBu), 27.5 (C6), 26.3 (C3). 
1H NMR (400 MHz, CDCl3): 
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13C NMR (100 MHz, CDCl3): 
 
Synthesis of acyl-aziridine 6.11 
 
To a solution of the free aziridine 6.3 (32 mg, 0.15 mmol) in dry THF (750 μl, 0.2 M), 3-chloropropionic acid 
(19.5 mg, 0.18 mmol) and DCC (37 mg, 0.18 mmol) were added at room temperature. After 2.5 h, the white 
precipitate was filtered over celite, washing with CH2Cl2 and finally the solvents were removed under reduced 
pressure. Amide 6.11 (34 mg, 0.11 mmol) was isolated through a chromatographic column 1:1 (Hex:EtOAc)  
in 75% yield. TLC: Rf 0.3 (1:1 Hex:EtOAc, permanganate stain); MS (ESI) calcd for C13H18ClNO5 [M + Na]+ m/z: 
326.09 (100%), 328.07 (32%); found: 326.38, 328.37. 
1H NMR (400 MHz, CDCl3): = 3.77 (t, J8-7= 6.4 Hz, 2H, CH2Cl), 3.68 (s, 3H, OMe), 3.67 (s, 3H, OMe), 2.91-2.78 
(m, 5H, H4, H5, H1, CH2-linker), 2.64 (ddd, J2-3ax= J2-1= 11.1 Hz, J2-3eq= 6.6 Hz, 1H, H2), 2.44 (ddd, J6eq-6ax= 14.3 Hz, 
J6eq-5=  4.2 Hz, J6eq-1= 1.3 Hz, 1H, H6eq), 2.36 (dt, J3eq-3ax= 14.8 Hz, J3eq-2=  J3eq-4= 6.4 Hz, 1H, H3eq), 2.03 (ddd, J3ax-
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3eq= 15.1 Hz, J3ax-4= 10.8 Hz, J3ax-2= 0.7 Hz, 1H, H3ax), 1.88 (ddd, J6ax-6eq= 14 Hz, J6ax-5= 10.2 Hz, J6ax-1= 0.9 Hz, 1H, 
H6ax). 
1H NMR (400 MHz, CDCl3): 
 
Synthesis of acyl-aziridine 6.13 
 
The free aziridine 6.3 (23 mg, 0.11 mmol) was dissolved in dry THF (550 μl, 0.2 M). Then propionic acid (9 μl, 
0.12 mmol) and DCC (27 mg, 0.13 mmol) were added in this order at room temperature under stirring. After 
4 h, DCU was filtered over celite, washing with CH2Cl2 and finally the solvents were evaporated under reduced 
pressure. Purification by flash chromatography (1:1 Hex:EtOAc) afforded compound 6.13 contaminated by 
residual DCU. TLC: Rf 0.38 (1:1 Hex:EtOAc, ninhydrin stain); MS (ESI) calcd for C13H19NO5 [M + H]+ m/z: 270.13; 
found: 270.25. 
Although compound 6.13 was not perfectly clean, assignment of the proton signals was possible and it is 
reported below. The N-acylaziridine 6.13 was employed in the next step without further purification. 
1H NMR (400 MHz, CDCl3): = 3.67 (s, 3H, OMe), 3.66 (s, 3H, OMe), 2.85 (dt, J1-6ax= J1-2=  10.7 Hz, J1-6eq= 4.9 
Hz, 1H, H1), 2.77-2.72 (m, 1H, H4), 2.7-2.64 (m, 1H, H5), 2.64-2.57 (m, 1H, H2), 2.47-2.30 (m, 2H, H6eq, H3eq), 
2.40 (dd, J7a-7b= 15 Hz, J7a-8= J7b-8= 7.6 Hz, 2H, CH2 linker), 2.00 (ddd, J3ax-3eq= 14.6 Hz, J3ax-4= 11 Hz, J3ax-2= 0.9 Hz, 
1H, H3ax), 1.85 (ddd, J6ax-6eq= 14 Hz, J6ax-5= 11 Hz, J6ax-1= 3.2 Hz, 1H, H6ax), 1.14 (t, J8-7a= J8-7b= 7.7 Hz, CH3 linker).  
1H NMR (400 MHz, CDCl3): 
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Below: on the top (in red) 1H spectrum of DCU, on the bottom (in blue) fractions isolated with compound 
6.13. 
 
Synthesis of acyl-aziridine 6.15 
 
The free aziridine 6.3 (28 mg, 0.13 mmol) was dissolved in freshly distilled THF (650 μl). 3-Chloro-2,2-
dimethylpropionic acid 6.14 (21 mg, 0.157 mmol) and DCC (32 mg, 0.157 mmol) were added in this order at 
room temperature and under nitrogen. After 4 h under stirring, the mixture was filtered over celite and 
washed with CH2Cl2. Flash chromatography (1:1 Hex:EtOAc) afforded the amide 6.15 (29 mg, 0.087 mmol) in 
67% yield. TLC: Rf 0.4 (1:1 Hex:EtOAc, permanganate stain); MS (ESI) calcd for C15H22ClNO5 [M + Na]+ m/z: 
354.12 (100%), 356.11 (33%); found: 354.43, 356.41. 
1H NMR (400 MHz, CDCl3): = 3.69 (s, 3H, OMe), 3.67 (s, 3H, OMe), 3.61 (AB system, Japp= 14.7 Hz, 2H, CH2Cl), 
2.93-2.82 (m, 3H, H4, H5, H1), 2.67 (dt, J2-3ax= J2-1= 10.1 Hz, J2-3eq= 6.6 Hz, 1H, H2), 2.44 (ddd, J6eq-6ax= 14.5 Hz,  
J6eq-1= 4.8 Hz, J6eq-5= 1.3 Hz, 1H, H6eq), 2.48-2.31 (m, 1H, H3eq), 2.02 (ddd, J3ax-3eq= 14.5 Hz, J3ax-2= 10.4 Hz, J3ax-4= 
1 Hz, 1H, H3ax), 1.9 (ddd, J6ax-6eq= 14 Hz, J6ax-5= 11 Hz, J6ax-1= 3.3 Hz, 1H, H6ax), 1.34 (s, 6H, 2xCH3 linker); 13C NMR 
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(100 MHz, CDCl3): = 188.7 (CO amide), 174.9 (CO), 174.3 (CO), 52.0 (CH2Cl), 52.0 (2xOMe), 40.4 (C2), 38.1 
(C4), 36.7 (C5), 34.0 (C1), 29.6 (CMe2)26.4 (C6), 25.5 (C3), 24.1, 23.9 (2xCH3 linker). 
1H NMR (400 MHz, CDCl3): 
 
13C NMR (100 MHz, CDCl3): 
 
Synthesis of acyl-aziridine 6.17 
 
Using DCC: 
To a solution of 6.3 (38 mg, 0.178 mmol) in dry THF (890 μl, 0.2 M) carboxylic acid 6.16 (31 mg, 0.213 mmol) 
was added and then the DCC (44 mg, 0.213 mmol). After 3 hours under stirring, the mixture was filtered over 
celite and washed with CH2Cl2. The chromatographic column afforded compound 6.17 (18 mg, 0.053 mmol) 
in 30% yield.  
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Using the activated ester 6.19: 
to a solution of aziridine 6.3 (39 mg, 0.18 mmol) in dry DMF (720 μL, 0.25 M) and pyridine (18 μL) the activated 
ester 6.19 (63 mg, 0.24 mmol) was added. The reaction proceeded at 60°C under stirring for 3 h. The mixture 
was cooled to room temperature and then solvent and pyridine were removed under reduced pressure. Flash 
chromatography (1:1 Hex:EtOAc) allowed to isolate compound 6.17 (36 mg, 0.11 mmol) in 70% yield. 
TLC: Rf 0.38 (1:1 Hex:EtOAc, permanganate stain); MS (ESI) calcd for C15H22N4O5 [M + Na]+ m/z: 361.15; found: 
361.61. 
1H NMR (400 MHz, CDCl3): = 3.69 (s, 3H, OMe), 3.67 (s, 3H, OMe), 3.43 (AB system, Japp= 14.7 Hz, 2H, CH2N3), 
2.90-2.79 (m, 3H, H1, H5, H4), 2.66 (dt, J1-6ax= J1-2=  10.6 Hz, J1-6eq= 6.7 Hz, 1H, H2), 2.44 (ddd, J6eq-6ax= 14.3 Hz,  
J6eq-1= 4.8 Hz, J6eq-5= 1.3 Hz, 1H, H6eq), 2.36 (ddd, J3eq-3ax= 15 Hz, J3eq-2= 6.9 Hz, J3eq-4= 6.4 Hz, 1H, H3eq), 2.01 (ddd, 
J3ax-3eq= 14.9 Hz, J3ax-2= 10.7 Hz, J3ax-4= 0.6 Hz, 1H, H3ax), 1.26 (s, 6H, 2 CH3 linker); 13C NMR (100 MHz, CDCl3): 
= 189.5 (CO amide), 175.1 (CO), 174.4 (CO), 60.3 (CH2N3), 52.2 (OMe), 52.1 (OMe), 40.5 (C2), 38.3 (C1), 36.9 
(C5), 34.2 (C4), 29.8 (C(CH3)2 linker), 26.6 (C6), 25.7 (C3), 23.9 (CH3 linker), 23.7 (CH3 linker). 
1H NMR (400 MHz, CDCl3): 
 
13C NMR (100 MHz, CDCl3): 
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Synthesis of the activated ester 6.19 
 
To a solution of the carboxylic acid 6.16 (311 mg, 2.17 mmol) in dry DMF (7.2 ml, 0.3 M) the p-nitro 
trifluoacetate 6.20 (766 mg, 3.25 mmol) was added and finally the dry pyridine (350 μl). The mixture was 
then warmed up to 60°C and left under stirring over night. The day after, the reaction was allowed to reach 
room temperature and then solvent and pyridine were removed under vacuum. Compound 6.19 (435 mg, 
1.65 mmol) was isolated in 76% yield through a chromatographic column. TLC: Rf 0.4 (8:2 Hex:EtOAc, 
permanganate stain, UV light). 
1H NMR (400 MHz, CDCl3): = 8.28 (d, J= 8.9 Hz, 2H, Har), 7.27 (d, J= 9.2 Hz, 2H, Har), 3.57 (s, 2H, CH2N3), 1.4 
(s, 6H, 2xCH3); 13C NMR (100 MHz, CDCl3): = 173.5 (CO), 155.5 (Car), 145.6 (Car), 125.3 (2xCHar), 122.5 
(2xCHar), 59.59 (CH2), 44.4 (C(CH3)2), 23.03 (2xCH3).  
1H NMR (400 MHz, CDCl3): 
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13C NMR (100 MHz, CDCl3): 
 
Synthesis of the pseudo-disaccharide 6.21 
 
Thioacetate 4.8 (37 mg, 0.09 mmol) and the N-Boc aziridine 6.5 (22 mg, 0.07 mmol) were dissolved in dry 
DMF (108 μl, 0.65M) under nitrogen atmosphere. Et2NH (14 μl, 0.13 mmol) was added to the mixture and 
the reaction was left stirring at room temperature for 4 h. The mixture was diluted with EtOAc and washed 
with HCl solution (1 M). The aqueous phase was extracted twice with EtOAc and finally the organic layers 
were collected, dried over Na2SO4, filtered and concentrated in vacuum. Falsh chromatography (1:1 
Hex:EtOAc) led to the isolation of compound 6.21 (39 mg, 0.06 mmol) in 82% yield. TLC: Rf 0.33 (1:1 
Hex:EtOAc, cerium ammonium molibdate stain); [α]𝐷
19 (CHCl3, c 1.95): + 59; MS (ESI) calcd for C29H43NO15S [M 
+ Na]+ m/z: 700.24; found: 701.01. 
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1H NMR (400 MHz, CDCl3): = 5.4-5.34 (m, 2H, H1, H2), 5.3 (dd, J4-5= 10.2 Hz, J4-3= 9.75 Hz, 1H, H4), 5.21 (dd, 
J3-4= 9.75 Hz, J3-2= 2.9 Hz ,1H, H3), 4.8-4.7(m, 1H, NH), 4.44-4.29 (m, 2H, H5, H6a), 4.17-4.07 (m, 1H, H6b), 3.95-
3.83 (m, 1H, H4’), 3.71 (s, 3H, OMe), 3.70, (s, 3H, OMe), 3.31-3.21 (m, 1H, H1’), 3.09-3.00 (m, 1H, H5’), 2.88-
2.77 (m, 1H, H2’), 2.21-1.95 (m, 3H, H6’eq, H3’eq, H6’ax), 2.16 (s, 3H, OAc), 2.08 (s, 3H, OAc), 2.04 (s, 3H, OAc), 
1.98 (s, 3H, OAc), 1.91-1.80 (m, 1H, H3’ax), 1.43 (s, 9H, tBu); 13C NMR (100 MHz, CDCl3): = 173.7 (CO), 173.7 
(CO), 170.6 (CO), 169.9 (CO), 169.9 (CO), 169.7 (CO), 169.6 (CO, carbammate), 82.1 (C1), 80.0 (CIV Boc), 70.9 
(C2), 69.4 (C3), 69.3 (C5), 66.1 (C4), 62.5 (C6), 52.3 (OMe), 52.2 (OMe), 49.0 (C4’), 44.5 (C1’), 39.9 (C5’, C2’),29.7 
(C6’), 29.1 (C3’), 28.3 (tBu), 20.9 (OAc), 20.7 (OAc), 20.7 (OAc), 20.6 (OAc). 
1H NMR (400 MHz, CDCl3): 
 
13C NMR (100 MHz, CDCl3): 
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Synthesis of the pseudo-disaccharide 6.24 
 
To a solution of the thioacetate 4.8 (29 mg, 0.072 mmol) and the aziridine 6.13 (15 mg, 0.056 mmol; sample 
contaminated by DCU) in dry DMF (85 μl), EtNH2 (11 μl, 0.106 mmol) was added. After 4 hstirring at room 
temperature, the reaction mixture was diluted with EtOAc and then washed with HCl solution (1 M). The 
aqueous layers were extracted twice with EtOAc and finally the organic phase was collected, dried over 
Na2SO4, filtered and concentrated under vacuum. Compound 6.24 (25 mg, 0.039 mmol) was isolated by flash 
chromatography (4:6 Hex:EtOAc) (36% yield over two steps). [α]𝐷
16 (CHCl3, c 1.05): + 59; TLC: Rf 0.14 (4:6 
Hex:EtOAc, cerium ammonium molibdate stain); MS (ESI) calcd for C27H39NO14S [M + Na]+ m/z: 656.20; found: 
656.60. 
1H NMR (400 MHz, CDCl3): = 5.82-5.74 (m, 1H, NH), 5.39 (d, J1-2= 1.3 Hz, 1H, H1), 5.34 (dd, J2-3= 3.5 Hz, J2-1= 
1.3 Hz, 1H, H2), 5.29 (t, J4-3= J4-5= 9.7 Hz ,1H, H4), 5.20 (dd, J3-4= 9.7 Hz, J3-2= 3.5, 1H, H3), 4.41-4.29 (m, 2H, H5, 
H6a), 4.22-4.07 (m, 2H, H4’, H6b),3.71 (s, 3H, OMe), 3.69, (s, 3H, OMe), 3.40-3.25 (m, 1H, H5’), 3.1-3.02 (m, 1H, 
H1’), 2.88-2.79 (m, 1H, H2’), 2.23-1.95 (m, 5H, CH2-linker,H3’eq, H6’eq, H6’ax), 2.15 (s, 3H, OAc), 2.07 (s, 3H, OAc), 
2.04 (s, 3H, OAc), 1.98 (s, 3H, OAc), 1.92-1.82 (m, 1H, H3ax), 1.13 (t, JCH3-CH2= 7.9 Hz, 3H, CH3-linker); 13C NMR (100 
MHz, CDCl3): = 174.5 (CO), 173.7 (CO), 173.3 (CO), 170.8 (CO), 170.0 (CO), 169.9 (CO), 169.7 (CO), 82.0 (C1), 
71.0 (C2), 69.5 (C3), 69.5 (C5), 66.3 (C4), 62.6 (C6), 52.4 (OMe), 52.3 (OMe), 48.0 (C4’), 43.9 (C5’), 40.1 (C1’), 39.9 
(C2’),  29.8 (CH2 linker), 29.1 (C6’), 28.7 (C3’), 21.0 (OAc), 20.8 (OAc), 20.7 (OAc), 20.7 (OAc), 9.7 (CH3 linker). 
 
1H NMR (400 MHz, CDCl3): 
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13C NMR (100 MHz, CDCl3): 
 
Synthesis of the pseudo-thiodisaccharide 6.25 
 
To a solution of thioacetate 4.8 (46 mg, 0.11 mmol) and aziridine 6.15 (29 mg, 0.09 mmol) in dry DMF (138 
μl, 0.65 M), EtNH2 (18 μl, 0.17 mmol) was added. After 4 h  stirring at room temperature, the reaction mixture 
was diluted with EtOAc and washed with a solution of HCl (1 M); the aqueous phase extracted twice with 
EtOAc; finally the organic layer was collected, dried over Na2SO4, filtered and concentrated under reduced 
pressure. Flash chromatography (ELUANT) allowed to isolate compound 6.25 (60 mg, 0.086 mmol) in 96% 
yield. [α]𝐷
19 (CHCl3, c 1.22): + 55; TLC: Rf 0.2 (Hex/EtOAc 1:1, cerium ammonium molibdate stain); MS (ESI) 
calcd for C29H42ClNO14S [M + Na]+ m/z: 718.19; found: 718.66. 
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1H NMR (400 MHz, CDCl3): = 5.96-5.89 (m, 1H, NH), 5.41 (d, J1-2= 0.9 Hz, 1H, H1), 5.34 (dd, J2-3= 3.5 Hz, J2-1= 
1.6 Hz, 1H, H2), 5.29 (t, J4-3= J4-5= 9.7 Hz ,1H, H4), 5.20 (dd, J3-4= 9.9 Hz, J3-2= 3.3, 1H, H3), 4.42-4.30 (m, 2H, H5, 
H6a), 4.21-4.07 (m, 2H, H4’, H6b),3.72 (s, 3H, OMe), 3.70, (s, 3H, OMe), 3.58 (AB system, Japp= 10.7 Hz, 2H, 
CH2Cl), 3.33-3.27 (m, 1H, H5’), 3.08 (ddd, J1’-2’= 13.5 Hz, J1’-6’ax= 8.8 Hz, J1’-6’eq= 5.34 Hz, 1H, H1’), 2.87-2.78 (m, 
1H, H2’), 2.23 (ddd, J3’eq-3’ax= 14.1 Hz, J3’eq-2’= 10 Hz, J3’eq-4’= 4.4 Hz, 1H, H3’eq), 2.18-1.94 (m, 2H, H6’eq, H6’ax), 2.15 
(s, 3H, OAc), 2.07 (s, 3H, OAc), 2.04 (s, 3H, OAc), 1.97 (s, 3H, OAc), 1.92-1.82 (m, 1H, H3’ax), 1.28 (s, 3H, CH3 
linker), 1.27 (s, 3H, CH3 linker); 13C NMR (100 MHz, CDCl3): = 174.34 (CO), 174.22 (CO), 173.56 (CO), 170.76 
(CO), 169.94 (CO), 169.83 (CO), 169.72 (CO), 81.80 (C1), 70.95 (C2), 69.52 (C3), 69.44 (C5), 66.26 (C4), 62.59 
(C6), 60.4 (C(CH3)2 linker), 52.82 (CH2 linker), 52.42 (OMe), 52.29 (OMe), 48.16 (C4’), 43.67 (C5’), 40.21 (C1’), 
40.03 (C2’), 29.35 (C6’), 28.76 (C3’), 23.63 (CH3 linker), 23.37 (CH3 linker), 20.96 (OAc), 20.77 (OAc), 20.73 (OAc), 
20.66 (OAc). 
1H NMR (400 MHz, CDCl3): 
 
13C NMR (100 MHz, CDCl3): 
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Synthesis of the pseudo-thiodisaccharide 6.26 
 
Thioacetate 4.8 (78 mg, 0.19 mmol) and aziridine 6.17 (50 mg, 0.15 mmol) were dissolved in dry DMF (250 
μl, 0.6 M) into a MW-reactor. After addition of EtNH2 (30μl, 0.28 mmol), the reaction was stirred at 60°C 
under MW irradiation for 2 h. After that, the mixture was diluted with EtOAc and washed with a HCl solution 
(1 M). The aqueous phase was extracted twice with EtOAc and finally the organic layers collected were dried 
over Na2SO4, filtered and the solvents removed under vacuum. Compound 6.26 (72 mg, 0.10 mmol) was 
isolated through flash chromatography (1:1 Hex:EtOAc) in 68% yield. [α]𝐷
18 (CHCl3, c 1.55): + 69; TLC: Rf 0.27 
(1:1 Hex:EtOAc, cerium ammonium molibdate stain); MS (ESI) calcd for C29H42N4O14 [M + Na]+ m/z: 725.23; 
found: 725.66. 
1H NMR (400 MHz, CDCl3): = 6.09-5.99 (m, 1H, NH), 5.41 (d, J1-2= 1.1 Hz, 1H, H1), 5.33 (dd, J2-3= 3.3 Hz, J2-1= 
1.1 Hz, 1H, H2), 5.29 (t, J4-3= 10.0 Hz ,1H, H4), 5.20 (dd, J3-4= 10.0 Hz, J3-2= 3.3, 1H, H3), 4.42-4.29 (m, 2H, H5, 
H6a), 4.18-4.08 (m, 2H, H4’, H6b), 3.72 (s, 3H, OMe), 3.71 (s, 3H, OMe), 3.40 (AB system, Japp= 15.0 Hz, 2H, 
CH2N3), 3.29-3.23 (m, 1H, H5’), 3.08 (ddd, J1’-2’= 12.6 Hz, J1’-6’ax= 8.8 Hz, J1’-6’eq= 4.21 Hz, 1H, H1’), 2.90-2.80 (m, 
1H, H2’), 2.28-2.18 (m, H3’eq), 2.18-2.00 (m, 2H, H6’eq, H6’ax), 2.15 (s, 3H, OAc), 2.07 (s, 3H, OAc), 2.04 (s, 3H, 
OAc), 1.97 (s, 3H, OAc), 1.92-1.80 (m, 1H, H3’ax), 1.20 (2xs, 6H, 2xCH3 linker); 13C NMR (100 MHz, CDCl3): = 
175.0 (CO), 174.2 (CO), 173.5 (CO), 170.7 (CO), 169.9 (CO), 169.8 (CO), 169.7 (CO), 81.8 (C1), 71.0 (C2), 69.5 
(C3), 69.5 (C5), 66.3 (C4), 62.6 (C6), 60.0 (CH2N3), 52.4 (OMe), 52.3 (OMe), 48.0 (C4’), 43.9 (C5’), 40.2 (C1’), 40.1 
(C2’), 29.5 (C6’), 28.9 (C3’), 23.4 (CH3 linker), 23.4 (CH3 linker), 20.1 (OAc), 20.7 (OAc), 20.7 (OAc), 20.7 (OAc). 
1H NMR (400 MHz, CDCl3): 
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13C NMR (100 MHz, CDCl3): 
 
 
General method for the deacetylation of the sugar moiety 
The substrates were dissolved in a MeNH2/EtOH solution (4 M) in order to have a final solution 0.05 M of the 
substrate, at room temperature and under stirring. After 4 h, the solvent and the unreacted MeNH2 were 
removed under reduced pressure. The reactions were monitored by reverse-phase TLC (eluents based on 
different ratios of H2O/MeOH, see below for individual compounds). The products were isolated from the N-
methylacetamide (MeNHCOMe) generated during the process using automated flash chromatography 
(Biotage Isolera Prime, SNAP Ultra HP-Sphere C18 cartridges) in reverse phase (isocratic elution, 1:1 
H2O:MeOH). 
Synthesis of the pseudo-thiodisaccharide 6.31 
 
Scale: 19 mg of 6.21, 0.028 mmol. 
Reaction time: 4 h.  
Isolated product (6.31): 10 mg, 0.02 mmol.  y= 70%  
[α]𝐷
18 (MeOH, c 0.5): + 113; RP TLC: Rf 0.24 (1:1 H2O:MeOH, cerium ammonium molibdate stain); MS (ESI) 
calcd for C21H35NO11S [M + Na]+ m/z: 532.18; found: 532.51; HR-MS (ESI) calcd for C21H35NO11S [M+Na]+ m/z: 
532.1829; found 532.1835. 
1H NMR (400 MHz, CD3OD): = 5.34 (d, J1-2= 1 Hz, 1H, H1), 3.96-3.81 (m, 4H, H2, H5, H4’, H6a), 3.78-3.71 (dd, 
J6a-6b= 12.5 Hz, J6b-5= 5.8 Hz, 1H, H6b), 3.68 (s, 3H, OMe), 3.68 (s, 3H, OMe), 3.66-3.59 (m, 2H, H4, H3), 3.24-3.17 
(m, 1H, H5’), 3.06-2.94 (m, 2H, H1’, H2’), 2.25-2.11 (m, 1H, H6’eq),  2.11-1.97 (m, 2H, H6’ax, H3’eq), 1.9-1.8 (m, 1H, 
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H3’ax), 1.45 (s, 9H, tBu); 13C NMR (100 MHz, CD3OD): = 176.1 (CO), 176.0 (CO), 157.2 (CO, carbammate), 86.4 
(C1), 80.4 (CIV Boc),75.4 (C5), 73.8 (C2), 73.2 (C3), 68.8 (C4), 62.9 (C6), 52.5 (2xOMe), 50.7 (C4’), 46.0 (C5’), 41.5 
(C1’), 41.0 (C2’), 30.3 (C6’), 30.3 (C3’), 28.8 (Me3). 
1H NMR (400 MHz, CD3OD): 
 
13C NMR (100 MHz, CD3OD): 
 
Synthesis of the pseudo-thiodisaccharide 6.32 
 
Scale: 21 mg (6.24), 0.033 mmol. 
Reaction time: 4 h. 
Isolated product (6.32): 7.9 mg, 0.017 mmol.  y= 52% 
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[α]𝐷
20 (MeOH, c 0.4): + 128; TLC: Rf 0.43 (85:15 CH2Cl2:MeOH, cerium ammonium molibdate stain); HR-MS 
(ESI) calcd for C19H31NO10S [M + Na]+ m/z: 488.1566; found: 488.1564.  
1H NMR (400 MHz, CD3OD): = 5.35 (d, J1-2= 1.1 Hz, 1H, H1), 4.19-4.12 (m, 1H, H4’), 3.95-3.82 (m, 3H, H2, H5, 
H6a), 3.73 (dd, J6a-6b= 11.8 Hz, J6b-5= 6.3 Hz, 1H, H6b), 3.69 (s, 3H, OMe), 3.69 (s, 3H, OMe), 3.70-3.59 (m, 2H, 
H4, H3), 3.24-3.18 (m, 1H, H5’), 3.11-2.97 (m, 2H, H1’, H2’), 2.24 (q, J= 7.7 Hz, 2H, CH2CH3), 2.19-2.01 (m, 3H, 
H6’eq, H6’ax, H3’eq), 1.89-1.80 (m, 1H, H3’ax), 1.12 (t, J= 8 Hz, 3H, CH2CH3-); 13C NMR (100 MHz, CD3OD): = 176.7 
(CO), 175.9 (CO), 175.9 (CO), 86.4 (C1), 75.5 (C5), 73.7 (C2), 73.1 (C4), 68.8 (C3), 62.9 (C6), 52.5 (OMe), 52.5 
(OMe), 49.4 (C4’), 45.4 (C5’), 41.5 (C1’), 41.0 (C2’), 30.4 (C6’), 29.9 (C3’), 29.9 (CH2CH3), 10.4 (CH2CH3). 
1H NMR (400 MHz, CD3OD): 
 
13C NMR (100 MHz, CD3OD): 
 
Experimental section 
170 
 
Synthesis of the pseudo-thiodisaccharide 6.27 
 
Scale: 22 mg (6.25), 0.032 mmol. 
Reaction time: 3 h. 
Isolated product (6.27): 10.5 mg, 0.02 mmol.  y= 62%  
[α]𝐷
20 (MeOH, c 0.47): + 110; RP TLC: Rf 0.31 (1:1 H2O:MeOH, cerium ammonium molibdate stain); HR-MS 
(ESI) calcd for C21H34ClNO10S [M + Na]+ m/z: 550.1490; found: 550.1495. 
1H NMR (400 MHz, CD3OD): = 5.34 (d, J1-2= 1.2 Hz, 1H, H1), 4.1 (ddd, J4’-3’ax= 8.2 Hz, J4’-3’eq= 7.3 Hz, J4’-5’= 4.2 
Hz, 1H, H4’), 3.93-3.82 (m, 3H, H5, H2, H6a), 3.77-3.56 (m, 5H, H6b, H4, H3, CH2Cl), 3.72 (s, 3H, OMe), 3.71 (s, 3H, 
OMe), 3.22-3.15 (m, 2H, H5’, H2’), 3.15-3.09 (m, 1H, H1’), 2.34 (ddd, J6’eq-6’ax= 14.4 Hz, J6’eq-1’= 7.7 Hz, J6’eq-5’= 3.6 
Hz, 1H, H6’eq), 2.19-2.10 (m, 1H, H3’eq), 2.02 (ddd, J6’ax-6’eq= 14.2 Hz, J6’ax-5’= 8.1 Hz, J6’ax-1’= 4.3 Hz, 1H, H6’ax), 1.88 
(ddd, J3’ax-3’eq= 14.2 Hz, J3’ax-4’= 7.7  Hz, J3’ax-2’= 4.7 Hz, 1H, H3’ax), 1.28 (s, 6H, 2x CH3 linker); 13C NMR (100 MHz, 
CD3OD): = 177.2 (CO), 175.7 (CO), 175.6 (CO), 85.3 (C1), 75.5 (C5), 73.9 (C2), 73.3 (C3), 68.9 (C4), 63.0 (C6), 
53.5 (CH2Cl), 52.8 (OMe), 52.7 (OMe), 49.9 (C4’), 45.1 (C5’), 42.0 (C1’), 41.6 (C2’), 31.4 (C6’), 30.5 (C3’), 24.0 (CH3 
linker), 23.8 (CH3 linker).  
1H NMR (400 MHz, CD3OD): 
 
13C NMR (100 MHz, CD3OD): 
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Characterization of the β-lactam side product 6.29 
 
1H NMR (400 MHz, CD3OD): = 5.37 (d, J1-2= 1.3 Hz, 1H, H1), 3.91 (dd, J2-3= 3 Hz, J2-1= 1.3 Hz, 1H, H2), 3.89-3.77 
(m, 2H, H5, H4’, H6a), 3.76-3.56 (m, 3H, H6b, H3, H4), 3.72 (s, 3H, OMe), 3.71 (s, 3H, OMe), 3.39-3.32 (m, 1H, H5’), 
3.18 (AB system, Japp= 15.7 Hz,2H, CH2 ß–lactam), 3.15-3.06 (m, 2H, H1’, H2’), 2.38-2.26 (m, 1H, H6’eq), 2.13-
2.07 (m, 2H, H3’eq, H3’ax), 2.03 (ddd, J6’ax-6’eq= 14.2 Hz, J6’ax-5’= 7.6 Hz, J6’ax-1’= 4 Hz, 1H, H6’ax), 1.3 (s, 3H, CH3 ß–
lactam), 1.27 (s, 3H, CH3 ß–lactam); 13C NMR (100 MHz, CD3OD): = 176.5 (CO), 175.4 (CO), 175.4 (CO), 85.4 
(C1), 75.7 (C5), 73.7 (C2), 73.1 (C3), 68.7 (C4), 62.8 (C6), 53.7 (CH2 ß–lactam), 52.7 (OMe), 52.7 (OMe), 50.3 (C4’), 
43.7 (C5’), 41.6 (C1’), 41.6 (C2’), 31.5 (C6’), 28.7 (C3’), 21.3 (CH3 ß–lactam), 21.3 (CH3 ß–lactam). MS (ESI) calcd 
for C21H33NO10S [M + Na]+ m/z: 514.17; found: 514.91. 
1H NMR (400 MHz, CD3OD): 
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13C NMR (100 MHz, CD3OD): 
 
Synthesis of the pseudo-thiodisaccharide 6.28 
 
Scale: 31 mg (6.26), 0.044 mmol. 
Reaction time: 3 h. 
Isolated product (6.28): 16 mg, 0.03 mmol. y= 68% 
[α]𝐷
16 (MeOH, c 0.55): + 105; TLC: Rf 0.21 (9:1 CH2Cl2:MeOH, cerium ammonium molibdate stain); HR-MS (ESI) 
calcd for C21H34N4O10S [M + Na]+ m/z: 557.1893; found: 557.1899.  
1H NMR (400 MHz, CD3OD): = 5.34 (d, J1-2= 1.2 Hz, 1H, H1), 4.1 (ddd, J4’-3’ax= 8.1 Hz, J4’-3’eq= 7.7 Hz, J4’-5’= 4.1 
Hz, 1H, H4’), 3.93-3.82 (m, 3H, H5, H2, H6a), 3.78-3.67 (m, 1H, H6b), 3.72 (s, 3H, OMe), 3.72 (s, 3H, OMe), 3.67-
3.57 (m, 2H, H4, H3), 3.44 (AB system, Japp= 15.7 Hz, 2H, CH2N3), 3.22-3.08 (m, 3H, H5’, H1’, H2’), 2.34 (ddd, J6’eq-
6’ax= 14.3 Hz, J6’eq-1’= 7.7 Hz, J6’eq-5’= 3.8 Hz, 1H, H6’eq), 2.15 (ddd, J3’eq-3’ax= 14 Hz, J3’eq-2’= 7 Hz, J3’eq-4’= 4 Hz, 1H, 
H3’eq), 2.02 (ddd, J6’ax-6’eq= 14.3 Hz, J6’ax-5’= 7.9 Hz, J6’ax-1’= 4.4 Hz, 1H, H6’ax), 1.88 (ddd, J3’ax-3’eq= 14.1 Hz, J3’ax-4’= 
7.8  Hz, J3’ax-2’= 4.6 Hz, 1H, H3’ax), 1.21 (s, 6H, 2x CH3 linker); 13C NMR (100 MHz, CD3OD): = 177.9 (CO), 175.6 
(CO), 175.6 (CO), 85.3 (C1), 75.5 (C5), 73.9 (C2), 73.3 (C3), 68.9 (C4), 63.0 (C6), 61.1 (CH2N3 ), 52.7 (2xOMe), 49.5 
(C4’), 45.2 (C5’), 42.0 (C1’), 41.6 (C2’), 31.4 (C6’), 30.5 (C3’), 23.8 (CH3 linker), 23.5 (CH3 linker). 
1H NMR (400 MHz, CD3OD): 
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13C NMR (100 MHz, CD3OD): 
 
Synthesis of the pseudo-thiodisaccharide 6.30 
 
1H NMR (400 MHz, CDCl3): = 5.45-5.5.20 (m, 3H, H1, H2, H4), 5.12-5.07 (m, 1H, H3), 4.33-4.09 (m, 3H, H5, H6a, 
H6b), 3.73 (s, 3H, OMe), 3.71 (s, 3H, OMe), 3.58-3.42 (m, 1H, H4’), 3.4-3.25 (m, 2H, H1’, H5’), 3.22-3.14 (m, 1H, 
H2’), 2.6-2.48 (m, 2H, H6’eq, H3’eq), 2.2-1.88 (m, 14H, 4xOAc, H6’ax, H3’ax); 13C NMR (100 MHz, CDCl3): = 172.9 
(CO), 172.6 (CO), 171.2 (CO), 170.1 (CO), 170.0 (CO), 169.7 (CO), 81.8 (C1), 70.8 (C2), 70.0 (C5), 69.3 (C3), 6.9 
(C4), 62.5 (C6), 52.6 (2xOMe), 51.35 (C4’), 44.3 (C5’), 40.6 (C2’), 39.6 (C1’), 29.8 (C6’), 29.6 (C3’), 20.8 (OAc), 20.7 
(OAc), 20.6 (OAc), 20.5 (OAc). 
MS (ESI) calcd for C24H35NO13S [M + H]+ m/z: 578.19; found: 578.10 (1154= [2M+H]+) 
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1H NMR (400 MHz, CDCl3): 
 
13C NMR (100 MHz, CDCl3): 
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